SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Morgan Stanley – ‘10-Q’ for 9/30/20

On:  Tuesday, 11/3/20, at 4:07pm ET   ·   For:  9/30/20   ·   Accession #:  895421-20-527   ·   File #:  1-11758

Previous ‘10-Q’:  ‘10-Q’ on 8/4/20 for 6/30/20   ·   Next:  ‘10-Q’ on 5/3/21 for 3/31/21   ·   Latest:  ‘10-Q’ on 11/3/23 for 9/30/23   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/03/20  Morgan Stanley                    10-Q        9/30/20  144:41M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   5.43M 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML   1.10M 
 3: EX-10.1     Material Contract                                   HTML     71K 
 4: EX-15       Letter re: Unaudited Interim Financial Info         HTML     49K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     46K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     46K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     42K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     42K 
15: R1          Cover Page                                          HTML    117K 
16: R2          Consolidated Income Statements (Unaudited)          HTML    125K 
17: R3          Consolidated Comprehensive Income Statements        HTML     71K 
                (Unaudited)                                                      
18: R4          Consolidated Balance Sheets                         HTML    125K 
19: R5          Consolidated Balance Sheets (Parenthetical)         HTML     71K 
20: R6          Consolidated Statements of Changes in Total Equity  HTML     94K 
                (Unaudited)                                                      
21: R7          Consolidated Cash Flow Statements (Unaudited)       HTML    129K 
22: R8          Introduction and Basis of Presentation              HTML     50K 
23: R9          Significant Accounting Policies                     HTML     73K 
24: R10         Acquisitions                                        HTML     45K 
25: R11         Cash and Cash Equivalents                           HTML     50K 
26: R12         Fair Values                                         HTML    912K 
27: R13         Fair Value Option                                   HTML    112K 
28: R14         Derivative Instruments and Hedging Activities       HTML    469K 
29: R15         Investment Securities                               HTML    308K 
30: R16         Collateralized Transactions                         HTML    174K 
31: R17         Loans, Lending Commitments and Related Allowance    HTML    338K 
                for Credit Losses                                                
32: R18         Other Assets - Equity Method Investments            HTML     59K 
33: R19         Deposits                                            HTML     58K 
34: R20         Borrowings and Other Secured Financings             HTML     63K 
35: R21         Commitments, Guarantees and Contingencies           HTML    139K 
36: R22         Variable Interest Entities and Securitization       HTML    285K 
                Activities                                                       
37: R23         Regulatory Requirements                             HTML    172K 
38: R24         Total Equity                                        HTML    363K 
39: R25         Interest Income and Interest Expense                HTML     84K 
40: R26         Income Taxes                                        HTML     53K 
41: R27         Segment, Geographic and Revenue Information         HTML    307K 
42: R28         Significant Accounting Policies (Policies)          HTML     84K 
43: R29         Cash and Cash Equivalents (Tables)                  HTML     48K 
44: R30         Fair Values (Tables)                                HTML   1.25M 
45: R31         Fair Value Option (Tables)                          HTML    105K 
46: R32         Derivative Instruments and Hedging Activities       HTML    479K 
                (Tables)                                                         
47: R33         Investment Securities (Tables)                      HTML    309K 
48: R34         Collateralized Transactions (Tables)                HTML    180K 
49: R35         Loans, Lending Commitments and Related Allowance    HTML    337K 
                for Credit Losses (Tables)                                       
50: R36         Other Assets - Equity Method Investments (Tables)   HTML     58K 
51: R37         Deposits (Tables)                                   HTML     58K 
52: R38         Borrowings and Other Secured Financings (Tables)    HTML     63K 
53: R39         Commitments, Guarantees and Contingencies (Tables)  HTML    120K 
54: R40         Variable Interest Entities and Securitization       HTML    291K 
                Activities (Tables)                                              
55: R41         Regulatory Requirements (Tables)                    HTML    168K 
56: R42         Total Equity (Tables)                               HTML    432K 
57: R43         Interest Income and Interest Expense (Tables)       HTML     85K 
58: R44         Income Taxes (Tables)                               HTML     51K 
59: R45         Segment, Geographic and Revenue Information         HTML    316K 
                (Tables)                                                         
60: R46         Significant Accounting Policies - Narrative         HTML     62K 
                (Details)                                                        
61: R47         Acquisitions - Narrative (Details)                  HTML     73K 
62: R48         Cash and Cash Equivalents - Summary (Details)       HTML     51K 
63: R49         Fair Values - Assets and Liabilities Measured at    HTML    222K 
                Fair Value on a Recurring Basis (Details)                        
64: R50         Fair Values - Detail of Loans and Lending           HTML     61K 
                Commitments at Fair Value and Unsettled Fair Value               
                of Futures Contracts (Details)                                   
65: R51         Fair Values - Activity of Level 3 Assets and        HTML    190K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
66: R52         Fair Values - Valuation Techniques and Sensitivity  HTML    346K 
                of Unobservable Inputs Used in Level 3 Fair Value                
                Measurements (Details)                                           
67: R53         Fair Values - Fund Interests Measured Based on Net  HTML     63K 
                Asset Value (Details)                                            
68: R54         Fair Values - Assets and Liabilities Measured at    HTML     82K 
                Fair Value on a Nonrecurring Basis (Details)                     
69: R55         Fair Values - Financial Instruments Not Measured    HTML    110K 
                at Fair Value (Details)                                          
70: R56         Fair Value Option - Borrowings Measured at Fair     HTML     55K 
                Value on a Recurring Basis (Details)                             
71: R57         Fair Value Option - Net Revenues from Borrowings    HTML     48K 
                under the Fair Value Option (Details)                            
72: R58         Fair Value Option - Gains (Losses) Due to Changes   HTML     61K 
                in Instrument-Specific Credit Risk (Details)                     
73: R59         Fair Value Option - Difference Between Contractual  HTML     46K 
                Principal and Fair Value (Details)                               
74: R60         Fair Value Option - Fair Value Loans on Nonaccrual  HTML     44K 
                Status (Details)                                                 
75: R61         Derivative Instruments and Hedging Activities -     HTML    178K 
                Fair Values of Derivative Contracts (Details)                    
76: R62         Derivative Instruments and Hedging Activities -     HTML    109K 
                Notionals of Derivative Contracts (Details)                      
77: R63         Derivative Instruments and Hedging Activities -     HTML     83K 
                Gains (Losses) on Accounting Hedges and Fair Value               
                Hedges (Details)                                                 
78: R64         Derivative Instruments and Hedging Activities -     HTML     54K 
                Credit Risk-Related Contingencies (Details)                      
79: R65         Derivative Instruments and Hedging Activities -     HTML    102K 
                Maximum Potential Payout/Notional of Credit                      
                Protection Sold (Details)                                        
80: R66         Derivative Instruments and Hedging Activities -     HTML     58K 
                Fair Value Asset/(Liability) of Credit Protection                
                Sold (Details)                                                   
81: R67         Derivative Instruments and Hedging Activities -     HTML     54K 
                Protection Purchased with CDS (Details)                          
82: R68         Investment Securities - AFS and HTM Securities      HTML    109K 
                (Details)                                                        
83: R69         Investment Securities - Narrative (Details)         HTML     49K 
84: R70         Investment Securities - Investment Securities in    HTML     89K 
                an Unrealized Loss Position (Details)                            
85: R71         Investment Securities - Investment Securities by    HTML    185K 
                Contractual Maturity (Details)                                   
86: R72         Investment Securities - Gross Realized Gains        HTML     46K 
                (Losses) on Sales of AFS Securities (Details)                    
87: R73         Collateralized Transactions - Offsetting of         HTML    108K 
                Certain Collateralized Transactions (Details)                    
88: R74         Collateralized Transactions - Gross Secured         HTML     85K 
                Financing Balances (Details)                                     
89: R75         Collateralized Transactions - Assets Loaned or      HTML     47K 
                Pledged (Details)                                                
90: R76         Collateralized Transactions - Collateral Received   HTML     44K 
                (Details)                                                        
91: R77         Collateralized Transactions - Securities            HTML     41K 
                Segregated for Regulatory Purposes (Details)                     
92: R78         Collateralized Transactions - Customer Margin       HTML     41K 
                Lending (Details)                                                
93: R79         Loans, Lending Commitments and Related Allowance    HTML     94K 
                for Credit Losses - Loans by Type (Details)                      
94: R80         Loans, Lending Commitments and Related Allowance    HTML    136K 
                for Credit Losses - Loans Held for Investment                    
                before Allowance by Origination Year (Details)                   
95: R81         Loans, Lending Commitments and Related Allowance    HTML     76K 
                for Credit Losses - Past Due Status of Loans Held                
                for Investment before Allowance (Details)                        
96: R82         Loans, Lending Commitments and Related Allowance    HTML     53K 
                for Credit Losses - Nonaccrual Loans Held for                    
                Investment before Allowance (Details)                            
97: R83         Loans, Lending Commitments and Related Allowance    HTML     45K 
                for Credit Losses - Troubled Debt Restructurings                 
                (Details)                                                        
98: R84         Loans, Lending Commitments and Related Allowance    HTML    108K 
                for Credit Losses - Allowance for Credit Losses                  
                Rollforward - Loans and Lending Commitments                      
                (Details)                                                        
99: R85         Loans, Lending Commitments and Related Allowance    HTML     60K 
                for Credit Losses - Employee Loans (Details)                     
100: R86         Other Assets - Equity Method Investments -          HTML     48K  
                Balances (Details)                                               
101: R87         Other Assets - Equity Method Investments - Joint    HTML     45K  
                Ventures (Details)                                               
102: R88         Deposits - Summary (Details)                        HTML     49K  
103: R89         Deposits - Time Deposit Maturities (Details)        HTML     54K  
104: R90         Borrowings and Other Secured Financings -           HTML     55K  
                Borrowings (Details)                                             
105: R91         Borrowings and Other Secured Financings - Other     HTML     47K  
                Secured Financings (Details)                                     
106: R92         Commitments, Guarantees and Contingencies -         HTML     82K  
                Commitments (Details)                                            
107: R93         Commitments, Guarantees and Contingencies -         HTML    116K  
                Obligations under Guarantee Arrangements (Details)               
108: R94         Commitments, Guarantees and Contingencies -         HTML     68K  
                Narrative (Details)                                              
109: R95         Variable Interest Entities and Securitization       HTML     54K  
                Activities - Assets and Liabilities by Type of                   
                Activity (Details)                                               
110: R96         Variable Interest Entities and Securitization       HTML     68K  
                Activities - Assets and Liabilities by Balance                   
                Sheet Caption (Details)                                          
111: R97         Variable Interest Entities and Securitization       HTML    105K  
                Activities - Non-Consolidated VIEs (Details)                     
112: R98         Variable Interest Entities and Securitization       HTML     59K  
                Activities - Mortgage and Asset Backed                           
                Securitization Assets (Details)                                  
113: R99         Variable Interest Entities and Securitization       HTML     83K  
                Activities - Transferred Assets with Continuing                  
                Involvement (Details)                                            
114: R100        Variable Interest Entities and Securitization       HTML     69K  
                Activities - Fair Value of Transferred Assets with               
                Continuing Involvement (Details)                                 
115: R101        Variable Interest Entities and Securitization       HTML     51K  
                Activities - Proceeds from New Securitization                    
                Transactions and Sales of Loans (Details)                        
116: R102        Variable Interest Entities and Securitization       HTML     55K  
                Activities - Assets Sold with Retained Exposure                  
                (Details)                                                        
117: R103        Regulatory Requirements - Narrative (Details)       HTML     44K  
118: R104        Regulatory Requirements - The Firm's Regulatory     HTML     78K  
                Capital and Capital Ratios (Details)                             
119: R105        Regulatory Requirements - U.S. Bank Subsidiaries'   HTML    105K  
                Regulatory Capital and Capital Ratios (Details)                  
120: R106        Regulatory Requirements - U.S. Broker-Dealer        HTML     49K  
                Regulatory Capital Requirements (Details)                        
121: R107        Total Equity - Preferred Stock Outstanding          HTML     74K  
                (Details)                                                        
122: R108        Total Equity - Common Shares Outstanding for Basic  HTML     50K  
                and Diluted EPS (Details)                                        
123: R109        Total Equity - Common Stock Repurchases (Details)   HTML     43K  
124: R110        Total Equity - Narrative (Details)                  HTML     42K  
125: R111        Total Equity - Dividends (Details)                  HTML     76K  
126: R112        Total Equity - Cumulative Adjustments to Beginning  HTML     56K  
                Retained Earnings Related to the Adoption of                     
                Accounting Updates (Details)                                     
127: R113        Total Equity - Accumulated Other Comprehensive      HTML     63K  
                Income (Loss) (Details)                                          
128: R114        Total Equity - Components of Period Changes in OCI  HTML    116K  
                (Details)                                                        
129: R115        Interest Income and Interest Expense - Summary      HTML     68K  
                (Details)                                                        
130: R116        Interest Income and Interest Expense - Accrued      HTML     44K  
                Interest (Details)                                               
131: R117        Income Taxes - Summary (Details)                    HTML     44K  
132: R118        Segment, Geographic and Revenue Information -       HTML    119K  
                Selected Financial Information by Business Segment               
                (Details)                                                        
133: R119        Segment, Geographic and Revenue Information -       HTML     55K  
                Institutional Securities - Investment Banking                    
                Revenues (Details)                                               
134: R120        Segment, Geographic and Revenue Information -       HTML     55K  
                Trading Revenues by Product Type (Details)                       
135: R121        Segment, Geographic and Revenue Information -       HTML     41K  
                Investment Management Investments Revenues - Net                 
                Unrealized Carried Interest (Details)                            
136: R122        Segment, Geographic and Revenue Information -       HTML     41K  
                Investment Management Asset Management Revenues -                
                Reduction of Fees due to Fee Waivers (Details)                   
137: R123        Segment, Geographic and Revenue Information - Net   HTML     49K  
                Revenues by Region (Details)                                     
138: R124        Segment, Geographic and Revenue Information -       HTML     42K  
                Revenue Recognized from Prior Services (Details)                 
139: R125        Segment, Geographic and Revenue Information -       HTML     42K  
                Receivables from Contracts with Customers                        
                (Details)                                                        
140: R126        Segment, Geographic and Revenue Information -       HTML     49K  
                Assets by Business Segment (Details)                             
142: XML         IDEA XML File -- Filing Summary                      XML    280K  
14: XML         XBRL Instance -- msq3202010q_htm                     XML  14.62M 
141: EXCEL       IDEA Workbook of Financial Reports                  XLSX    248K  
10: EX-101.CAL  XBRL Calculations -- ms-20200930_cal                 XML    425K 
11: EX-101.DEF  XBRL Definitions -- ms-20200930_def                  XML   1.72M 
12: EX-101.LAB  XBRL Labels -- ms-20200930_lab                       XML   3.44M 
13: EX-101.PRE  XBRL Presentations -- ms-20200930_pre                XML   2.26M 
 9: EX-101.SCH  XBRL Schema -- ms-20200930                           XSD    393K 
143: JSON        XBRL Instance as JSON Data -- MetaLinks              684±  1.10M  
144: ZIP         XBRL Zipped Folder -- 0000895421-20-000527-xbrl      Zip   1.36M  


‘10-Q’   —   Quarterly Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Table of Contents
"Risk Factors
"Financial Information
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Introduction
"Executive Summary
"Business Segments
"Supplemental Financial Information
"Accounting Development Updates
"Critical Accounting Policies
"Liquidity and Capital Resources
"Balance Sheet
"Regulatory Requirements
"Quantitative and Qualitative Disclosures about Risk
"Market Risk
"Credit Risk
"Country and Other Risks
"Report of Independent Registered Public Accounting Firm
"Consolidated Financial Statements and Notes
"Consolidated Income Statements (Unaudited)
"Consolidated Comprehensive Income Statements (Unaudited)
"Consolidated Balance Sheets (Unaudited at September 30, 2020)
"Consolidated Statements of Changes in Total Equity (Unaudited)
"Consolidated Cash Flow Statements (Unaudited)
"Notes to Consolidated Financial Statements (Unaudited)
"Introduction and Basis of Presentation
"Significant Accounting Policies
"Acquisitions
"Cash and Cash Equivalents
"Fair Values
"Fair Value Option
"Derivative Instruments and Hedging Activities
"Investment Securities
"Collateralized Transactions
"10
"Loans, Lending Commitments and Related Allowance for Credit Losses
"11
"Other Assets-Equity Method Investments
"12
"Deposits
"13
"Borrowings and Other Secured Financings
"14
"Commitments, Guarantees and Contingencies
"15
"Variable Interest Entities and Securitization Activities
"16
"17
"Total Equity
"18
"Interest Income and Interest Expense
"19
"Income Taxes
"20
"Segment, Geographic and Revenue Information
"Financial Data Supplement (Unaudited)
"Glossary of Common Terms and Acronyms
"Other Information
"Legal Proceedings
"Unregistered Sales of Equity Securities and Use of Proceeds
"Controls and Procedures
"Exhibits
"Signatures

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 
  Document  
 i false i --12-31 i Q3 i 2020 i true i false i 0000895421 i MORGAN STANLEY i 0.37 i 0.16 i 0.20 i 0.23 i 0.07 i 0.07 i 7809000000 i 10185000000 i 0.0124 i 0.0111 i 0.0117 i 0.0101 i 0.0025 i 0.0110 i 0.0068 i 0.0110 i 0.0130 i 0.0105 i 0.0114 i 128386000000 i 122933000000 i 1.00 i 1.00 i 16 i 0.17 i 24 i 1.00 i 7 i 0.08 i 7 i 0.75 i 11 i 0.15 i 11 i 0.99 i 17 i 0.21 i 29 i 1.00 i 7 i 0.10 i 8 i 0.50 i 11 i 0.15 i 11 i 0.98 i 0.01 i 0.01 i 3500000000 i 3500000000 i 2038893979 i 2038893979 i 1593973680 i 1576447988 i 64461000000 i 69144000000 i 0.07 i 0.44 i 0.94 i 0.26 i 0.10 i 0.00 i 0.07 i 0.05 i 0.38 i 0.75 i 0.26 i 0.02 i 0.21 i 0.78 i 0.25 i 0.00 i 0.06 i 0.70 i 0.98 i 0.13 i 0.06 i 0.00 i 0.06 i 0.06 i 0.37 i 0.72 i 0.28 i 0.02 i 0.23 i 0.81 i 0.28 i 0.00 i 1.08 i 0.96 i 1.00 i 0.80 i 0.0039 i 0.09 i 0.11 i 0.00 i 0.69 i 0.15 i 0.0009 i 0.01 i 0.84 i 0.47 i 0.93 i 0.28 i 0.0019 i 0.02 i 0.53 i 1.03 i 0.62 i 0.80 i 1.03 i 0.05 i 1.08 i 0.51 i 0.10 i 0.51 i 0.00 i 0.70 i 0.01 i 1.02 i 0.94 i 0.47 i 0.96 i 0.03 i 1.04 i 2099000000 i 3679000000 i 0.18 i 0.94 i 0.10 i 0.46 i 0.63 i 0.13 i 0.44 i 0.72 i 0.63 i 1.83 i 0.99 i 182 i 1.04 i 0.62 i 0.0117 i 0.0469 i 0.90 i 0.98 i 0.60 i 0.44 i 0.00 i 0.95 i 0.11 i 0.56 i 1.56 i 0.15 i 0.63 i 0.90 i 1.56 i 0.16 i 0.95 i 0.10 i 0.46 i 0.59 i 0.14 i 0.41 i 0.72 i 0.59 i 0.07 i 0.43 i 3 i 0.00 i 0.29 i 0.0047 i 0.0009 i 0.09 i 0.05 i 0.79 i 0.11 i 0.02 i 0.85 i 0.10 i 0.32 i 0.24 i 0.04 i 0.24 i 0.47 i 0.24 i 0.18 i 0.93 i 28 i 0.45 i 0.36 i 0.0084 i 0.0081 i 0.36 i 0.70 i 0.37 i 0.01 i 0.06 i 0.20 i 0.06 i 0.08 i 0.37 i 0.62 i 0.13 i 0.44 i 0.87 i 0.62 i 0.95 i 0.99 i 116 i 0.95 i 0.56 i 0.0138 i 0.0435 i 0.92 i 0.96 i 0.60 i 0.44 i 0.00 i 0.05 i 0.09 i 0.59 i 1.62 i 0.32 i 0.64 i 0.97 i 1.62 i 0.18 i 0.06 i 0.08 i 0.37 i 0.75 i 0.08 i 0.42 i 0.92 i 0.75 i 0.08 i 0.43 i 1 i 0.00 i 0.29 i 0.0071 i 0.0020 i 0.16 i 0.05 i 0.60 i 0.07 i 0.02 i 0.07 i 0.08 i 0.13 i 0.00 i 0.04 i 0.25 i 0.59 i 0.00 i 0.19 i 0.92 i 28 i 0.52 i 0.35 i 0.0116 i 0.0079 i 0.42 i 0.70 i 0.17 i 0.01 i 0.95 i 0.06 i 0.95 i 4000000 i 15000000 i 3204000000 i 3442000000 i 0.0446 i 0.0318 i 0.0069 i 0.0287 i 0.0225 i 0.0297 i 0.0668 i 0.0580 i 0.0052 i 0.0191 i 0.0380 i 0.0379 i 733000000 i 1166000000 i 444920299 i 462445991 0000895421 2020-01-01 2020-09-30 0000895421 ms:MorganStanleyCushingMLPHighIncomeIndexETNsdueMarch212031Member 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0000895421 ms:GlobalMediumTermNotesSeriesAFixedRateStepUpSeniorNotesDue2026ofMorganStanleyFinanceLLCMember 2020-01-01 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2020-01-01 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2020-01-01 2020-09-30 0000895421 2020-10-30 0000895421 2020-07-01 2020-09-30 0000895421 2019-07-01 2019-09-30 0000895421 2019-01-01 2019-09-30 0000895421 2020-09-30 0000895421 2019-12-31 0000895421 us-gaap:PreferredStockMember 2019-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-06-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000895421 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-12-31 0000895421 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-09-30 0000895421 2019-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-01-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000895421 us-gaap:TreasuryStockMember 2019-09-30 0000895421 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-09-30 0000895421 us-gaap:RetainedEarningsMember 2020-06-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000895421 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000895421 us-gaap:PreferredStockMember 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0000895421 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-12-31 0000895421 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2018-12-31 0000895421 us-gaap:TreasuryStockMember 2018-12-31 0000895421 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-06-30 0000895421 us-gaap:NoncontrollingInterestMember 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-06-30 0000895421 us-gaap:NoncontrollingInterestMember 2018-12-31 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-06-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2018-12-31 0000895421 us-gaap:CommonStockMember 2019-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-01-01 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2020-06-30 0000895421 us-gaap:TreasuryStockMember 2019-12-31 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-06-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2020-06-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2018-12-31 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2018-12-31 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-09-30 0000895421 us-gaap:TreasuryStockMember 2020-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-07-01 2020-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000895421 us-gaap:TreasuryStockMember 2019-06-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-07-01 2020-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-06-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-07-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommonStockMember 2020-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-07-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-06-30 0000895421 us-gaap:TreasuryStockMember 2020-06-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-01-01 2019-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-12-31 0000895421 us-gaap:RetainedEarningsMember 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000895421 2018-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member ms:AllowanceforCreditLossesonEmployeeLoansMember 2019-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member ms:AllowanceforCreditLossesMember 2019-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember 2019-12-31 0000895421 ms:ETRADEFinancialCorporationMember us-gaap:SubsequentEventMember 2020-10-02 0000895421 ms:EatonVanceCorp.Member us-gaap:SubsequentEventMember 2020-10-08 0000895421 ms:EatonVanceCorp.Member us-gaap:SubsequentEventMember 2020-10-08 2020-10-08 0000895421 ms:ETRADEFinancialCorporationMember us-gaap:SubsequentEventMember 2020-10-02 2020-10-02 0000895421 ms:ETRADEFinancialCorporationMember ms:SeriesMPreferredStockandSeriesNPreferredStockMember us-gaap:SubsequentEventMember 2020-10-02 2020-10-02 0000895421 ms:ETRADEFinancialCorporationMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2020-10-02 2020-10-02 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuredLendingFacilitiesMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuritiesBasedLendingandOtherLoansMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuritiesBasedLendingandOtherLoansMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-01-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-07-01 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-01-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-01-01 2019-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-06-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2018-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2018-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2018-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2018-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 2020-04-01 2020-06-30 0000895421 2020-01-01 2020-03-31 0000895421 ms:AccountsReceivableAndOtherReceivablesNetMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FutureMember 2019-12-31 0000895421 ms:AccountsReceivableAndOtherReceivablesNetMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FutureMember 2020-09-30 0000895421 us-gaap:PrivateEquityFundsMember 2020-09-30 0000895421 us-gaap:RealEstateFundsMember 2020-09-30 0000895421 us-gaap:RealEstateFundsMember 2019-12-31 0000895421 us-gaap:HedgeFundsMember 2020-09-30 0000895421 us-gaap:HedgeFundsMember 2019-12-31 0000895421 us-gaap:PrivateEquityFundsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputMarginLoanMember ms:ValuationTechniqueMarginLoanMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputVolatilitySkewMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputMarginLoanMember ms:ValuationTechniqueMarginLoanMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputVolatilitySkewMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputDiscountRateMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputVolatilitySkewMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputDiscountRateMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputDiscountRateMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCashSyntheticBasisMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputMarginLoanMember ms:ValuationTechniqueMarginLoanMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCashSyntheticBasisMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember 2019-01-01 2019-09-30 0000895421 us-gaap:DebtMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember 2020-07-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:DebtMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:IndexAndBasketCreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:TranchedIndexAndBasketCreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:IndexAndBasketCreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:TranchedIndexAndBasketCreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:BorrowingsMember 2019-12-31 0000895421 us-gaap:DepositsMember 2020-09-30 0000895421 us-gaap:BorrowingsMember 2020-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember 2019-12-31 0000895421 us-gaap:AvailableforsaleSecuritiesMember 2020-09-30 0000895421 us-gaap:DepositsMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-07-01 2020-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-07-01 2019-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-07-01 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:DerivativeCreditRiskRelatedContingentFeaturestriggeringCircumstancesTwoNotchCreditRatingDowngradeMember 2020-09-30 0000895421 ms:DerivativeCreditRiskRelatedContingentFeaturesTriggeringCircumstancesOneNotchCreditRatingDowngradeMember 2020-09-30 0000895421 us-gaap:CollaborativeArrangementMember 2020-09-30 0000895421 ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember 2019-12-31 0000895421 us-gaap:USTreasurySecuritiesMember 2019-12-31 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 us-gaap:CorporateBondSecuritiesMember 2019-12-31 0000895421 us-gaap:CorporateBondSecuritiesMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:USTreasurySecuritiesMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2019-12-31 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2020-09-30 0000895421 us-gaap:USTreasurySecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-01-01 2020-09-30 0000895421 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2020-01-01 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-01-01 2020-09-30 0000895421 us-gaap:CorporateBondSecuritiesMember 2020-01-01 2020-09-30 0000895421 ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember 2020-01-01 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:MaturityOvernightMember 2019-12-31 0000895421 us-gaap:MaturityUpTo30DaysMember 2019-12-31 0000895421 us-gaap:Maturity30To90DaysMember 2019-12-31 0000895421 us-gaap:MaturityOver90DaysMember 2019-12-31 0000895421 us-gaap:MaturityOver90DaysMember 2020-09-30 0000895421 us-gaap:MaturityUpTo30DaysMember 2020-09-30 0000895421 us-gaap:MaturityOvernightMember 2020-09-30 0000895421 us-gaap:Maturity30To90DaysMember 2020-09-30 0000895421 us-gaap:CollateralizedSecuritiesOtherMember 2019-12-31 0000895421 ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:AssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:AssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:CollateralizedSecuritiesOtherMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 ms:InvestmentGradeMember ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2020-01-01 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember 2020-01-01 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2019-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000895421 us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember 2019-12-31 0000895421 us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2019-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2018-12-31 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2019-01-01 2019-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember 2018-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2018-12-31 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2019-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2018-12-31 0000895421 us-gaap:CommercialPortfolioSegmentMember 2019-09-30 0000895421 ms:SecuredLendingFacilitiesMember 2018-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2019-09-30 0000895421 ms:SecuritiesBasedLendingMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember ms:OtherLoansMember 2020-09-30 0000895421 ms:InvestmentGradeMember ms:OtherLoansMember 2020-09-30 0000895421 ms:InvestmentGradeMember us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 ms:InvestmentGradeMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:DebttoValueRatioGreaterthan80PercentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:DebttoValueRatioLessthanorEqualto80PercentMember 2020-09-30 0000895421 ms:FICOScoreBetween680and739Member us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 ms:FICOScoreGreaterthanorEqualto740Member us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 ms:FICOScoreLessthan680Member us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 ms:FinancialAssetPastDueMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 2019-01-01 2019-12-31 0000895421 ms:NoLongerEmployedbytheFirmMember 2020-09-30 0000895421 ms:CurrentlyEmployedbytheFirmMember 2020-09-30 0000895421 ms:InvestmentManagementSegmentMember 2019-01-01 2019-09-30 0000895421 ms:InvestmentManagementSegmentMember 2019-07-01 2019-09-30 0000895421 ms:InvestmentManagementSegmentMember 2020-01-01 2020-09-30 0000895421 ms:InvestmentManagementSegmentMember 2020-07-01 2020-09-30 0000895421 ms:InvestmentManagementSegmentMember 2019-12-31 0000895421 ms:InvestmentManagementSegmentMember 2020-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2020-01-01 2020-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2020-07-01 2020-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2019-07-01 2019-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2019-01-01 2019-09-30 0000895421 ms:DeutscheBankNationalTrustCompany2007Nc4VMorganStanleyMortgageCapitalHoldingsLlcMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:CaseNumber153637AndCaseNumber154353Member us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:DeutscheBankNationalTrustCompany2007Nc4VMorganStanleyMortgageCapitalHoldingsLlcMember srt:MaximumMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:FinancialGuarantyInsuranceCompanyVMorganStanleyAbsCapitalIIncEtAlTrust2007Nc4Member us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:CaseNumber153637AndCaseNumber154353Member srt:MaximumMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember us-gaap:PendingLitigationMember 2020-01-01 2020-09-30 0000895421 ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember srt:MaximumMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 us-gaap:CommercialLoanMember 2020-09-30 0000895421 ms:CentralCounterpartyCommitmentMember 2020-09-30 0000895421 ms:CommitmentsForwardStartingReverseRepurchaseAgreementsMember 2020-09-30 0000895421 ms:CommitmentsLettersOfCreditAndOtherFinancialGuaranteesObtainedToSatisfyCollateralRequirementsMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2020-09-30 0000895421 ms:CommitmentsInvestmentActivitiesMember 2020-09-30 0000895421 us-gaap:RealEstateMember 2020-09-30 0000895421 ms:FirmCommitmentContractMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember 2020-09-30 0000895421 us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 us-gaap:DerivativeMember 2020-09-30 0000895421 ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:OtherConsumerAndCommercialLoansMember 2019-12-31 0000895421 ms:OtherConsumerAndCommercialLoansMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember ms:OtherConsumerAndCommercialLoansMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember ms:OtherConsumerAndCommercialLoansMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:StructuredFinanceMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:AssetsMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 us-gaap:AssetsMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:AssetsMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:AssetsMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:AssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:ResidentialMortgageMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:CreditLinkedNotesAndOtherMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:ResidentialMortgageMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:ResidentialMortgageMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2020-09-30 0000895421 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 us-gaap:AssetsMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:LiabilityMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:StructuredFinanceMember 2020-09-30 0000895421 ms:OtherVariableInterestsMember 2020-09-30 0000895421 ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 us-gaap:AssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:LiabilityMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:AssetsMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:LiabilityMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:LiabilityMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:LiabilityMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:AssetsMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:AssetsMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2020-07-01 2020-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2019-01-01 2019-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2020-01-01 2020-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2019-07-01 2019-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:ResidentialMortgageMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:ResidentialMortgageMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:CreditLinkedNotesAndOtherMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2019-12-31 0000895421 ms:MSAndCoMember 2020-01-01 2020-09-30 0000895421 ms:MorganStanleyPrivateBankNationalAssociationMember 2020-01-01 2020-09-30 0000895421 ms:MorganStanleySmithBarneyLlcMember 2020-01-01 2020-09-30 0000895421 ms:MorganStanleyBankNationalAssociationMember 2020-01-01 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:ResidentialMortgageMember 2019-12-31 0000895421 ms:MortgageAndAssetBackedSecuritiesMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 us-gaap:StructuredFinanceMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 ms:MortgageAndAssetBackedSecuritiesMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 ms:OtherVariableInterestsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 ms:OtherVariableInterestsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 us-gaap:StructuredFinanceMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000895421 ms:MSAndCoMember 2020-09-30 0000895421 ms:MSAndCoMember 2019-12-31 0000895421 ms:MorganStanleyPrivateBankNationalAssociationMember 2019-12-31 0000895421 ms:MorganStanleyBankNationalAssociationMember 2020-09-30 0000895421 ms:MorganStanleyPrivateBankNationalAssociationMember 2020-09-30 0000895421 ms:MorganStanleyBankNationalAssociationMember 2019-12-31 0000895421 ms:MorganStanleySmithBarneyLlcMember 2020-09-30 0000895421 ms:MorganStanleySmithBarneyLlcMember 2019-12-31 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2019-12-31 0000895421 ms:SeriesIPreferredStockMember 2019-12-31 0000895421 ms:SeriesJPreferredStockMember 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2019-12-31 0000895421 ms:SeriesKPreferredStockMember 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesEPreferredStockMember 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesHPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesFPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesFPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesCPreferredStockMember 2019-12-31 0000895421 ms:SeriesLPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-09-30 0000895421 ms:SeriesIPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2019-01-01 2019-09-30 0000895421 ms:SeriesJPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2019-01-01 2019-09-30 0000895421 ms:SeriesKPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2020-01-01 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2019-07-01 2019-09-30 0000895421 ms:SeriesLPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2019-07-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-12-31 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-06-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-06-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2018-12-31 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 ms:MitsubishiUfjFinancialGroupIncMember 2020-01-01 2020-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2018-12-31 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2019-07-01 2019-09-30 0000895421 us-gaap:CreditRiskContractMember 2019-01-01 2019-09-30 0000895421 ms:EquityAndIndexContractMember 2019-07-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember 2020-01-01 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember 2019-01-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember 2020-01-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember 2020-07-01 2020-09-30 0000895421 ms:EquityAndIndexContractMember 2020-01-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-09-30 0000895421 us-gaap:CreditRiskContractMember 2020-07-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-09-30 0000895421 us-gaap:CreditRiskContractMember 2019-07-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember 2020-07-01 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember 2019-07-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember 2019-01-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember 2019-07-01 2019-09-30 0000895421 ms:EquityAndIndexContractMember 2020-07-01 2020-09-30 0000895421 ms:EquityAndIndexContractMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2020-07-01 2020-09-30 0000895421 us-gaap:CreditRiskContractMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2019-07-01 2019-09-30 0000895421 srt:AsiaMember 2020-07-01 2020-09-30 0000895421 srt:AsiaMember 2019-07-01 2019-09-30 0000895421 us-gaap:EMEAMember 2019-07-01 2019-09-30 0000895421 us-gaap:EMEAMember 2020-07-01 2020-09-30 0000895421 srt:AmericasMember 2019-01-01 2019-09-30 0000895421 us-gaap:EMEAMember 2019-01-01 2019-09-30 0000895421 srt:AmericasMember 2019-07-01 2019-09-30 0000895421 srt:AmericasMember 2020-07-01 2020-09-30 0000895421 srt:AsiaMember 2019-01-01 2019-09-30 0000895421 srt:AmericasMember 2020-01-01 2020-09-30 0000895421 srt:AsiaMember 2020-01-01 2020-09-30 0000895421 us-gaap:EMEAMember 2020-01-01 2020-09-30 0000895421 ms:WealthManagementSegmentMember 2019-12-31 0000895421 ms:InstitutionalSecuritiesSegmentMember 2020-09-30 0000895421 ms:InstitutionalSecuritiesSegmentMember 2019-12-31 0000895421 ms:WealthManagementSegmentMember 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2019-01-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2019-07-01 2019-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2020-01-01 2020-09-30 xbrli:pure xbrli:shares iso4217:USD xbrli:shares iso4217:USD ms:security iso4217:EUR


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM  i 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended  i September 30, 2020
Commission File Number  i 1-11758
mslogo3q20.jpg
(Exact name of Registrant as specified in its charter)
 
 
 
 
 
 
 
 
 
 i Delaware
 i 1585 Broadway
 i 36-3145972
 i (212)
 i 761-4000
 
(State or other jurisdiction of
incorporation or organization)
 i New York,
 i NY
 i 10036
(I.R.S. Employer Identification No.)
(Registrant’s telephone number, including area code)
(Address of principal executive offices, including zip code)
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
Title of each class
Trading
Symbol(s)
Name of exchange on
which registered
 i Common Stock, $0.01 par value
 i MS
 i New York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate
 i MS/PA
 i New York Stock Exchange
 i Non-Cumulative Preferred Stock, Series A, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
 i MS/PE
 i New York Stock Exchange
 i Non-Cumulative Preferred Stock, Series E, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
 i MS/PF
 i New York Stock Exchange
 i Non-Cumulative Preferred Stock, Series F, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
 i MS/PI
 i New York Stock Exchange
 i Non-Cumulative Preferred Stock, Series I, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
 i MS/PK
 i New York Stock Exchange
 i Non-Cumulative Preferred Stock, Series K, $0.01 par value
Depository Shares, each representing 1/1000th interest in a share of 4.875%
 i MS/PL
 i New York Stock Exchange
 i Non-Cumulative Preferred Stock, Series L, $0.01 par value
 i Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026
 i MS/26C
 i New York Stock Exchange
of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
 i Morgan Stanley Cushing® MLP High Income Index ETNs due March 21, 2031
 i MLPY
 i NYSE Arca, Inc.
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     i Yes       No  
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).     i Yes      No  
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
 i Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 i 
Emerging growth company
 i 
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   i     No 
As of October 30, 2020, there were  i 1,809,198,248 shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding.



QUARTERLY REPORT ON FORM 10-Q
For the quarter ended September 30, 2020
Part
Item
Page
II
1A

I
 
I
2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I
3

 
 
 
 
 
 
 
 
I
1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II
 
II
1

II
2

I
4

II
6

 
 
S-1

i


Available Information
We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website, www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC. Our electronic SEC filings are available to the public at the SEC’s website.
Our website is www.morganstanley.com. You can access our Investor Relations webpage at www.morganstanley.com/about-us-ir. We make available free of charge, on or through our Investor Relations webpage, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (“Exchange Act”), as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, via a link to the SEC’s website, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the Exchange Act.
You can access information about our corporate governance at www.morganstanley.com/about-us-governance and our sustainability initiatives at www.morganstanley.com/about-us/sustainability-at-morgan-stanley. Our webpages include:
 
Amended and Restated Certificate of Incorporation;
Amended and Restated Bylaws;
Charters for our Audit Committee, Compensation, Management Development and Succession Committee, Nominating and Governance Committee, Operations and Technology Committee, and Risk Committee;
Corporate Governance Policies;
Policy Regarding Corporate Political Activities;
Policy Regarding Shareholder Rights Plan;
Equity Ownership Commitment;
Code of Ethics and Business Conduct;
Code of Conduct;
Integrity Hotline Information;
Environmental and Social Policies; and
Sustainability Report.
Our Code of Ethics and Business Conduct applies to all directors, officers and employees, including our Chief Executive Officer, Chief Financial Officer and Deputy Chief Financial Officer. We will post any amendments to the Code of Ethics and Business Conduct and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange LLC (“NYSE”) on our website. You can request a copy of these documents, excluding exhibits, at no cost, by contacting Investor Relations, 1585 Broadway, New York, NY 10036 (212-761-4000). The information on our website is not incorporated by reference into this report.

ii


Risk Factors
In addition to “Risk Factors” in Part I, Item 1A of the 2019 Form 10-K, please refer to the risk factors under Item 8.01 “Other Matters” in each of the the Current Reports on Form 8-K filed with the SEC on April 16, 2020 and October 2, 2020, respectively.

 
1
September 2020 Form 10-Q


Management’s Discussion and Analysis of Financial Condition and Results of Operations
Introduction
Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments—Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley,” “Firm,” “us,” “we” or “our” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form 10-Q.
A description of the clients and principal products and services of each of our business segments is as follows:
Institutional Securities provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in the equity and fixed income businesses. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research.
Wealth Management provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services.
 
Investment Management provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors and corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors.
Management’s Discussion and Analysis includes certain metrics which we believe to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an additional means of assessing, our financial condition and operating results. Such metrics, when used, are defined and may be different from or inconsistent with metrics used by other companies.
The results of operations in the past have been, and in the future may continue to be, materially affected by: competition; risk factors; legislative, legal and regulatory developments; and other factors. These factors also may have an adverse impact on our ability to achieve our strategic objectives. Additionally, the discussion of our results of operations herein may contain forward-looking statements. These statements, which reflect management’s beliefs and expectations, are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of the risks and uncertainties that may affect our future results, see “Forward-Looking Statements,” “Business—Competition,” “Business—Supervision and Regulation,” and “Risk Factors” herein and in the 2019 Form 10-K, and “Liquidity and Capital Resources—Regulatory Requirements” herein. In addition, see “Executive Summary” herein and “Risk Factors” for information on the current and possible future effects of the COVID-19 pandemic on our results.


September 2020 Form 10-Q
2
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Executive Summary
Overview of Financial Results
Consolidated Results—Three Months Ended September 30, 2020
Firm Net revenues were up 16% and Net income applicable to Morgan Stanley was up 25%, reflecting strength across all business segments, and resulting in an annualized ROTCE of 15.0% (see “Non-GAAP Financial Measures” herein).
Institutional Securities Net revenues of $6,062 million increased as a result of higher sales and trading and strength in equity underwriting.
Wealth Management delivered pre-tax income of $1.1 billion with a pre-tax profit margin of 24%, reflecting strong fee-based flows and increased loan and deposit balances.
Investment Management reported long-term net flows of $10.4 billion and AUM of $715 billion driving revenue growth of 38%.
Our provision for credit losses on loans and lending commitments was $111 million.
At September 30, 2020, our standardized Common Equity Tier 1 capital ratio was 17.4%.
Strategic Transactions
On October 2, 2020, we completed the acquisition of E*TRADE Financial Corporation (“E*TRADE”). For further information, see “Business Segments—Wealth Management.”
On October 8, 2020, we entered into a definitive agreement under which we will acquire Eaton Vance Corp. (“Eaton Vance”), subject to customary closing conditions. For further information, see “Business Segments—Investment Management.”
Net Revenues
($ in millions)
netrevenuesa.jpg
 


Net Income Applicable to Morgan Stanley
($ in millions)
netincomea.jpg
Earnings per Diluted Common Share
eps2.jpg
We reported net revenues of $11,657 million in the quarter ended September 30, 2020 (“current quarter,” or “3Q 2020”), compared with $10,032 million in the quarter ended September 30, 2019 (“prior year quarter,” or “3Q 2019”). For the current quarter, net income applicable to Morgan Stanley was $2,717 million, or $1.66 per diluted common share, compared with $2,173 million or $1.27 per diluted common share, in the prior year quarter.
We reported net revenues of $34,558 million in the nine months ended September 30, 2020 (“current year period,” or “YTD 2020”), compared with $30,562 million in the period ended September 30, 2019 (“prior year period,” or “YTD 2019”). For the current year period, net income applicable to Morgan Stanley was $7,611 million, or $4.62 per diluted common share, compared with $6,803 million or $3.89 per diluted common share, in the prior year period.


 
3
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Non-interest Expenses1 
($ in millions)
noninterestexpensesqtda.jpg
noninterestexpensesytda.jpg
1.
The percentages on the bars in the chart represent the contribution of compensation and benefits expenses and non-compensation expenses to the total.
Current Quarter
Compensation and benefits expenses of $5,086 million in the current quarter increased 15% from the prior year quarter, primarily as a result of increases in discretionary incentive compensation and the formulaic payout to Wealth Management representatives, driven by higher revenues, and higher expenses related to certain deferred compensation plans linked to investment performance.
Non-compensation expenses of $3,084 million in the current quarter increased 7% from the prior year quarter, primarily as a result of higher volume-related expenses and increased information processing and communication expenses, partially offset by a decrease in marketing and business development expenses.
 
Current Year Period
Compensation and benefits expenses of $15,404 million in the current year period increased 13% from the prior year period, primarily as a result of increases in discretionary incentive compensation and the formulaic payout to Wealth Management representatives, driven by higher revenues, partially offset by lower compensation associated with carried interest and certain deferred compensation plans linked to investment performance.
Non-compensation expenses of $9,166 million in the current year period increased 9% from the prior year period, primarily as a result of higher volume-related expenses, an increase in the provision for credit losses for lending commitments and off-balance sheet instruments, and increased information processing and communication expenses. These increases were partially offset by a decrease in marketing and business development expenses.
Income Taxes
The current quarter included intermittent net discrete tax benefits of $113 million, principally associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of tax examinations in certain jurisdictions. The prior year quarter included intermittent net discrete tax benefits of $89 million primarily associated with the filing of the 2018 federal tax return and the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.
The current year period included intermittent net discrete tax benefits of $10 million. The prior year period included intermittent net discrete tax benefits of $190 million, primarily associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations and other matters. For further information, see “Supplemental Financial Information—Income Tax Matters”
herein.

September 2020 Form 10-Q
4
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Business Segment Results
Net Revenues by Segment1 
($ in millions)
segmentrevenueqtda01.jpg
 
segmentrevenueytd.jpg

 

Net Income Applicable to Morgan Stanley by Segment1 
($ in millions)

segmentincomeqtda01.jpg


segmentincomeytda02.jpg
1.
The percentages on the bars in the charts represent the contribution of each business segment to the total of the applicable financial category and may not sum to 100% due to intersegment eliminations. See Note 20 to the financial statements for details of intersegment eliminations.
Current Quarter
Institutional Securities net revenues of $6,062 million in the current quarter increased 21% from the prior year quarter primarily due to higher sales and trading and equity underwriting revenues.
Wealth Management net revenues of $4,657 million in the current quarter increased 7% principally due to gains from investments associated with certain employee deferred compensation plans. Excluding these investment gains, revenues increased modestly, reflecting higher Asset management revenues on positive net flows, partially offset by lower Net interest.
Investment Management net revenues of $1,056 million in the current quarter increased 38% from the prior year quarter, primarily due to higher Investments revenues, driven by accrued carried interest and investment gains in an Asia private equity fund, and higher Asset management revenues as a result of higher average AUM.

 
5
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Current Year Period
Institutional Securities net revenues of $18,944 million in the current year period increased 24% from the prior year period. The increase is primarily due to higher sales and trading and underwriting revenues, partially offset by losses on loans and lending commitments held for sale, an increase in the provision for credit losses on loans held for investment, and a decrease in advisory revenues.
Wealth Management net revenues of $13,374 million in the current year period increased 2% from the prior year period, primarily due to higher Asset management revenues, largely as a result of market appreciation, and higher Commissions and fees, partially offset by lower Net interest.
Investment Management net revenues of $2,634 million in the current year period increased 9% from the prior year period primarily due to higher Asset management revenues as a result of higher average AUM.
Net Revenues by Region1, 2 
($ in millions)
regionalrevenuesqtd.jpg
regionalrevenuesytda.jpg
1.
The percentages on the bars in the charts represent the contribution of each region to the total.
2.
For a discussion of how the geographic breakdown of net revenues is determined, see Note 20 to the financial statements in the 2019 Form 10-K.
Current quarter revenues in Asia increased 58%, primarily driven by Equity sales and trading within the Institutional Securities business segment. Americas revenues increased 12%,
 
primarily driven by Institutional Securities business segment sales and trading, as well as the Wealth Management business segment. EMEA revenues were relatively unchanged in the current quarter.

Current year period revenues in Asia increased 44% and the Americas increased 11%, primarily driven by the Institutional Securities business segment. EMEA revenues were relatively unchanged in the current year period.
Coronavirus Disease (“COVID-19”) Pandemic
The COVID-19 pandemic and related voluntary and government-imposed social and business restrictions have had, and will likely continue to have, a severe impact on global economic conditions and the environment in which we operate our businesses. We have implemented a return-to-workplace program, which is phased based on role, location and employee willingness and ability to return, and focused on the health and safety of all staff. The Firm continues to be fully operational, with more than 85% of global employees and more than 90% of employees in the Americas working from home as of September 30, 2020.
Though we are unable to estimate the extent of the impact, the ongoing COVID-19 pandemic and related global economic crisis may have adverse impacts on our future operating results. To date, given our unique business model, economic conditions have affected our businesses in different ways. We have increased our allowance for credit losses on loans and lending commitments, and the persistence of low interest rates has continued to negatively affect our net interest margin in the Wealth Management business segment. Overall for the Firm, increased client trading and capital markets activity, particularly in the first half of the year, has benefited Institutional Securities business segment results in Sales and trading and Investment banking underwriting revenues. However, the high levels of client trading and capital markets activity experienced in the current year period may not be repeated and Investment banking advisory activity may continue to be subdued. Refer to “Risk Factors” herein and Forward Looking Statements in the 2019 Form 10-K.
We continue to use the elements of our Enterprise Risk Management framework to manage the significant uncertainty in the present economic and market conditions. See “Quantitative and Qualitative Disclosures about Risk” in the 2019 Form 10-K for further information.

September 2020 Form 10-Q
6
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Selected Financial Information and Other Statistical Data
 
Three Months Ended September 30,
Nine Months Ended September 30,
$ in millions
2020
2019
2020
2019
Net income applicable to Morgan Stanley
$
2,717

$
2,173

$
7,611

$
6,803

Preferred stock dividends
120

113

377

376

Earnings applicable to Morgan Stanley common shareholders
$
2,597

$
2,060

$
7,234

$
6,427

 
 
 
 
 
Expense efficiency ratio1
70.1
%
73.0
%
71.1
%
72.0
%
ROE2
13.2
%
11.2
%
12.6
%
11.8
%
Adjusted ROE3
12.6
%
10.7
%
12.5
%
11.5
%
ROTCE2,3
15.0
%
12.9
%
14.3
%
13.5
%
Adjusted ROTCE3
14.3
%
12.3
%
14.2
%
13.1
%
Pre-tax profit margin4
29.9
%
27.0
%
28.9
%
28.0
%
Pre-tax profit margin by segment4
 
 
 
Institutional Securities
34
%
26
%
32
%
28
%
Wealth Management
24
%
28
%
25
%
28
%
Investment Management
30
%
22
%
26
%
22
%
in millions, except per share and employee data
Liquidity resources5
$
267,292

$
215,868

Loans6
$
146,237

$
130,637

Total assets
$
955,940

$
895,429

Deposits
$
239,253

$
190,356

Borrowings
$
203,444

$
192,627

Common shares outstanding
1,576

1,594

Common shareholders' equity
$
79,874

$
73,029

Tangible common shareholders’ equity3
$
70,646

$
63,780

Book value per common share7
$
50.67

$
45.82

Tangible book value per common share3,7
$
44.81

$
40.01

Worldwide employees
63,051

60,431

Capital ratios8
 
 
Common Equity Tier 1 capital—Advanced
16.9
%
16.9
%
Common Equity Tier 1 capital—Standardized
17.4
%
16.4
%
Tier 1 capital—Advanced
19.0
%
19.2
%
Tier 1 capital—Standardized
19.5
%
18.6
%
Tier 1 leverage
8.3
%
8.3
%
SLR9
7.4
%
6.4
%
1.
The expense efficiency ratio represents total non-interest expenses as a percentage of net revenues.
2.
ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively.
3.
Represents a non-GAAP financial measure. See “Selected Non-GAAP Financial Information” herein.
4.
Pre-tax profit margin represents income before income taxes as a percentage of net revenues.
5.
For a discussion of Liquidity resources, see “Liquidity and Capital Resources—Liquidity Risk Management Framework—Liquidity Resources” herein.
6.
Amounts include loans held for investment (net of allowance) and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see Note 10 to the financial statements).
7.
Book value per common share and tangible book value per common share equal common shareholders’ equity and tangible common shareholders’ equity, respectively, divided by common shares outstanding.
8.
At September 30, 2020 and December 31, 2019, our risk-based capital ratios are based on the Advanced Approach and the Standardized Approach rules, respectively. For a discussion of our capital ratios, see “Liquidity and Capital Resources—Regulatory Requirements” herein.
9.
At September 30, 2020, our SLR reflects the impact of a Federal Reserve interim final rule in effect until March 31, 2021. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.
 
Selected Non-GAAP Financial Information
We prepare our financial statements using U.S. GAAP. From time to time, we may disclose certain “non-GAAP financial measures” in this document or in the course of our earnings releases, earnings and other conference calls, financial presentations, definitive proxy statement and otherwise. A “non-GAAP financial measure” excludes, or includes, amounts from the most directly comparable measure calculated and presented in accordance with U.S. GAAP. We consider the non-GAAP financial measures we disclose to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an alternate means of assessing, our financial condition, operating results, prospective regulatory capital requirements or capital adequacy.
These measures are not in accordance with, or a substitute for, U.S. GAAP and may be different from or inconsistent with non-GAAP financial measures used by other companies. Whenever we refer to a non-GAAP financial measure, we will also generally define it or present the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP, along with a reconciliation of the differences between the U.S. GAAP financial measure and the non-GAAP financial measure.
The principal non-GAAP financial measures presented in this document are set forth in the following tables.

 
7
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions, except per share data
2020
2019
2020
2019
Earnings applicable to Morgan Stanley common shareholders
$
2,597

$
2,060

$
7,234

$
6,427

Impact of adjustments
(113
)
(89
)
(10
)
(190
)
Adjusted earnings applicable to Morgan Stanley common shareholders—non-GAAP1
$
2,484

$
1,971

$
7,224

$
6,237

Earnings per diluted common share
$
1.66

$
1.27

$
4.62

$
3.89

Impact of adjustments
(0.07
)
(0.06
)

(0.12
)
Adjusted earnings per diluted common share—non-GAAP1
$
1.59

$
1.21

$
4.62

$
3.77

Effective income tax rate
21.1
%
18.2
%
22.2
%
19.1
%
Impact of adjustments
3.2
%
3.2
%
0.1
%
2.2
%
Adjusted effective income tax rate—non-GAAP1
24.3
%
21.4
%
22.3
%
21.3
%
 
Average Monthly Balance
 
Three Months Ended September 30,
Nine Months Ended September 30,
$ in millions
2020
2019
2020
2019
Tangible equity
 
 
 
 
Morgan Stanley shareholders' equity
$
87,210

$
81,912

$
85,378

$
81,028

Less: Goodwill and net intangible assets
(9,260
)
(9,389
)
(9,248
)
(9,097
)
Tangible Morgan Stanley shareholders' equity—Non-GAAP
$
77,950

$
72,523

$
76,130

$
71,931

Common shareholders' equity
$
78,690

$
73,392

$
76,858

$
72,508

Less: Goodwill and net intangible assets
(9,260
)
(9,389
)
(9,248
)
(9,097
)
Tangible common shareholders' equity—Non-GAAP
$
69,430

$
64,003

$
67,610

$
63,411

 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in billions
2020
2019
2020
2019
Average common equity
 
 
 
 
Unadjusted—GAAP
$
78.7

$
73.4

$
76.9

$
72.5

Adjusted1—Non-GAAP
78.7

73.4

76.9

72.4

ROE2
 
 
 
 
Unadjusted—GAAP
13.2
%
11.2
%
12.6
%
11.8
%
Adjusted—Non-GAAP1, 3
12.6
%
10.7
%
12.5
%
11.5
%
Average tangible common equity—Non-GAAP
Unadjusted
$
69.4

$
64.0

$
67.6

$
63.4

Adjusted1
69.4

64.0

67.6

63.3

ROTCE2—Non-GAAP
 
 
 
 
Unadjusted
15.0
%
12.9
%
14.3
%
13.5
%
Adjusted1, 3
14.3
%
12.3
%
14.2
%
13.1
%
 
Non-GAAP Financial Measures by Business Segment
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in billions
2020
2019
2020
2019
Average common equity4, 5
 
 
 
Institutional Securities
$
42.8

$
40.4

$
42.8

$
40.4

Wealth Management
18.2

18.2

18.2

18.2

Investment Management
2.6

2.5

2.6

2.5

Average tangible common equity4, 5
 
 
 
Institutional Securities
$
42.3

$
39.9

$
42.3

$
39.9

Wealth Management
10.4

10.2

10.4

10.2

Investment Management
1.7

1.5

1.7

1.5

ROE6
 
 
 
 
Institutional Securities
14.5
%
9.8
%
13.4
%
10.8
%
Wealth Management
17.9
%
20.6
%
18.2
%
20.2
%
Investment Management
34.0
%
22.1
%
23.0
%
21.5
%
ROTCE6
 
 
 
 
Institutional Securities
14.7
%
9.9
%
13.5
%
10.9
%
Wealth Management
31.4
%
36.9
%
31.7
%
36.2
%
Investment Management
52.6
%
35.6
%
35.6
%
34.7
%
 
1.
Adjusted amounts exclude net discrete tax provisions (benefits) that are intermittent and include those that are recurring. Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items. For further information on net discrete tax provisions (benefits), seeSupplemental Financial Information—Income Tax Matters” herein.
2.
ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively. When excluding intermittent net discrete tax provisions (benefits), both the numerator and average denominator are adjusted.
3.
The calculations used in determining our “ROE and ROTCE Targets” referred to in the following section are the Adjusted ROE and Adjusted ROTCE amounts shown in this table.
4.
Average common equity and average tangible common equity for each business segment is determined using our Required Capital framework (see "Liquidity and Capital Resources—Regulatory Requirements—Attribution of Average Common Equity According to the Required Capital Framework” herein).
5.
The sums of the segments' Average common equity and Average tangible common equity do not equal the Consolidated measures due to Parent equity.
6.
The calculation of ROE and ROTCE by segment uses annualized net income applicable to Morgan Stanley by segment less preferred dividends allocated to each segment as a percentage of average common equity and average tangible common equity, respectively, allocated to each segment.

September 2020 Form 10-Q
8
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Return on Tangible Common Equity Target
In January 2020, we established an ROTCE Target of 13% to 15% to be achieved over the next two years.
Our ROTCE Target is a forward-looking statement that was based on a normal market environment and may be materially affected by many factors, including, among other things: mergers and acquisitions; macroeconomic and market conditions; legislative and regulatory developments; industry trading and investment banking volumes; equity market levels; interest rate environment; outsized legal expenses or penalties; the ability to maintain a reduced level of expenses; and capital levels.
With the COVID–19 pandemic, and the current global economic crisis, it is uncertain that the ROTCE Target will be met within the originally stated time frame. See “Coronavirus Disease (COVID–19) Pandemic” herein and “Risk Factors” for further information on market and economic conditions and their effects on our financial results.
For further information on non-GAAP measures (ROTCE excluding intermittent net discrete tax items), see “Selected Non-GAAP Financial Information” herein. For information on the impact of intermittent net discrete tax items, see “Supplemental Financial Information—Income Tax Matters” herein.
Business Segments
Substantially all of our operating revenues and operating expenses are directly attributable to our business segments. Certain revenues and expenses have been allocated to each business segment, generally in proportion to its respective net revenues, non-interest expenses or other relevant measures.
For an overview of the components of our business segments, net revenues, compensation expense and income taxes, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments” in the 2019 Form 10-K.


 
9
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Institutional Securities
Income Statement Information
 
Three Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Revenues
 
 
 
Investment banking
$
1,707

$
1,535

11
 %
Trading
2,807

2,533

11
 %
Investments
87

(18
)
N/M

Commissions and fees
639

643

(1
)%
Asset management
114

100

14
 %
Other
114

51

124
 %
Total non-interest revenues
5,468

4,844

13
 %
Interest income
1,086

3,112

(65
)%
Interest expense
492

2,933

(83
)%
Net interest
594

179

N/M

Net revenues
6,062

5,023

21
 %
Compensation and benefits
2,001

1,768

13
 %
Non-compensation expenses
2,013

1,948

3
 %
Total non-interest expenses
4,014

3,716

8
 %
Income before provision for income taxes
2,048

1,307

57
 %
Provision for income taxes
385

189

104
 %
Net income
1,663

1,118

49
 %
Net income applicable to noncontrolling interests
16

45

(64
)%
Net income applicable to Morgan Stanley
$
1,647

$
1,073

53
 %

 
 
 
 
Nine Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Revenues
 
 
 
Investment banking
$
4,902

$
4,158

18
 %
Trading
10,375

8,221

26
 %
Investments
98

257

(62
)%
Commissions and fees
2,230

1,889

18
 %
Asset management
342

310

10
 %
Other
(628
)
416

N/M

Total non-interest revenues
17,319

15,251

14
 %
Interest income
4,809

9,457

(49
)%
Interest expense
3,184

9,376

(66
)%
Net interest
1,625

81

N/M

Net revenues
18,944

15,332

24
 %
Compensation and benefits
6,767

5,376

26
 %
Non-compensation expenses
6,186

5,591

11
 %
Total non-interest expenses
12,953

10,967

18
 %
Income before provision for income taxes
5,991

4,365

37
 %
Provision for income taxes
1,326

703

89
 %
Net income
4,665

3,662

27
 %
Net income applicable to noncontrolling interests
75

97

(23
)%
Net income applicable to Morgan Stanley
$
4,590

$
3,565

29
 %

Investment Banking
Investment Banking Revenues
 
Three Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Advisory
$
357

$
550

(35
)%
Underwriting:


 
   Equity
874

401

118
 %
   Fixed income
476

584

(18
)%
Total Underwriting
1,350

985

37
 %
Total Investment banking
$
1,707

$
1,535

11
 %
 
Nine Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Advisory
$
1,181

$
1,462

(19
)%
Underwriting:


 
Equity
2,092

1,286

63
 %
Fixed income
1,629

1,410

16
 %
Total Underwriting
3,721

2,696

38
 %
Total Investment banking
$
4,902

$
4,158

18
 %

September 2020 Form 10-Q
10
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Investment Banking Volumes
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in billions
2020
2019
2020
2019
Completed mergers and acquisitions1
$
88

$
215

$
633

$
582

Equity and equity-related offerings2, 3
25

17

74

47

Fixed income offerings2, 4
91

90

304

211

Source: Refinitiv data as of October 1, 2020. Transaction volumes may not be indicative of net revenues in a given period. In addition, transaction volumes for prior periods may vary from amounts previously reported due to the subsequent withdrawal, change in value or change in timing of certain transactions.
1.
Includes transactions of $100 million or more. Based on full credit to each of the advisors in a transaction.
2.
Based on full credit for single book managers and equal credit for joint book managers.
3.
Includes Rule 144A issuances and registered public offerings of common stock, convertible securities and rights offerings.
4.
Includes Rule 144A and publicly registered issuances, non-convertible preferred stock, mortgage-backed and asset-backed securities, and taxable municipal debt. Excludes leveraged loans and self-led issuances.
Investment Banking Revenues in the Current Quarter
Investment banking revenues of $1,707 million in the current quarter increased 11% from the prior year quarter, reflecting an increase in revenues in our Equity underwriting business, partially offset by a decrease in revenues in our Advisory and Fixed income underwriting businesses.
Advisory revenues decreased in the current quarter primarily as a result of lower volumes of completed M&A activity.

Equity underwriting revenues increased, primarily in initial public offerings, follow-on offerings and secondary block share trades, on overall higher volumes in the current quarter.

Fixed income underwriting revenues decreased in the current quarter primarily in non-investment grade and investment grade loan issuances, reflecting lower event-driven activity.
Investment Banking Revenues in the Current Year Period
Investment banking revenues of $4,902 million in the current year period increased 18% from the prior year period, reflecting an increase in revenues in our underwriting businesses, partially offset by a decrease in revenues in our Advisory business.
Advisory revenues decreased in the current year period as there were fewer completed transactions.

Equity underwriting revenues increased, primarily in follow-on offerings, secondary block share trades, initial public offerings and convertible issuances, on overall higher volumes in the current year period.

 
Fixed income underwriting revenues increased, primarily in investment grade and non-investment grade bond issuances, partially offset by investment grade loan issuances, on overall higher volumes.
See “Investment Banking Volumes” herein.
Sales and Trading Net Revenues

By Income Statement Line Item
 
Three Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Trading
$
2,807

$
2,533

11
 %
Commissions and fees
639

643

(1
)%
Asset management
114

100

14
 %
Net interest
594

179

N/M

Total
$
4,154

$
3,455

20
 %
 
Nine Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Trading
$
10,375

$
8,221

26
%
Commissions and fees
2,230

1,889

18
%
Asset management
342

310

10
%
Net interest
1,625

81

N/M

Total
$
14,572

$
10,501

39
%
By Business
 
Three Months Ended
September 30,
 
 
 
$ in millions
2020
2019
% Change
Equity
$
2,262

$
1,991

14
 %
Fixed Income
1,924

1,430

35
 %
Other
(32
)
34

(194
)%
Total
$
4,154

$
3,455

20
 %
 
Nine Months Ended
September 30,
 
 
 
$ in millions
2020
2019
% Change
Equity
$
7,303

$
6,136

19
%
Fixed Income
7,160

4,273

68
%
Other
109

92

18
%
Total
$
14,572

$
10,501

39
%


 
11
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Sales and Trading Revenues—Equity and Fixed Income
 
Three Months Ended
September 30, 2020
 
 
 
Net
 
$ in millions
Trading
Fees1
Interest2
Total
Financing
$
929

$
108

$
116

$
1,153

Execution services
606

580

(77
)
1,109

Total Equity
$
1,535

$
688

$
39

$
2,262

Total Fixed Income
$
1,420

$
65

$
439

$
1,924

 
Three Months Ended
September 30, 2019
 
 
 
Net
 
$ in millions
Trading
Fees1
Interest2
Total
Financing
$
1,049

$
88

$
(90
)
$
1,047

Execution services
446

564

(66
)
944

Total Equity
$
1,495

$
652

$
(156
)
$
1,991

Total Fixed Income
$
1,329

$
90

$
11

$
1,430


 
Nine Months Ended
September 30, 2020
 
 
 
Net
 
$ in millions
Trading
Fees1
Interest2
Total
Financing
$
2,847

$
325

$
172

$
3,344

Execution services
2,134

2,014

(189
)
3,959

Total Equity
$
4,981

$
2,339

$
(17
)
$
7,303

Total Fixed Income
$
5,661

$
234

$
1,265

$
7,160

 
Nine Months Ended
September 30, 2019
 
 
 
Net
 
$ in millions
Trading
Fees1
Interest2
Total
Financing
$
3,249

$
280

$
(500
)
$
3,029

Execution services
1,597

1,671

(161
)
3,107

Total Equity
$
4,846

$
1,951

$
(661
)
$
6,136

Total Fixed Income
$
4,200

$
249

$
(176
)
$
4,273

1.
Includes Commissions and fees and Asset management revenues.
2.
Includes funding costs, which are allocated to the businesses based on funding usage.
Sales and Trading Net Revenues in the Current Quarter
Equity
Equity sales and trading net revenues of $2,262 million in the current quarter increased 14% from the prior year quarter, reflecting increases in both our execution services and financing businesses.
Financing revenues increased from the prior year quarter, primarily driven by client activity. The effect of lower interest rates was an increase in Net interest driven by lower funding costs, partially offset by reduced Trading revenues.
Execution services revenues increased from the prior year quarter primarily due to higher Trading revenues reflecting
 
favorable inventory management results and higher client activity in derivatives products.
Fixed Income
Fixed Income sales and trading net revenues of $1,924 million in the current quarter were 35% higher than the prior year quarter, reflecting strong performance across all products.
Global macro products revenues increased primarily due to improved inventory management in rates and foreign exchange products, partially offset by lower levels of client activity across all products.
Credit products revenues increased primarily driven by improved inventory management and higher client activity, which benefited from an active primary market in the current quarter. Net interest revenues increased reflecting lower funding costs.
Commodities products and Other revenues increased primarily due to favorable inventory management in Commodities, mainly in precious metals products.
Other
Other sales and trading losses of $32 million in the current quarter primarily reflect losses on economic hedges related to certain Borrowings and corporate lending activity, partially offset by gains from investments associated with certain employee deferred compensation plans.
Sales and Trading Net Revenues in the Current Year Period
Equity
Equity sales and trading net revenues of $7,303 million in the current year period increased 19% from the prior year period, reflecting increases in both our execution services and financing businesses.
Financing revenues increased from the prior year period, primarily driven by client activity. The effect of lower interest rates was an increase in Net interest driven by lower funding costs, partially offset by reduced Trading revenues.
Execution services revenues increased from the prior year period, reflecting higher client activity and favorable inventory management results in cash equities and derivatives, partially offset by the impact of counterparty exposure losses.

September 2020 Form 10-Q
12
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Fixed Income
Fixed Income sales and trading net revenues of $7,160 million in the current year period were 68% higher than the prior year period, reflecting strong performance across all products.
Global macro products revenues increased primarily due to higher client activity in both rates and foreign exchange products and improved inventory management results.
Credit products revenues increased primarily due to higher client activity in corporate credit and securitized products from higher volumes and wider bid-offer spreads, partially offset by the effect of widening credit spreads on inventory. Net interest revenues increased reflecting lower funding costs and higher average balances in secured lending facilities.
Commodities products and Other revenues increased primarily reflecting favorable inventory management and higher client activity in commodities, partially offset by lower client structuring activity within derivatives counterparty credit risk management.
Other
Other sales and trading revenues of $109 million in the current year period increased from the prior year period reflecting gains on hedges associated with corporate lending activity, partially offset by lower yields on liquidity investments, lower gains from investments associated with certain employee deferred compensation plans and losses on economic hedges related to certain Borrowings.

Investments, Other Revenues, Non-interest Expenses, and Income Tax Items
Investments
Net investments gains of $87 million in the current quarter include gains on certain business-related investments compared with losses in the prior year quarter.
Net investments gains of $98 million in the current year period include gains on certain business-related investments. The prior year period included gains associated with an investment’s initial public offering.
Other Revenues
Other revenues of $114 million in the current quarter increased compared to the prior year quarter primarily as a result of mark-to-market gains on loans and lending commitments held for sale as credit spreads tightened, partially offset by an increase in the provision for credit losses on loans held for investment.
Other net losses of $628 million in the current year period were primarily as a result of mark-to-market losses on loans
 
and lending commitments held for sale as credit spreads widened and an increase in the provision for credit losses on loans held for investment.
Non-interest Expenses
Non-interest expenses of $4,014 million in the current quarter increased from the prior year quarter, primarily reflecting a 13% increase in Compensation and benefits expenses.
Compensation and benefits expenses increased in the current quarter primarily due to increases in discretionary incentive compensation, driven by higher revenues, and higher expenses related to certain deferred compensation plans linked to investment performance.

Non-compensation expenses increased in the current quarter primarily due to higher volume-related expenses and information processing and communications expenses, partially offset by lower litigation costs.
Non-interest expenses of $12,953 million in the current year period increased from the prior year period, reflecting a 26% increase in Compensation and benefits expenses and an 11% increase in Non-compensation expenses.
Compensation and benefits expenses increased in the current year period primarily due to increases in discretionary incentive compensation, driven by higher revenues, partially offset by lower expenses related to certain deferred compensation plans linked to investment performance.

Non-compensation expenses increased in the current year period primarily due to higher volume-related expenses, an increase in the provision for credit losses for lending commitments held for investment and off-balance sheet instruments, and higher information processing and communications expenses. Partially offsetting these increases were lower marketing and business development expenses.
Income Tax Items
The current quarter and prior year quarter included intermittent net discrete tax benefits of $115 million and $67 million, respectively.
The current year period and prior year period included intermittent net discrete tax benefits of $17 million and $168 million, respectively.
For further information, see “Supplemental Financial Information—Income Tax Matters” herein.

 
13
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Wealth Management

Income Statement Information
 
Three Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Revenues
 
 
 
Investment banking
$
135

$
118

14
 %
Trading
268

61

N/M

Investments
1


N/M

Commissions and fees
477

416

15
 %
Asset management
2,793

2,639

6
 %
Other
94

81

16
 %
Total non-interest revenues
3,768

3,315

14
 %
Interest income
1,065

1,378

(23
)%
Interest expense
176

335

(47
)%
Net interest
889

1,043

(15
)%
Net revenues
4,657

4,358

7
 %
Compensation and benefits
2,684

2,340

15
 %
Non-compensation expenses
853

780

9
 %
Total non-interest expenses
3,537

3,120

13
 %
Income before provision for income taxes
$
1,120

$
1,238

(10
)%
Provision for income taxes
278

276

1
 %
Net income applicable to Morgan Stanley
$
842

$
962

(12
)%

 
Nine Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Revenues
 
 
 
Investment banking
$
403

$
365

10
 %
Trading
413

525

(21
)%
Investments
9

1

N/M

Commissions and fees
1,538

1,250

23
 %
Asset management
7,980

7,544

6
 %
Other
216

281

(23
)%
Total non-interest revenues
10,559

9,966

6
 %
Interest income
3,468

4,139

(16
)%
Interest expense
653

950

(31
)%
Net interest
2,815

3,189

(12
)%
Net revenues
13,374

13,155

2
 %
Compensation and benefits
7,625

7,184

6
 %
Non-compensation expenses
2,432

2,302

6
 %
Total non-interest expenses
10,057

9,486

6
 %
Income before provision for income taxes
$
3,317

$
3,669

(10
)%
Provision for income taxes
758

830

(9
)%
Net income applicable to Morgan Stanley
$
2,559

$
2,839

(10
)%


 

Financial Information and Statistical Data
 
$ in billions, except employee data
Client assets
$
2,852

$
2,700

Fee-based client assets1
$
1,333

$
1,267

Fee-based client assets as a percentage of total client assets
47
%
47
%
Client liabilities2
$
100

$
90

Investment securities
$
88.6

$
67.2

Loans and lending commitments
$
105.9

$
93.2

Wealth Management representatives
15,469

15,468

 
Three Months Ended
September 30,
 
2020
2019
Per representative:
 
 
Annualized revenues ($ in thousands)3
$
1,207

$
1,118

Client assets ($ in millions)4
$
184

$
165

Fee-based asset flows ($ in billions)5
$
23.8

$
15.5

 
Nine Months Ended
September 30,
 
2020
2019
Per representative:
 
 
Annualized revenues ($ in thousands)3
$
1,155

$
1,121

Client assets ($ in millions)4
$
184

$
165

Fee-based asset flows ($ in billions)5
$
53.3

$
40.1

 
1.
Fee-based client assets represent the amount of assets in client accounts where the fee for services is calculated based on those assets.
2.
Client liabilities include securities-based and other loans (including tailored lending), residential real estate loans and margin lending.
3.
Revenues per representative equals Wealth Management’s annualized net revenues divided by the average number of representatives.
4.
Client assets per representative equals total period-end client assets divided by period-end number of representatives.
5.
Excludes institutional cash management-related activity. For a description of the Inflows and Outflows included within Fee-based asset flows, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management” in the 2019 Form 10-K.

September 2020 Form 10-Q
14
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Transactional Revenues
 
Three Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Investment banking
$
135

$
118

14
%
Trading
268

61

N/M

Commissions and fees
477

416

15
%
Total
$
880

$
595

48
%
Transactional revenues as a % of Net revenues
19
%
14
%
 
 
Nine Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Investment banking
$
403

$
365

10
 %
Trading
413

525

(21
)%
Commissions and fees
1,538

1,250

23
 %
Total
$
2,354

$
2,140

10
 %
Transactional revenues as a % of Net revenues
18
%
16
%
 
Net Revenues
Transactional Revenues
Transactional revenues of $880 million in the current quarter increased 48% from the prior year quarter primarily as a result of higher Trading revenues and higher Commissions and fees.
Trading revenues increased in the current quarter primarily due to gains from investments associated with certain employee deferred compensation plans, partially offset by lower fixed income revenues.
Commissions and fees increased in the current quarter primarily due to increased client activity in equities.
Transactional revenues of $2,354 million in the current year period increased 10% from the prior year period primarily as a result of higher Commissions and fees, partially offset by lower Trading revenues.
Trading revenues decreased in the current year period primarily due to lower fixed income revenues.
Commissions and fees increased in the current year period primarily due to increased client activity in equities.
Asset Management
Asset management revenues of $2,793 million in the current quarter increased 6% compared with the prior year quarter due to higher fee-based asset levels during the current quarter as a result of positive net flows and market appreciation, partially offset by lower average fee rates.
Asset management revenues of $7,980 million in the current year period increased 6% from the prior year period primarily
 
due to higher fee-based asset levels during the current year period as a result of market appreciation and positive net flows, partially offset by lower average fee rates.
See “Fee-Based Client Assets—Rollforwards” herein.
Other
Other revenues of $216 million in the current year period decreased 23% from the prior year period primarily due to lower realized gains from the AFS securities portfolio and an increase in the provision for credit losses.
Net Interest
Net interest of $889 million and $2,815 million decreased 15% and 12%, from the prior year periods primarily due to the net effect of lower interest rates, partially offset by growth in Loans and increases in investment portfolio balances driven by higher brokerage sweep deposits.
Non-interest Expenses
Non-interest expenses of $3,537 million in the current quarter increased 13% from the prior year quarter, primarily as a result of higher Compensation and benefits expenses.
Compensation and benefits expenses increased in the current quarter, primarily due to higher expenses related to certain deferred compensation plans linked to investment performance and an increase in the formulaic payout to Wealth Management representatives, driven by higher compensable revenues.
Non-compensation expenses increased in the current quarter, reflecting a regulatory charge, as well as expenses associated with the E*TRADE acquisition, partially offset by lower marketing and business development expenses.
Non-interest expenses of $10,057 million in the current year period increased 6% from the prior year period, primarily as a result of higher Compensation and benefits expenses.
Compensation and benefits expenses increased in the current year period primarily due to an increase in the formulaic payout to Wealth Management representatives, driven by higher compensable revenues, as well as higher salaries.
Non-compensation expenses increased in the current year period, reflecting a regulatory charge, as well as expenses associated with the E*TRADE acquisition and incremental expenses related to Solium Capital, Inc., partially offset by lower marketing and business development expenses.


 
15
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Fee-Based Client Assets

Rollforwards
$ in billions
Inflows
Outflows
Market
Impact
Separately managed1
$
313

$
19

$
(4
)
$
14

$
342

Unified managed
305

16

(12
)
18

327

Advisor
149

8

(8
)
9

158

Portfolio manager
431

21

(16
)
23

459

Subtotal
$
1,198

$
64

$
(40
)
$
64

$
1,286

Cash management
38

12

(3
)

47

Total fee-based client assets
$
1,236

$
76

$
(43
)
$
64

$
1,333

$ in billions
Inflows
Outflows
Market
Impact
Separately managed1
$
296

$
15

$
(5
)
$
6

$
312

Unified managed
292

12

(10
)
1

295

Advisor
149

7

(8
)

148

Portfolio manager
400

19

(14
)
2

407

Subtotal
$
1,137

$
53

$
(37
)
$
9

$
1,162

Cash management
22

4

(3
)
1

24

Total fee-based client assets
$
1,159

$
57

$
(40
)
$
10

$
1,186

$ in billions
Inflows
Outflows
Market
Impact
Separately managed1
$
322

$
37

$
(14
)
$
(3
)
$
342

Unified managed
313

43

(33
)
4

327

Advisor
155

22

(21
)
2

158

Portfolio manager
435

62

(43
)
5

459

Subtotal
$
1,225

$
164

$
(111
)
$
8

$
1,286

Cash management
42

21

(16
)

47

Total fee-based client assets
$
1,267

$
185

$
(127
)
$
8

$
1,333

$ in billions
Inflows
Outflows
Market
Impact
Separately managed1
$
279

$
38

$
(15
)
$
10

$
312

Unified managed
257

35

(30
)
33

295

Advisor
137

20

(24
)
15

148

Portfolio manager
353

54

(38
)
38

407

Subtotal
$
1,026

$
147

$
(107
)
$
96

$
1,162

Cash management
20

12

(12
)
4

24

Total fee-based client assets
$
1,046

$
159

$
(119
)
$
100

$
1,186

1.
Includes non-custody account values reflecting prior quarter-end balances due to a lag in the reporting of asset values by third-party custodians.

 

Average Fee Rates
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
Fee rate in bps
2020
2019
2020
2019
Separately managed
15

15

14

15

Unified managed
99

99

99

100

Advisor
85

86

85

87

Portfolio manager
94

96

94

95

Subtotal
73

74

72

74

Cash management
5

6

5

6

Total fee-based client assets
71

73

70

73

For a description of fee-based client assets and rollforward items in the previous tables, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management—Fee-Based Client Assets” in the 2019 Form 10-K.
Acquisition of E*TRADE
On October 2, 2020, we completed the acquisition of E*TRADE principally via the issuance of approximately $11 billion of common shares. In addition, we issued $0.7 billion of preferred shares in exchange for E*TRADE’s existing preferred stock. We believe the combination will increase the scale and breadth of Morgan Stanley’s Wealth Management franchise, and position us to be an industry leader in Wealth Management across all channels and wealth segments.

The business activities of E*TRADE will be reported within the Wealth Management business segment beginning in the fourth quarter of 2020, and the following table illustrates how E*TRADE’s primary revenues will be presented.
E*TRADE Revenues
Morgan Stanley Revenues
Net interest income
Net interest
Fees and service charges
Commissions and fees1
Asset management
Commissions
Commissions and fees
1.
The primary element of this mapping is revenues from order flow payments.

Non-interest expenses are also expected to be impacted by integration costs. For additional information on the acquisition of E*TRADE, see Note 3 to the financial statements.



September 2020 Form 10-Q
16
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Investment Management
Income Statement Information
 
Three Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Revenues
 
 
 
Trading
$
2

$
2

 %
Investments
258

105

146
 %
Commissions and fees
1

1

 %
Asset management
795

664

20
 %
Other
1


N/M

Total non-interest revenues
1,057

772

37
 %
Interest income
7

4

75
 %
Interest expense
8

12

(33
)%
Net interest
(1
)
(8
)
88
 %
Net revenues
1,056

764

38
 %
Compensation and benefits
401

319

26
 %
Non-compensation expenses
340

280

21
 %
Total non-interest expenses
741

599

24
 %
Income before provision for income taxes
315

165

91
 %
Provision for income taxes
72

27

167
 %
Net income
243

138

76
 %
Net income applicable to noncontrolling interests
18


N/M

Net income applicable to Morgan Stanley
$
225

$
138

63
 %

 

 
Nine Months Ended
September 30,
 
$ in millions
2020
2019
% Change
Revenues
 
 

Investment banking
$

$
(1
)
100
 %
Trading
(13
)
(2
)
N/M

Investments
552

543

2
 %
Commissions and fees
1

1

 %
Asset management
2,144

1,893

13
 %
Other
(39
)
(6
)
N/M

Total non-interest revenues
2,645

2,428

9
 %
Interest income
22

14

57
 %
Interest expense
33

35

(6
)%
Net interest
(11
)
(21
)
48
 %
Net revenues
2,634

2,407

9
 %
Compensation and benefits
1,012

1,049

(4
)%
Non-compensation expenses
948

820

16
 %
Total non-interest expenses
1,960

1,869

5
 %
Income before provision for income taxes
674

538

25
 %
Provision for income taxes
136

104

31
 %
Net income
538

434

24
 %
Net income applicable to noncontrolling interests
81

32

153
 %
Net income applicable to Morgan Stanley
$
457

$
402

14
 %
Net Revenues
Investments
Investments revenues of $258 million in the current quarter increased 146% from the prior year quarter, primarily due to higher accrued carried interest and investment gains in an Asia private equity fund, principally driven by gains from an underlying investment.
Investments revenues of $552 million in the current year period were relatively unchanged from the prior year period as higher accrued carried interest and investment gains in an Asia private equity fund, principally driven by gains from an underlying investment, were mostly offset by the reversal of accrued carried interest and investment losses in real estate, infrastructure and certain private equity funds.
Asset Management
Asset management revenues of $795 million in the current quarter and $2,144 million in the current year period increased 20% and 13% from the prior year quarter and prior year period, respectively, primarily as a result of higher average AUM, driven by strong investment performance and positive long-term net flows.
See “Assets Under Management or Supervision” herein.

 
17
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Other
Other losses of $39 million in the current year period primarily reflect an impairment of an investment in a third-party asset manager in the second quarter of 2020.
Non-interest Expenses
Non-interest expenses of $741 million in the current quarter increased 24% from the prior year quarter as a result of higher Compensation and benefits expenses and higher Non-compensation expenses.
Compensation and benefits expenses increased in the current quarter primarily as a result of higher expenses related to certain deferred compensation plans linked to investment performance, increases in discretionary incentive compensation driven by higher Asset management revenues, and higher compensation associated with carried interest.
Non-compensation expenses in the current quarter increased from the prior year quarter primarily as a result of higher fee sharing paid to intermediaries on higher average AUM.
Non-interest expenses of $1,960 million in the current year period increased 5% from the prior year period primarily as a result of higher Non-compensation expenses.
Compensation and benefits expenses decreased in the current year period primarily as a result of lower compensation associated with carried interest partially offset by higher expenses related to certain deferred compensation plans linked to investment performance, and increases in discretionary incentive compensation driven by higher Asset management revenues.
Non-compensation expenses in the current year period increased from the prior year period primarily as a result of higher fee sharing paid to intermediaries on higher average AUM.
Assets Under Management or Supervision
Rollforwards
$ in billions
Inflows
Outflows
Market
Impact
Other
Equity
$
168

$
24

$
(14
)
$
23

$
1

$
202

Fixed income
84

8

(5
)
1

4

92

Alternative/Other
145

6

(7
)
4

2

150

Long-term AUM subtotal
397

38

(26
)
28

7

444

Liquidity
268

319

(317
)

1

271

Total AUM
$
665

$
357

$
(343
)
$
28

$
8

$
715

 
$ in billions
Inflows
Outflows
Market
Impact
Other
Equity
$
128

$
10

$
(8
)
$
(4
)
$

$
126

Fixed income
71

6

(4
)
2

(1
)
74

Alternative/Other
135

5

(4
)
2

(3
)
135

Long-term AUM subtotal
334

21

(16
)

(4
)
335

Liquidity
163

311

(301
)
(1
)

172

Total AUM
$
497

$
332

$
(317
)
$
(1
)
$
(4
)
$
507

$ in billions
Inflows
Outflows
Market
Impact
Other
Equity
$
138

$
56

$
(35
)
$
42

$
1

$
202

Fixed income
79

29

(20
)
1

3

92

Alternative/Other
139

21

(15
)
(1
)
6

150

Long-term AUM subtotal
356

106

(70
)
42

10

444

Liquidity
196

1,174

(1,100
)
1


271

Total AUM
$
552

$
1,280

$
(1,170
)
$
43

$
10

$
715

$ in billions
Inflows
Outflows
Market
Impact
Other
Equity
$
103

$
28

$
(23
)
$
18

$

$
126

Fixed income
68

17

(15
)
5

(1
)
74

Alternative/Other
128

17

(14
)
8

(4
)
135

Long-term AUM subtotal
299

62

(52
)
31

(5
)
335

Liquidity
164

965

(956
)
1

(2
)
172

Total AUM
$
463

$
1,027

$
(1,008
)
$
32

$
(7
)
$
507

Average AUM
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in billions
2020
2019
2020
2019
Equity
$
190

$
127

$
159

$
120

Fixed income
90

73

84

70

Alternative/Other
148

135

143

133

Long-term AUM subtotal
428

335

386

323

Liquidity
267

169

244

166

Total AUM
$
695

504

$
630

$
489

Average Fee Rates
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
Fee rate in bps
2020
2019
2020
2019
Equity
76

76
75

76
Fixed income
29

32
29

32
Alternative/Other
58

62
59

65
Long-term AUM
60

61
59

62
Liquidity
15

17
16

17
Total AUM
43

46
42

47
For a description of the asset classes and rollforward items in the previous tables, see Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Investment Management—Assets Under Management or Supervision” in the 2019 Form 10-K.

September 2020 Form 10-Q
18
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Planned Acquisition of Eaton Vance
On October 8, 2020, we entered into a definitive agreement under which we will acquire Eaton Vance Corp. (“Eaton Vance”), a leading provider of advanced investment management strategies and wealth management solutions, in a cash and stock transaction valued, as of the announcement, at approximately $7 billion, based on the closing price of our common stock and the number of Eaton Vance’s fully diluted shares outstanding on October 7, 2020. Under the terms of the agreement, Eaton Vance common stockholders will receive $28.25 in cash and 0.5833 shares of our common shares for each Eaton Vance common share. In addition, Eaton Vance common shareholders will receive a one-time special cash dividend of $4.25 per share to be paid pre-closing by Eaton Vance. The acquisition is subject to customary closing conditions, and is expected to close in the second quarter of 2021.


 
19
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Supplemental Financial Information
Income Tax Matters
Effective Tax Rate
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
U.S. GAAP
21.1
%
18.2
%
22.2
%
19.1
%
Adjusted effective income tax rate—non-GAAP1
24.3
%
21.4
%
22.3
%
21.3
%
Net discrete tax provisions (benefits)
 
 
Recurring2
$

$

$
(94
)
$
(127
)
Intermittent3
(113
)
(89
)
(10
)
(190
)
 
1.
The adjusted effective income tax rate is a non-GAAP measure that excludes net discrete tax provisions (benefits) that are intermittent and includes those that are recurring. For further information on non-GAAP measures, seeSelected Non-GAAP Financial Information” herein.
2.
Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items.
3.
Includes all tax provisions (benefits) that have been determined to be discrete, other than Recurring items as defined above.
The current quarter included intermittent net discrete tax benefits principally associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of tax examinations in certain jurisdictions.
The prior year quarter included intermittent net discrete tax benefits primarily associated with the filing of the 2018 federal tax return and the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.
The prior year period included intermittent net discrete tax benefits primarily associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations and other matters. See Note 19 to the financial statements for further information.
U.S. Bank Subsidiaries
Our U.S. bank subsidiaries as of September 30, 2020, Morgan Stanley Bank N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) (collectively, “U.S. Bank Subsidiaries) accept deposits; provide loans to corporations, governments, financial institutions and high to ultra-high net worth clients; and invest in securities. Lending activity recorded in the U.S. Bank Subsidiaries from the Institutional Securities business segment primarily includes loans and lending commitments to corporate clients. Lending activity recorded in the U.S. Bank Subsidiaries from the Wealth Management business segment primarily includes securities-based lending, which allows clients to borrow money against
 
the value of qualifying securities, and residential real estate loans.
For a further discussion of our credit risks, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk.” For a further discussion about loans and lending commitments, see Notes 10 and 14 to the financial statements.
U.S. Bank Subsidiaries’ Supplemental Financial Information1 
$ in billions
Assets
$
266.2

$
219.6

Investment securities portfolio:
 
 
Investment securities—AFS
62.9

42.4

Investment securities—HTM
28.2

26.1

Total investment securities
$
91.1

$
68.5

Deposits2
$
238.0

$
189.3

Wealth Management Loans3
Residential real estate
$
33.6

$
30.2

Securities-based lending and Other4
57.7

49.9

Total
$
91.3

$
80.1

Institutional Securities Loans3
Corporate
$
7.8

$
5.6

Secured lending facilities
28.2

26.8

Commercial and Residential real estate
8.6

12.0

Securities-based lending and Other
4.7

5.4

Total
$
49.3

$
49.8


1.
Amounts exclude transactions between the bank subsidiaries, as well as deposits from the Parent Company and affiliates.
2.
For further information on deposits, seeLiquidity and Capital Resources—Funding Management—Unsecured Financing” herein.
3.
For a further discussion of loans in the Wealth Management and Institutional Securities business segments, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” herein.
4.
Other loans primarily include tailored lending.
Accounting Development Updates
The Financial Accounting Standards Board has issued certain accounting updates, which we have either determined are not applicable or are not expected to have a significant impact on our financial statements.

September 2020 Form 10-Q
20
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Critical Accounting Policies
Our financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions (see Note 1 to the financial statements). We believe that of our significant accounting policies (see Note 2 to the financial statements in the 2019 Form 10-K and Note 2 to the financial statements), the fair value, goodwill and intangible assets, legal and regulatory contingencies and income taxes policies involve a higher degree of judgment and complexity. For a further discussion about our critical accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in the 2019 Form 10-K.
Liquidity and Capital Resources
Senior management, with oversight by the Asset/Liability Management Committee and the Board of Directors (“Board”), establishes and maintains our liquidity and capital policies. Through various risk and control committees, senior management reviews business performance relative to these policies, monitors the availability of alternative sources of financing, and oversees the liquidity, interest rate and currency sensitivity of our asset and liability position. Our Treasury department, Firm Risk Committee, Asset/Liability Management Committee, and other committees and control groups assist in evaluating, monitoring and controlling the impact that our business activities have on our balance sheet, liquidity and capital structure. Liquidity and capital matters are reported regularly to the Board and the Risk Committee of the Board.
Balance Sheet
We monitor and evaluate the composition and size of our balance sheet on a regular basis. Our balance sheet management process includes quarterly planning, business-specific thresholds, monitoring of business-specific usage versus key performance metrics and new business impact assessments.
We establish balance sheet thresholds at the consolidated and business segment levels. We monitor balance sheet utilization and review variances resulting from business activity and market fluctuations. On a regular basis, we review current performance versus established thresholds and assess the need to re-allocate our balance sheet based on business unit needs. We also monitor key metrics, including asset and liability size and capital usage.
 
Total Assets by Business Segment
 
$ in millions
IS
WM
IM
Total
Assets




Cash and cash equivalents
$
72,592

$
22,018

$
162

$
94,772

Trading assets at fair value
289,528

298

4,142

293,968

Investment securities
42,149

88,556


130,705

Securities purchased under agreements to resell
73,637

14,646


88,283

Securities borrowed
100,175

628


100,803

Customer and other receivables
57,593

14,067

877

72,537

Loans1
54,918

91,302

17

146,237

Other assets2
13,731

12,910

1,994

28,635

Total assets
$
704,323

$
244,425

$
7,192

$
955,940

 
 
$ in millions
IS
WM
IM
Total
Assets
 
 
 
 
Cash and cash equivalents
$
67,657

$
14,247

$
267

$
82,171

Trading assets at fair value
293,477

47

3,586

297,110

Investment securities
38,524

67,201


105,725

Securities purchased under agreements to resell
80,744

7,480


88,224

Securities borrowed
106,199

350


106,549

Customer and other receivables
39,743

15,190

713

55,646

Loans1
50,557

80,075

5

130,637

Other assets2
14,300

13,092

1,975

29,367

Total assets
$
691,201

$
197,682

$
6,546

$
895,429

IS—Institutional Securities
WM—Wealth Management
IM—Investment Management
1.
Amounts include loans held for investment, net of allowance, and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see Note 10 to the financial statements).
2.
Other assets primarily includes Goodwill and Intangible assets, premises, equipment and software, ROU assets related to leases, other investments, and deferred tax assets.
A substantial portion of total assets consists of liquid marketable securities and short-term receivables arising principally from sales and trading activities in the Institutional Securities business segment. Total assets increased to $956 billion at September 30, 2020 from $895 billion at December 31, 2019.
Wealth Management assets increased driven by continued growth in Loans as well as in the investment portfolio, comprising Investment securities, Cash and cash equivalents, and Securities purchased under agreements to resell, as a result of significantly higher deposits in this segment.
Institutional Securities’ assets were also higher, reflecting increases within Customer and other receivables, primarily in Equity financing.
Liquidity Risk Management Framework
The core components of our Liquidity Risk Management Framework are the Required Liquidity Framework, Liquidity Stress Tests and Liquidity Resources, which support our target

 
21
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

liquidity profile. For a further discussion about the Firm’s Required Liquidity Framework and Liquidity Stress Tests, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Liquidity Risk Management Framework” in the 2019 Form 10-K.
At September 30, 2020 and December 31, 2019, we maintained sufficient liquidity to meet current and contingent funding obligations as modeled in our Liquidity Stress Tests.
Liquidity Resources
We maintain sufficient liquidity resources, which consist of HQLA and cash deposits with banks (“Liquidity Resources”) to cover daily funding needs and to meet strategic liquidity targets sized by the Required Liquidity Framework and Liquidity Stress Tests. The total amount of Liquidity Resources is actively managed by us considering the following components: unsecured debt maturity profile; balance sheet size and composition; funding needs in a stressed environment, inclusive of contingent cash outflows; legal entity, regional and segment liquidity requirements; regulatory requirements; and collateral requirements.
The amount of Liquidity Resources we hold is based on our risk tolerance and is subject to change depending on market and Firm-specific events. The Liquidity Resources are primarily held within the Parent Company and its major operating subsidiaries. The Total HQLA values in the tables immediately following are different from Eligible HQLA which, in accordance with the LCR rule, also takes into account certain regulatory weightings and other operational considerations.
Liquidity Resources by Type of Investment1 
$ in millions
Cash deposits with central banks
$
41,639

$
35,025

Unencumbered HQLA Securities2:
 
 
U.S. government obligations
113,058

88,754

U.S. agency and agency mortgage-backed securities
63,961

50,732

Non-U.S. sovereign obligations3
37,470

29,909

Other investment grade securities
1,398

1,591

Total HQLA2
$
257,526

$
206,011

Cash deposits with banks (non-HQLA)
9,766

9,857

Total Liquidity Resources
$
267,292

$
215,868

1.
In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation.
2.
HQLA is presented prior to applying weightings and includes all HQLA held in subsidiaries.
3.
Primarily composed of unencumbered Japanese, UK, French, German and Dutch government obligations.
4.
 
Liquidity Resources by Bank and Non-Bank Legal Entities1 
$ in millions
Average Daily Balance
Three Months Ended
September 30, 2020
Bank legal entities


Domestic
$
115,821

$
75,894

$
113,991

Foreign
5,384

4,049

5,624

Total Bank legal entities
121,205

79,943

119,615

Non-Bank legal entities


Domestic:



Parent Company
62,561

53,128

74,587

Non-Parent Company
30,215

28,905

34,341

Total Domestic
92,776

82,033

108,928

Foreign
53,311

53,892

55,933

Total Non-Bank legal entities
146,087

135,925

164,861

Total Liquidity Resources
$
267,292

$
215,868

$
284,476

 
1.
In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation.
Liquidity Resources may fluctuate from period to period based on the overall size and composition of our balance sheet, the maturity profile of our unsecured debt and estimates of funding needs in a stressed environment, among other factors. Liquidity Resources increased in the current year period primarily due to an increase in deposits.
Regulatory Liquidity Framework
Liquidity Coverage Ratio
We and our U.S. Bank Subsidiaries are subject to LCR requirements, including a requirement to calculate each entity’s LCR on each business day. The requirements are designed to ensure that banking organizations have sufficient Eligible HQLA to cover net cash outflows arising from significant stress over 30 calendar days, thus promoting the short-term resilience of the liquidity risk profile of banking organizations. In determining Eligible HQLA for LCR purposes, weightings (or asset haircuts) are applied to HQLA and certain HQLA held in subsidiaries are excluded.
As of September 30, 2020, we and our U.S. Bank Subsidiaries are compliant with the minimum required LCR of 100%.

September 2020 Form 10-Q
22
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Liquidity Coverage Ratio
 
Average Daily Balance
Three Months Ended
$ in millions
Eligible HQLA1
 
 
Cash deposits with central banks
$
36,481

$
52,369

Securities2
170,817

155,251

Total Eligible HQLA1
$
207,298

$
207,620

LCR
136
%
147
%
1.
Under the LCR rule, Eligible HQLA is calculated using weightings and excluding certain HQLA held in subsidiaries.
2.
Primarily includes U.S. Treasuries, U.S. agency mortgage-backed securities, sovereign bonds and investment grade corporate bonds.
The decrease in the LCR in the current quarter is due to higher average outflows, primarily related to secured funding with remaining maturities of less than 30 days.
Net Stable Funding Ratio
The U.S. banking agencies have finalized a rule to implement the NSFR, which requires large banking organizations to maintain sufficiently stable sources of funding over a one-year time horizon, and will apply to us and our U.S. Bank Subsidiaries. These requirements become effective on July 1, 2021 and we will be in compliance with the final rule by the effective date.
Funding Management
We manage our funding in a manner that reduces the risk of disruption to our operations. We pursue a strategy of diversification of secured and unsecured funding sources (by product, investor and region) and attempt to ensure that the tenor of our liabilities equals or exceeds the expected holding period of the assets being financed.
We fund our balance sheet on a global basis through diverse sources. These sources include our equity capital, borrowings, securities sold under agreements to repurchase, securities lending, deposits, letters of credit and lines of credit. We have active financing programs for both standard and structured products targeting global investors and currencies.
Secured Financing
For a discussion of our secured financing activities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Funding Management—Secured Financing” in the 2019 Form 10-K.
 
Collateralized Financing Transactions
$ in millions
Securities purchased under agreements to resell and Securities borrowed
$
189,086

$
194,773

Securities sold under agreements to repurchase and Securities loaned
$
49,300

$
62,706

Securities received as collateral1
$
8,799

$
13,022

 
Average Daily Balance
Three Months Ended
$ in millions
Securities purchased under agreements to resell and Securities borrowed
$
182,181

$
210,257

Securities sold under agreements to repurchase and Securities loaned
$
58,474

$
64,870

1.
Included within Trading assets in the balance sheets.
Securities sold under agreements to repurchase and Securities loaned decreased to $49 billion at September 30, 2020 from $63 billion at December 31, 2019 primarily as a result of changes to our funding profile as a result of changes in the composition of our assets and liabilities.
See Note 2 to the financial statements in the 2019 Form 10-K and Note 9 to the financial statements for more details on collateralized financing transactions.
In addition to the collateralized financing transactions shown in the previous table, we engage in financing transactions collateralized by customer-owned securities, which are segregated in accordance with regulatory requirements. Receivables under these financing transactions, primarily margin loans, are included in Customer and other receivables in the balance sheets, and payables under these financing transactions, primarily to prime brokerage customers, are included in Customer and other payables in the balance sheets. Our risk exposure on these transactions is mitigated by collateral maintenance policies. We also hold related liquidity reserves.
Unsecured Financing
For a discussion of our unsecured financing activities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Funding Management—Unsecured Financing” in the 2019 Form 10-K.

 
23
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Deposits
$ in millions
Savings and demand deposits:
 
 
Brokerage sweep deposits1
$
164,146

$
121,077

Savings and other
38,431

28,388

Total Savings and demand deposits
202,577

149,465

Time deposits
36,676

40,891

Total
$
239,253

$
190,356

1.
Amounts represent balances swept from client brokerage accounts.
 
Deposits are primarily sourced from our Wealth Management clients and are considered to have stable, low-cost funding characteristics. Total deposits at September 30, 2020 increased compared with December 31, 2019, primarily driven by continued increases in brokerage sweep and savings deposits.
Borrowings by Remaining Maturity at September 30, 20201 
$ in millions
Parent Company
Total
Original maturities of one year or less
$

$
4,553

$
4,553

Original maturities greater than one year
2020
$
641

$
828

$
1,469

2021
19,964

6,186

26,150

2022
16,418

4,011

20,429

2023
15,316

4,657

19,973

2024
15,938

5,436

21,374

Thereafter
83,172

26,324

109,496

Total
$
151,449

$
47,442

$
198,891

Total Borrowings
$
151,449

$
51,995

$
203,444

Maturities over next 12 months2
 
 
$
20,247

1.
Original maturity in the table is generally based on contractual final maturity. For borrowings with put options, remaining maturity represents the earliest put date.
2.
Includes only borrowings with original maturities greater than one year.
Borrowings of $203 billion as of September 30, 2020 increased modestly when compared with $193 billion at December 31, 2019.
We believe that accessing debt investors through multiple distribution channels helps provide consistent access to the unsecured markets. In addition, the issuance of borrowings with original maturities greater than one year allows us to reduce reliance on short-term credit sensitive instruments. Borrowings with original maturities greater than one year are generally managed to achieve staggered maturities, thereby mitigating refinancing risk, and to maximize investor diversification through sales to global institutional and retail clients across regions, currencies and product types.
The availability and cost of financing to us can vary depending on market conditions, the volume of certain trading and lending activities, our credit ratings and the overall availability of credit. We also engage in, and may continue to engage in, repurchases of our borrowings in the ordinary course of business.
 
For further information on Borrowings, see Note 13 to the financial statements.
Credit Ratings
We rely on external sources to finance a significant portion of our daily operations. The cost and availability of financing generally are impacted by our credit ratings, among other things. In addition, our credit ratings can have an impact on certain trading revenues, particularly in those businesses where longer-term counterparty performance is a key consideration, such as certain OTC derivative transactions. When determining credit ratings, rating agencies consider both company-specific and industry-wide factors. These include regulatory or legislative changes, the macroeconomic environment and perceived levels of support, among other things. See also “Risk Factors— Liquidity Risk” in the 2019 Form 10-K.
Parent Company and U.S. Bank Subsidiaries' Issuer Ratings at October 30, 2020
 
Parent Company
 
Short-Term
Debt
Long-Term
Debt
Rating
Outlook
DBRS, Inc.
R-1 (middle)
A (high)
Stable
Fitch Ratings, Inc.
F1
A
Negative
Moody’s Investors Service, Inc.
P-1
A2
Rating Under Review
Rating and Investment Information, Inc.
a-1
A
Stable
S&P Global Ratings
A-2
BBB+
Stable
 
MSBNA
 
Short-Term
Debt
Long-Term
Debt
Rating
Outlook
Fitch Ratings, Inc.
F1
A+
Negative
Moody’s Investors Service, Inc.
P-1
Aa3
Stable
S&P Global Ratings
A-1
A+
Stable
 
MSPBNA
 
Short-Term
Debt
Long-Term
Debt
Rating
Outlook
Moody’s Investors Service, Inc.
P-1
Aa3
Stable
S&P Global Ratings
A-1
A+
Stable
On April 22, 2020, Fitch Ratings, Inc. placed the Parent Company and MSBNA ratings on Negative outlook, a change from Stable, related to their expectation of significant operating environment headwinds due to the disruption to economic activity and financial markets from the COVID-19 pandemic.
On October 2, 2020, Moody’s Investors Service, Inc. (“Moody’s”) upgraded the issuer ratings of the Parent Company from A3 to A2 and U.S. Bank Subsidiaries from A1 to Aa3 and changed the outlooks to Stable. On October 29, Moody’s placed issuer ratings of the Parent Company under review for possible upgrade, changing their outlook from Stable to Rating Under Review.

September 2020 Form 10-Q
24
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Incremental Collateral or Terminating Payments
In connection with certain OTC derivatives and certain other agreements where we are a liquidity provider to certain financing vehicles associated with the Institutional Securities business segment, we may be required to provide additional collateral, immediately settle any outstanding liability balances with certain counterparties or pledge additional collateral to certain clearing organizations in the event of a future credit rating downgrade irrespective of whether we are in a net asset or net liability position. See Note 7 to the financial statements for additional information on OTC derivatives that contain such contingent features.
While certain aspects of a credit rating downgrade are quantifiable pursuant to contractual provisions, the impact it would have on our business and results of operations in future periods is inherently uncertain and would depend on a number of interrelated factors, including, among other things, the magnitude of the downgrade, the rating relative to peers, the rating assigned by the relevant agency pre-downgrade, individual client behavior and future mitigating actions we might take. The liquidity impact of additional collateral requirements is included in our Liquidity Stress Tests.
Capital Management
We view capital as an important source of financial strength and actively manage our consolidated capital position based upon, among other things, business opportunities, risks, capital availability and rates of return together with internal capital policies, regulatory requirements and rating agency guidelines. In the future, we may expand or contract our capital base to address the changing needs of our businesses.
Common Stock Repurchases
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
in millions, except for per share data
2020
2019
2020
2019
Number of shares

36

29

90

Average price per share
$

$
41.92

$
46.01

$
42.77

Total
$

$
1,500

$
1,347

$
3,860

On March 15, 2020, the Financial Services Forum announced that its eight U.S. Bank members, including us, had voluntarily suspended their share repurchase programs. On June 25, 2020, the Federal Reserve published summary results of CCAR and announced that large BHCs generally would be restricted in making share repurchases during the current quarter, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020. For more information on our capital plan, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests” herein.
For further information on our common stock repurchases, see Note 17 to the financial statements.
 
For a description of our capital plan, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests” herein.
Common Stock Dividend Announcement
Announcement date

Amount per share

$0.35

Date to be paid

Shareholders of record as of

  


On June 25, 2020, the Federal Reserve announced that it would limit common stock dividend payments in the current quarter for all large BHCs, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020. For additional information, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests” herein.
Preferred Stock Dividend Announcement
Announcement date
Date paid
Shareholders of record as of
For additional information on common and preferred stock, see Note 17 to the financial statements.
Off-Balance Sheet Arrangements and Contractual Obligations
Off-Balance Sheet Arrangements
We enter into various off-balance sheet arrangements, including through unconsolidated SPEs and lending-related financial instruments (e.g., guarantees and commitments), primarily in connection with the Institutional Securities and Investment Management business segments.
We utilize SPEs primarily in connection with securitization activities. For information on our securitization activities, see Note 14 to the financial statements in the 2019 Form 10-K.
For information on our commitments, obligations under certain guarantee arrangements and indemnities, see Note 14 to the financial statements. For a further discussion of our lending commitments, see Quantitative and Qualitative Disclosures about Risk—Credit Risk—Loans and Lending Commitments.”
Contractual Obligations
For a discussion about our contractual obligations, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Contractual Obligations” in the 2019 Form 10-K.

 
25
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Regulatory Requirements
Regulatory Capital Framework
We are an FHC under the Bank Holding Company Act of 1956, as amended (“BHC Act”), and are subject to the regulation and oversight of the Federal Reserve. The Federal Reserve establishes capital requirements for us, including “well-capitalized” standards, and evaluates our compliance with such capital requirements. Regulatory capital requirements established by the Federal Reserve are largely based on the Basel III capital standards established by the Basel Committee and also implement certain provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”). The OCC establishes similar capital requirements and standards for our U.S. Bank Subsidiaries. For us to remain an FHC, we must remain well-capitalized in accordance with standards established by the Federal Reserve and our U.S. Bank Subsidiaries must remain well-capitalized in accordance with standards established by the OCC. For additional information on regulatory capital requirements for our U.S. Bank Subsidiaries, see Note 16 to the financial statements.
Regulatory Capital Requirements
We are required to maintain minimum risk-based and leverage-based capital and TLAC ratios. For more information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Capital Requirements” in the 2019 Form 10-K. For additional information on TLAC, see “Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” herein.
Risk-Based Regulatory Capital. Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios.
 
Risk-Based Regulatory Capital Ratio Requirements
 
At
Beginning
 
Standardized and Advanced
Standardized
Advanced
Capital buffers
 
 
 
 
Capital conservation buffer
2.5
%

2.5
%
Stress capital buffer (“SCB”)1
N/A

5.7
%
N/A

G-SIB capital surcharge2
3
%
3
%
3
%
CCyB3
0
%
0
%
0
%
Capital buffer requirement4
5.5
%
8.7
%
5.5
%
 
 
At
Beginning
 
Regulatory Minimum
Standardized and Advanced
Standardized
Advanced
Required ratios5
 
 
 
 
Common Equity Tier 1 capital ratio
4.5
%
10.0
%
13.2
%
10.0
%
Tier 1 capital ratio
6.0
%
11.5
%
14.7
%
11.5
%
Total capital ratio
8.0
%
13.5
%
16.7
%
13.5
%
1.
For additional information on the SCB, see “Capital Plans and Stress Tests” and “Regulatory Developments—Stress Capital Buffer Final Rule” herein.
2.
For a further discussion of the G-SIB capital surcharge, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—G-SIB Capital Surcharge” in the 2019 Form 10-K.
3.
The CCyB can be set up to 2.5%, but is currently set by the U.S. banking agencies at zero.
4.
The capital buffer requirement represents the amount of Common Equity Tier 1 capital we must maintain above the minimum risk-based capital requirements in order to avoid restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers. Beginning October 1, 2020, our Standardized Approach capital buffer requirement is equal to the sum of our SCB, G-SIB capital surcharge and CCyB, and our Advanced Approach capital buffer requirement is equal to our 2.5% capital conservation buffer, G-SIB capital surcharge and CCyB.
5.
Required ratios represent the regulatory minimum plus the capital buffer requirement.
Our risk-based capital ratios for purposes of determining regulatory compliance are the lower of the capital ratios computed under (i) the standardized approaches for calculating credit risk and market risk RWA (“Standardized Approach”) or (ii) the applicable advanced approaches for calculating credit risk, market risk and operational risk RWA (“Advanced Approach”). The credit risk RWA calculations between the two approaches differ in that the Standardized Approach requires calculation of RWA using prescribed risk weights, whereas the Advanced Approach utilizes models to calculate exposure amounts and risk weights. At September 30, 2020 and December 31, 2019, our ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively.
Leverage-Based Regulatory Capital. Minimum leverage-based capital requirements include a Tier 1 leverage ratio and an SLR. We are required to maintain an SLR of 5%, inclusive of an enhanced SLR capital buffer of at least 2%.
As of September 30, 2020, our risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated

September 2020 Form 10-Q
26
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.
Regulatory Capital Ratios 
 
$ in millions
Required
Ratio
1
Standardized
Advanced
Risk-based capital
 
 
 
Common Equity Tier 1 capital
 
$
71,157

$
71,157

Tier 1 capital
 
79,905

79,905

Total capital
 
90,018

89,763

Total RWA
 
408,850

420,081

Common Equity Tier 1 capital ratio
10.0
%
17.4
%
16.9
%
Tier 1 capital ratio
11.5
%
19.5
%
19.0
%
Total capital ratio
13.5
%
22.0
%
21.4
%
 
 
 
 
$ in millions
 
Required
Ratio1
Leverage-based capital
 
 
 
Adjusted average assets2
 
 
$
962,435

Tier 1 leverage ratio
 
4.0
%
8.3
%
Supplementary leverage exposure3,4
 
$
1,084,348

SLR4
 
5.0
%
7.4
%

 
 
$ in millions
Required
Ratio1
Standardized
Advanced
Risk-based capital
 
 
 
Common Equity Tier 1 capital
 
$
64,751

$
64,751

Tier 1 capital
 
73,443

73,443

Total capital
 
82,708

82,423

Total RWA
 
394,177

382,496

Common Equity Tier 1 capital ratio
10.0
%
16.4
%
16.9
%
Tier 1 capital ratio
11.5
%
18.6
%
19.2
%
Total capital ratio
13.5
%
21.0
%
21.5
%
 
 
 
 
$ in millions
 
Required
Ratio1
Leverage-based capital
 
 
 
Adjusted average assets2
 
 
$
889,195

Tier 1 leverage ratio
 
4.0
%
8.3
%
Supplementary leverage exposure3
 
$
1,155,177

SLR
 
5.0
%
6.4
%
 
1.
Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.
2.
Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments, certain deferred tax assets and other capital deductions.
3.
Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures.
4.
Based on a Federal Reserve interim final rule in effect until March 31, 2021, our SLR and Supplementary leverage exposure as of September 30, 2020 reflect the exclusion of U.S. Treasury securities and deposits at Federal Reserve Banks. As of September 30, 2020, the impact of the interim final rule on our SLR was an improvement of 87 bps. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.

 
27
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Regulatory Capital
$ in millions
Change
Common Equity Tier 1 capital
 
 
 
Common stock and surplus
$
4,350

$
5,228

$
(878
)
Retained earnings
76,353

70,589

5,764

AOCI
(537
)
(2,788
)
2,251

Regulatory adjustments and deductions:
 
 
Net goodwill
(7,242
)
(7,081
)
(161
)
Net intangible assets
(1,776
)
(2,012
)
236

Other adjustments and deductions1
9

815

(806
)
Total Common Equity Tier 1
capital
$
71,157

$
64,751

$
6,406

Additional Tier 1 capital
 
 
 
Preferred stock
$
8,520

$
8,520

$

Noncontrolling interests
625

607

18

Additional Tier 1 capital
$
9,145

$
9,127

$
18

Deduction for investments in covered funds
(397
)
(435
)
38

Total Tier 1 capital
$
79,905

$
73,443

$
6,462

Standardized Tier 2 capital
 
 
 
Subordinated debt
$
8,681

$
8,538

$
143

Noncontrolling interests
147

143

4

Eligible ACL
1,287

590

697

Other adjustments and deductions
(2
)
(6
)
4

Total Standardized Tier 2
capital
$
10,113

$
9,265

$
848

Total Standardized capital
$
90,018

$
82,708

$
7,310

Advanced Tier 2 capital
 
 
 
Subordinated debt
$
8,681

$
8,538

$
143

Noncontrolling interests
147

143

4

Eligible credit reserves
1,032

305

727

Other adjustments and
 deductions
(2
)
(6
)
4

Total Advanced Tier 2 capital
$
9,858

$
8,980

$
878

Total Advanced capital
$
89,763

$
82,423

$
7,340

 
1.
Other adjustments and deductions used in the calculation of Common Equity Tier 1 capital primarily includes net after-tax DVA, the credit spread premium over risk-free rate for derivative liabilities, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments and certain deferred tax assets.
 
RWA Rollforward
 
Nine Months Ended
September 30, 2020
$ in millions
Standardized
Advanced
Credit risk RWA
 
 
$
342,684

$
228,927

Change related to the following items:
 
 
Derivatives
4,622

24,322

Securities financing transactions
(9,314
)
514

Securitizations
(1,595
)
(3,016
)
Investment securities
2,468

3,904

Commitments, guarantees and loans
5,017

1,776

Cash
718

1,838

Equity investments
3,027

3,207

Other credit risk1
(601
)
(762
)
Total change in credit risk RWA
$
4,342

$
31,783

$
347,026

$
260,710

Market risk RWA
 
 
$
51,493

$
51,597

Change related to the following items:
 
 
Regulatory VaR
9,673

9,673

Regulatory stressed VaR
1,987

1,987

Incremental risk charge
180

180

Comprehensive risk measure
210

106

Specific risk:
 
 
Non-securitization
(99
)
(99
)
Securitization
(1,620
)
(1,620
)
Total change in market risk RWA
$
10,331

$
10,227

$
61,824

$
61,824

Operational risk RWA
 
 
N/A

$
101,972

Change in operational risk RWA
N/A

(4,425
)
N/A

$
97,547

Total RWA
$
408,850

$
420,081

 
Regulatory VaR—VaR for regulatory capital requirements

1.
Amounts reflect assets not in a defined category, non-material portfolios of exposures and unsettled transactions, as applicable.
Credit risk RWA increased in the current year period under both the Standardized and Advanced Approaches primarily from an increase in Derivatives exposure driven by market volatility, an increase in Investment securities mainly due to increased exposures to U.S. government and agency securities, and an increase in Equity investments due to increased exposure and market value gains. Under the Standardized Approach, increased exposures in lending activities within the Wealth Management and Institutional Securities business segments were partially offset by a decrease in Securities financing transactions. Under the Advanced Approach, the increased exposure in Derivatives and higher credit spread volatilities also led to an increase in RWA related to CVA.
Market risk RWA increased in the current year period under both the Standardized and Advanced Approaches primarily due to an increase in Regulatory VaR mainly as a result of higher market volatility.

September 2020 Form 10-Q
28
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements
The Federal Reserve has established external TLAC, long-term debt (“LTD”) and clean holding company requirements for top-tier BHCs of U.S. G-SIBs (“covered BHCs”), including the Parent Company. These requirements are designed to ensure that covered BHCs will have enough loss-absorbing resources at the point of failure to be recapitalized through the conversion of eligible LTD to equity or otherwise by imposing losses on eligible LTD or other forms of TLAC where an SPOE resolution strategy is used.
Required and Actual TLAC and Eligible LTD Ratios
 
 
 
Actual
Amount/Ratio
$ in millions
Regulatory Minimum
Required 
Ratio1
External TLAC2
 
 
$
202,472

$
196,888

External TLAC as a % of RWA
18.0
%
21.5
%
48.2
%
49.9
%
External TLAC as a % of leverage exposure
7.5
%
9.5
%
18.7
%
17.0
%
Eligible LTD3
 
 
$
114,952

$
113,624

Eligible LTD as a % of RWA
9.0
%
9.0
%
27.4
%
28.8
%
Eligible LTD as a % of leverage exposure
4.5
%
4.5
%
10.6
%
9.8
%
 
1.
Required ratios are inclusive of applicable buffers.The final rule imposes TLAC buffer requirements on top of both the risk-based and leverage exposure-based external TLAC minimum requirements. The risk-based TLAC buffer is equal to the sum of 2.5%, our Method 1 G-SIB surcharge and the CCyB, if any, as a percentage of total RWA. The leverage exposure-based TLAC buffer is equal to 2% of our total leverage exposure. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.
2.
External TLAC consists of Common Equity Tier 1 capital and Additional Tier 1 capital (each excluding any noncontrolling minority interests), as well as eligible LTD.
3.
Consists of TLAC-eligible LTD reduced by 50% for amounts of unpaid principal due to be paid in more than one year but less than two years from each respective balance sheet date.
We are in compliance with all TLAC requirements as of September 30, 2020 and December 31, 2019. For a further discussion of TLAC and related requirements, see Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Regulatory Capital Requirements—Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” in the 2019 Form 10-K.
Capital Plans and Stress Tests
Pursuant to the Dodd-Frank Act, the Federal Reserve has adopted capital planning and stress test requirements for large BHCs, which form part of the Federal Reserve’s annual CCAR framework.
We submitted our 2020 Capital Plan (“Capital Plan”) and company-run stress test results to the Federal Reserve on April 6, 2020. On June 25, 2020, the Federal Reserve published
 
summary results of its supervisory stress tests of each large BHC. On June 29, 2020, we disclosed a summary of the results of our company-run stress tests on our Investor Relations website. On September 4, 2020, we announced we will be subject to an SCB of 5.7% beginning October 1, 2020, which reflects the Federal Reserve’s corrected 2020 supervisory stress test results. We had previously announced that we would be subject to an SCB of 5.9%, which reflected the Federal Reserve’s original 2020 supervisory stress test results released in June 2020. Together with other features of the regulatory capital framework, this revised SCB results in an aggregate Standardized Approach Common Equity Tier 1 required ratio of 13.2%. Generally, our SCB will be updated annually based on the results of the supervisory stress test. See “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments—Stress Capital Buffer Final Rule” herein for additional information on the SCB.
The Federal Reserve required each large BHC to update and resubmit its capital plan. On November 2, 2020, we resubmitted our 2020 Capital Plan and company-run stress test results based on revised scenarios released by the Federal Reserve on September 17, 2020. We expect that the Federal Reserve will publish summary results of the second round of supervisory stress tests for each large BHC, including us, by the end of this year.
Based on the Federal Reserve announcement on June 25, 2020, all large BHCs were subject to capital action restrictions in the current quarter. Except as noted below, these restrictions generally prohibit large BHCs from making any capital distribution (excluding any capital distribution arising from the issuance of a capital instrument eligible for inclusion in the numerator of a regulatory capital ratio), unless otherwise approved by the Federal Reserve. Large BHCs are, however, authorized to make share repurchases relating to issuances of common stock related to employee stock ownership plans; provided that a BHC does not increase the amount of its common stock dividends, to pay common stock dividends that do not exceed an amount equal to the average of the BHC’s net income for the four preceding calendar quarters, unless otherwise specified by the Federal Reserve; and to make scheduled payments on additional Tier 1 and Tier 2 capital instruments. On September 30, 2020, the Federal Reserve announced that such capital action restrictions would be extended through the fourth quarter of 2020. For a further discussion of our capital plans, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Balance Sheet—Capital Management” herein and in the 2019 Form 10-K.
Attribution of Average Common Equity According to the Required Capital Framework
Our required capital (“Required Capital”) estimation is based on the Required Capital framework, an internal capital adequacy measure. Common equity attribution to the business segments

 
29
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

is based on capital usage calculated under the Required Capital framework, as well as each business segment’s relative contribution to our total Required Capital.
The Required Capital framework is a risk-based and leverage-based capital measure, which is compared with our regulatory capital to ensure that we maintain an amount of going concern capital after absorbing potential losses from stress events, where applicable, at a point in time. The amount of capital allocated to the business segments is generally set at the beginning of each year and remains fixed throughout the year until the next annual reset unless a significant business change occurs (e.g., acquisition or disposition). We define the difference between our total average common equity and the sum of the average common equity amounts allocated to our business segments as Parent common equity. We generally hold Parent common equity for prospective regulatory requirements, organic growth, acquisitions and other capital needs.
We are currently evaluating potential updates to our Required Capital framework to take into account changes to our risk-based capital requirements resulting from the SCB and we will continue to evaluate the framework with respect to the impact of other future regulatory requirements, as appropriate.
Average Common Equity Attribution1   
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in billions
2020
2019
2020
2019
Institutional Securities
$
42.8

$
40.4

$
42.8

$
40.4

Wealth Management
18.2

18.2

18.2

18.2

Investment Management
2.6

2.5

2.6

2.5

Parent
15.1

12.3

13.3

11.4

Total
$
78.7

$
73.4

$
76.9

$
72.5

 
1.
The attribution of average common equity to the business segments is a non-GAAP financial measure. See “Selected Non-GAAP Financial Information” herein.
Resolution and Recovery Planning
Pursuant to the Dodd-Frank Act, we are required to periodically submit to the Federal Reserve and the FDIC a resolution plan that describes our strategy for a rapid and orderly resolution under the U.S. Bankruptcy Code in the event of our material financial distress or failure. Our next resolution plan submission will be a targeted resolution plan in July 2021.
As described in our most recent resolution plan, which was submitted on June 28, 2019, our preferred resolution strategy is an SPOE strategy. In line with our SPOE strategy, the Parent Company has transferred, and has agreed to transfer on an ongoing basis, certain assets to its wholly owned, direct subsidiary Morgan Stanley Holdings LLC (the “Funding IHC”). In addition, the Parent Company has entered into an amended and restated support agreement with its material entities (including the Funding IHC) and certain other subsidiaries. In the event of a resolution scenario, the Parent Company would be obligated to contribute all of its Contributable Assets to our
 
material entities and/or the Funding IHC. The Funding IHC would be obligated to provide capital and liquidity, as applicable, to our material entities. The combined implication of the SPOE resolution strategy and the requirement to maintain certain levels of TLAC is that losses in resolution would be imposed on the holders of eligible long-term debt and other forms of eligible TLAC issued by the Parent Company before any losses are imposed on the holders of the debt securities of our operating subsidiaries or before putting U.S. taxpayers at risk.
For more information about resolution and recovery planning requirements and our activities in these areas, including the implications of such activities in a resolution scenario, see Business—Supervision and Regulation—Financial Holding Company—Resolution and Recovery Planning,”Risk Factors—Legal, Regulatory and Compliance Risk” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Resolution and Recovery Planning” in the 2019 Form 10-K.
Regulatory Developments
Final Rule on the Regulatory Capital Treatment for Investments in Certain Unsecured Debt Instruments Issued by G-SIBs
The U.S. banking agencies have issued a final rule that, among other things, modifies the regulatory capital framework for large U.S. banking organizations, including us and our U.S. Bank Subsidiaries. Under the final rule, such organizations are required to make certain deductions from regulatory capital for their investments in certain unsecured debt instruments (including eligible LTD in the TLAC framework) issued by the Parent Company and other G-SIBs. These requirements become effective on April 1, 2021 and we expect to be in compliance with the final rule by the effective date.
CFTC Final Rule on Capital Requirements for Swap Dealers
The CFTC has finalized rules establishing capital requirements for CFTC-registered swap dealers not subject to regulation by a prudential regulator. Compliance with these rules, which will apply to a number of our subsidiaries that are CFTC-registered swap dealers, is required by October 6, 2021.
Final Rule to Amend the Covered Fund Provisions of the Volcker Rule
The Federal financial regulatory agencies responsible for the Volcker Rule’s implementing regulations have finalized a rule that revises the prohibition on certain investments by banking entities with defined covered funds. The final rule adds certain new exclusions from the definition of covered fund, while streamlining others. It also simplifies certain restrictions on

September 2020 Form 10-Q
30
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

inter-affiliate relationships with covered funds. The final rule was effective October 1, 2020.
Stress Capital Buffer Final Rule
The Federal Reserve has adopted a final rule to integrate its annual capital planning and stress testing requirements with existing applicable regulatory capital requirements. The final rule, which applies to certain BHCs, introduces an SCB and related changes to the capital planning and stress testing processes.
The SCB applies only with respect to Standardized Approach risk-based capital requirements and replaces the existing Common Equity Tier 1 capital conservation buffer of 2.5%. The SCB is the greater of (i) the maximum decline in our Common Equity Tier 1 capital ratio under the severely adverse scenario over the supervisory stress test measurement period plus the sum of the four quarters of planned common stock dividends divided by the projected RWAs from the quarter in which the Firm’s projected Common Equity Tier 1 capital ratio reaches its minimum in the supervisory stress test and (ii) 2.5%. Beginning October 1, 2020, risk-based regulatory capital requirements under the Standardized Approach include the SCB, as summarized above, as well as our Common Equity Tier 1 GSIB capital surcharge and any applicable Common Equity Tier 1 CCyB.
The final rule makes related changes to capital planning and stress testing processes for BHCs subject to the SCB. In particular, the supervisory stress test will assume that BHCs generally maintain a constant level of assets and RWAs throughout the projection period. In addition, the supervisory stress test will no longer assume that BHCs make all planned capital distributions, although the SCB will incorporate the dollar amount of four quarters of planned common stock dividends, as summarized above.
The final rule does not change regulatory capital requirements under the Advanced Approach, the Tier 1 leverage ratio or the SLR.
Regulatory Developments in Response to COVID-19
In the United States, the Federal Reserve, the other U.S. state and federal financial regulatory agencies and Congress have taken actions to mitigate disruptions to economic activity and financial stability resulting from COVID-19.
Federal Reserve and other U.S. Banking Agency Actions
The Federal Reserve has established, or has taken steps to establish, a range of facilities and programs to support the U.S. economy and U.S. marketplace participants in response to economic disruptions associated with COVID-19. Through these facilities and programs, the Federal Reserve has taken steps to directly or indirectly purchase assets or debt instruments
 
from, or make loans to, U.S. companies, financial institutions, municipalities and other market participants. In the current year period, we have participated as principal, as well as on behalf of clients, in certain of these facilities and programs and we may participate in other of these facilities and programs in the future.
In addition, the Federal Reserve has taken a range of other actions to support the flow of credit to households and businesses. For example, the Federal Reserve has set the target range for the federal funds rate at 0 to 0.25% and has increased its holdings of U.S. Treasury securities and agency mortgage-backed securities, purchased agency commercial mortgage-backed securities, and established a facility to purchase corporate debt securities and shares of exchange-traded funds holding such securities. The Federal Reserve has also encouraged depository institutions to borrow from the discount window and has lowered the primary credit rate for such borrowings by 150 basis points to 0.25% while extending the term of such loans up to 90 days. In addition, reserve requirements have been reduced to zero.
Acting in concert with the other U.S. banking agencies, the Federal Reserve has also issued statements encouraging banking organizations to use their capital and liquidity buffers as they lend to households and businesses affected by COVID-19.
Further, the Federal Reserve along with the other U.S. banking agencies, issued guidance stating that granting certain concessions to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of the COVID-19 pandemic, generally would not be considered TDRs under applicable U.S. GAAP. This guidance also clarifies that efforts to work with borrowers of one-to-four family residential mortgages impacted by the COVID-19 pandemic and meeting certain criteria will not result in such loans being deemed restructured or modified for purposes of regulatory capital requirements.
The Federal Reserve and other U.S. banking agencies have also issued a series of rulemakings in response to the COVID-19 pandemic, including to facilitate banking organizations’ use of their capital buffers:
Supplementary Leverage Ratio Interim Final Rules. The Federal Reserve has adopted an interim final rule that excludes, on a temporary basis, U.S. Treasury securities and deposits at Federal Reserve Banks from our supplementary leverage exposure from April 1, 2020 to March 31, 2021.
A similar interim final rule issued by the OCC along with the other U.S. banking agencies provides national banks, including MSBNA and MSPBNA, an optional election, which is considered on a case-by-case basis by the OCC if received after June 30, 2020, to apply similar relief. If elected and approved, a national bank must receive prior approval from the OCC before making any capital distributions while the

 
31
September 2020 Form 10-Q

 
Management’s Discussion and Analysis
mslogo3q20.jpg

exclusion is in effect. As of September 30, 2020, neither MSBNA nor MSPBNA made this optional election.
Revisions to Definition of Eligible Retained Income. The U.S. banking agencies have adopted as final an interim final rule, which was effective March 20, 2020, amending the definition of eligible retained income in their respective capital rules. As amended, eligible retained income is defined by the U.S. banking agencies as the greater of (i) net income for the four preceding calendar quarters, net of any distributions and associated tax effects not already reflected in net income, and (ii) the average of net income over the preceding four quarters. This definition applies with respect to any payout restrictions applicable in the event of a breach of any regulatory capital buffers, including any applicable CCyB, G-SIB capital surcharge, capital conservation buffer, the enhanced SLR and, once effective, SCB, which replaces the capital conservation buffer under the Standardized Approach.
Separately, the Federal Reserve has adopted as final an interim final rule, which was effective March 26, 2020, amending the definition of eligible retained income under its TLAC rule to be consistent with the revised definition of eligible retained income in the regulatory capital framework, as summarized above.
Regulatory Capital and Stress Testing Developments Related to Implementation of CECL. The U.S. banking agencies have adopted a final rule, consistent with an interim final rule which was effective March 31, 2020, altering, for purposes of the regulatory capital and TLAC requirements, the required adoption time period for CECL. We have elected to apply a transition method provided by the rule, under which the effects of CECL on our regulatory capital and TLAC requirements are deferred for two years, followed by a three-year phase-in of the aggregate capital effects of the two-year deferral.
Non-U.S. Central Bank Actions
In addition to actions taken by the Federal Reserve, many non-U.S. central banks have announced similar facilities and programs in response to the economic and market disruptions associated with COVID-19. Firm subsidiaries operating in non-U.S. markets may participate, or perform customer facilitation roles, in such non-U.S. facilities or programs.
The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”)
The CARES Act was signed into law on March 27, 2020. Pursuant to the CARES Act, the U.S. Treasury has the authority to provide loans, guarantees and other investments in support of eligible businesses, states and municipalities affected by the economic effects of COVID-19. Some of these funds may also be used to support the several Federal Reserve programs and facilities described in “Federal Reserve Actions” previously or additional programs or facilities that are established by the
 
Federal Reserve under its Section 13(3) authority and meet certain criteria. Among other provisions, the CARES Act also includes funding for the Small Business Administration to expand lending, relief from certain U.S. GAAP requirements to allow COVID-19-related loan modifications to not be categorized as TDRs and a range of incentives to encourage deferment, forbearance or modification of consumer credit and mortgage contracts.
The CARES Act also includes several measures that temporarily adjust existing laws or regulations. These include providing the FDIC with additional authority to guarantee the deposits of solvent insured depository institutions held in non-interest-bearing business transaction accounts to a maximum amount specified by the FDIC, reinstating the FDIC’s Temporary Liquidity Guarantee Authority to guarantee debt obligations of solvent insured depository institutions or depository institution holding companies, temporarily allowing the U.S. Treasury to fully guarantee money market mutual funds and granting additional authority to the OCC to provide certain exemptions to the lending limits imposed on national banks.
Other Matters
U.K. Withdrawal from the E.U.
On January 31, 2020, the U.K. withdrew from the E.U. under the terms of a withdrawal agreement between the U.K. and the E.U. The withdrawal agreement provides for a transition period to the end of December 2020, during which time the U.K. will continue to apply E.U. law as if it were a member state, and U.K. firms’ rights to provide financial services in E.U. member states will continue. Access to the E.U. market after the transition period remains subject to negotiation.
We have prepared the structure of our European operations for a range of potential outcomes, including for the possibility that U.K. financial firms’ access to E.U. markets after the transition period is limited, and we expect to be able to continue to serve our clients and customers under each of these potential outcomes.
For more information on the U.K.’s withdrawal from the E.U., our related preparations and the potential impact on our operations, see “Risk Factors— International Risk” in the 2019 Form 10-K. For further information regarding our exposure to the U.K., see also Quantitative and Qualitative Disclosures about Risk—Country and Other Risks."
Planned Replacement of London Interbank Offered Rate and Replacement or Reform of Other Interest Rates
Central banks around the world, including the Federal Reserve, have commissioned committees and working groups of market participants and official sector representatives to replace LIBOR and replace or reform other interest rate benchmarks (collectively, the “IBORs”). Accordingly, we have established

September 2020 Form 10-Q
32
 

 
Management’s Discussion and Analysis
mslogo3q20.jpg

and are undertaking a Firmwide IBOR transition plan to promote the transition to alternative reference rates, which takes into account the considerable uncertainty regarding the availability of LIBOR beyond 2021.
For a further discussion of the expected replacement of the IBORs and/or reform of interest rate benchmarks, and the related risks and our transition plan, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Other Matters” and Risk Factors—Risk Management,” respectively, in the 2019 Form 10-K.

 
33
September 2020 Form 10-Q


Quantitative and Qualitative Disclosures about Risk
Management believes effective risk management is vital to the success of our business activities. For a discussion of our Enterprise Risk Management framework and risk management functions, see “Quantitative and Qualitative Disclosures about Risk—Risk Management” in the 2019 Form 10-K.
Market Risk
Market risk refers to the risk that a change in the level of one or more market prices, rates, spreads, indices, volatilities, correlations or other market factors, such as market liquidity, will result in losses for a position or portfolio. Generally, we incur market risk as a result of trading, investing and client facilitation activities, principally within the Institutional Securities business segment where the substantial majority of our VaR for market risk exposures is generated. In addition, we incur non-trading market risk, principally within the Wealth Management and Investment Management business segments. The Wealth Management business segment primarily incurs non-trading market risk from lending and deposit-taking activities. The Investment Management business segment primarily incurs non-trading market risk from capital investments in alternative and other funds. For a further discussion of market risk, see “Quantitative and Qualitative Disclosures about Risk—Market Risk” in the 2019 Form 10-K.
Trading Risks
We are exposed to a wide range of risks related to interest rates and credit spreads, equity prices, foreign exchange rates and commodity prices, and the associated implied volatilities and spreads, related to the global markets in which we conduct our trading activities.
The statistical technique known as VaR is one of the tools we use to measure, monitor and review the market risk exposures of our trading portfolios.
For information regarding our primary risk exposures and market risk management, VaR methodology, assumptions and limitations, see “Quantitative and Qualitative Disclosures about Risk—Market Risk—Trading Risks” in the 2019 Form 10-K.

 


 
95%/One-Day Management VaR for the Trading Portfolio
 
Three Months Ended
 
$ in millions
Period
End
Average
High2
Low2
Interest rate and credit spread
$
32

$
38

$
49

$
29

Equity price
27

30

39

19

Foreign exchange rate
11

9

12

7

Commodity price
17

22

29

16

Less: Diversification benefit1
(38
)
(53
)
N/A

N/A

Primary Risk Categories
$
49

$
46

$
57

$
37

Credit Portfolio
21

25

31

20

Less: Diversification benefit1
(8
)
(13
)
N/A

N/A

Total Management VaR
$
62

$
58

$
78

$
45

 
Three Months Ended
 
$ in millions
Period
End
Average
High2
Low2
Interest rate and credit spread
$
42

$
47

$
59

$
36

Equity price
38

25

38

20

Foreign exchange rate
10

11

15

8

Commodity price
25

16

25

11

Less: Diversification benefit1
(68
)
(49
)
N/A

N/A

Primary Risk Categories
$
47

$
50

$
62

$
44

Credit Portfolio
26

25

30

23

Less: Diversification benefit1
(1
)
(15
)
N/A

N/A

Total Management VaR
$
72

$
60

$
78

$
47

1.
Diversification benefit equals the difference between the total Management VaR and the sum of the component VaRs. This benefit arises because the simulated one-day losses for each of the components occur on different days; similar diversification benefits also are taken into account within each component.
2.
The high and low VaR values for the total Management VaR and each of the component VaRs might have occurred on different days during the quarter, and therefore, the diversification benefit is not an applicable measure.
Average total Management VaR and Management VaR for the Primary Risk Categories decreased from the three months ended June 30, 2020 primarily as a result of reduced credit spread risk partially offset by increased equity risk.

September 2020 Form 10-Q
34
 

 
Risk Disclosures
mslogo3q20.jpg

Distribution of VaR Statistics and Net Revenues
We evaluate the reasonableness of our VaR model by comparing the potential declines in portfolio values generated by the model with corresponding actual trading results for the Firm, as well as individual business units. For days where losses exceed the VaR statistic, we examine the drivers of trading losses to evaluate the VaR model’s accuracy relative to realized trading results. There were no loss days in the current quarter.
Daily 95%/One-Day Total Management VaR for the Current Quarter
($ in millions)
a3q20vara03.jpg
 
Daily Net Trading Revenues for the Current Quarter
($ in millions)
a3q20pnl.jpg
 
The previous histogram shows the distribution of daily net trading revenues for the current quarter. Daily net trading revenues include profits and losses from Interest rate and credit spread, Equity price, Foreign exchange rate, Commodity price, and Credit Portfolio positions and intraday trading activities for our trading businesses. Certain items such as fees, commissions and net interest income are excluded from daily net trading revenues and the VaR model. Revenues required for Regulatory VaR backtesting further exclude intraday trading.
 
Non-Trading Risks
We believe that sensitivity analysis is an appropriate representation of our non-trading risks. The following sensitivity analyses cover substantially all of the non-trading risk in our portfolio.
Credit Spread Risk Sensitivity1 
$ in millions
Derivatives
$
7

$
7

Funding liabilities2
46

45

 
1.
Amounts represent the potential gain for each 1 bps widening of our credit spread.
2.
Relates to Borrowings carried at fair value.
U.S. Bank Subsidiaries’ Net Interest Income Sensitivity Analysis
$ in millions
Basis point change
 
 
+100
$
1,014

$
599

 -100
(338
)
(351
)
The previous table presents an analysis of selected instantaneous upward and downward parallel interest rate shocks (subject to a floor of zero percent in the downward scenario) on net interest income over the next 12 months for our U.S. Bank Subsidiaries. These shocks are applied to our 12-month forecast for our U.S. Bank Subsidiaries, which incorporates market expectations of interest rates and our forecasted business activity.
We do not manage to any single rate scenario but rather manage net interest income in our U.S. Bank Subsidiaries to optimize across a range of possible outcomes, including non-parallel rate change scenarios. The sensitivity analysis assumes that we take no action in response to these scenarios, assumes there are no changes in other macroeconomic variables normally correlated with changes in interest rates, and includes subjective assumptions regarding customer and market re-pricing behavior and other factors. The change in sensitivity to interest rates in the positive 100 basis point scenario between September 30, 2020 and June 30, 2020 was primarily driven by the impact of changes to assumptions as a result of an analysis of deposit pricing through a full interest rate cycle.

 
35
September 2020 Form 10-Q

 
Risk Disclosures
mslogo3q20.jpg

Investments Sensitivity, Including Related Carried Interest
 
Loss from 10% Decline
$ in millions
Investments related to Investment Management activities
$
349

$
329

Other investments:
 
 
MUMSS
176

170

Other Firm investments
203

188

MUMSS—Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
We have exposure to public and private companies through direct investments, as well as through funds that invest in these assets. These investments are predominantly equity positions with long investment horizons, a portion of which is for business facilitation purposes. The market risk related to these investments is measured by estimating the potential reduction in net income associated with a 10% decline in investment values and related impact on performance-based fees, as applicable.
Asset Management Revenue Sensitivity
Certain asset management revenues in the Wealth Management and Investment Management business segments are derived from management fees, which are based on fee-based client assets in Wealth Management or AUM in Investment Management (together, “client holdings”). The assets underlying client holdings are primarily composed of equity, fixed income and alternative investments, and are sensitive to changes in related markets. The overall level of these revenues depends on multiple factors that include, but are not limited to, the level and duration of a market increase or decline, price volatility, the geographic and industry mix of client assets, and client behavior such as the rate and magnitude of client investments and redemptions. Therefore, overall revenues do not correlate completely with changes in the related markets.
Credit Risk
Credit risk refers to the risk of loss arising when a borrower, counterparty or issuer does not meet its financial obligations to us. We are primarily exposed to credit risk from institutions and individuals through our Institutional Securities and Wealth Management business segments. For a further discussion of our credit risks, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” in the 2019 Form 10-K.
 
Loans and Lending Commitments
 
$ in millions
HFI
HFS
FVO
Total
Institutional Securities:
 
 
 
 
Corporate
$
7,628

$
8,552

$
14

$
16,194

Secured lending facilities
26,496

3,521

445

30,462

Commercial and Residential real estate
7,265

928

1,593

9,786

Securities-based lending and Other
1,277

57

5,729

7,063

Total Institutional Securities
42,666

13,058

7,781

63,505

Wealth Management:
 
 
 
 
Residential real estate
33,674

12


33,686

Securities-based lending and Other
57,723



57,723

Total Wealth Management
91,397

12


91,409

Total Investment Management1
6

11

552

569

Total loans
134,069

13,081

8,333

155,483

ACL
(913
)
 
 
(913
)
Total loans, net of ACL
$
133,156

$
13,081

$
8,333

$
154,570

Lending commitments2
 
 
 
$
120,098

Total exposure






$
274,668

 
$ in millions
HFI
HFS
FVO
Total
Institutional Securities:
 
 
 
 
Corporate
$
5,426

$
6,192

$
20

$
11,638

Secured lending facilities
24,502

4,200

951

29,653

Commercial and Residential real estate
7,859

2,049

3,290

13,198

Securities-based lending and Other
503

123

6,814

7,440

Total Institutional Securities
38,290

12,564

11,075

61,929

Wealth Management:
 
 
 
 
Residential real estate
30,184

13


30,197

Securities-based lending and Other
49,930



49,930

Total Wealth Management
80,114

13


80,127

Total Investment Management1
5


251

256

Total loans
118,409

12,577

11,326

142,312

ACL
(349
)
 
 
(349
)
Total loans, net of ACL
$
118,060

$
12,577

$
11,326

$
141,963

Lending commitments2
 
 
 
$
120,068

Total exposure






$
262,031

HFI—Held for investment; HFS—Held for sale; FVO—Fair value option
Total exposure—consists of Total loans, net of ACL, and Lending commitments
1.
Investment Management business segment loans are related to certain of our activities as an investment advisor and manager. At September 30, 2020 and December 31, 2019, loans held at fair value are predominantly the result of the consolidation of CLO vehicles, managed by Investment Management, composed primarily of senior secured loans to corporations.
2.
Lending commitments represent the notional amount of legally binding obligations to provide funding to clients for lending transactions. Since commitments associated with these business activities may expire unused or may not be utilized to full capacity, they do not necessarily reflect the actual future cash funding requirements.

We provide loans and lending commitments to a variety of customers including large corporate and institutional clients as well as high to ultra-high net worth individuals. In addition, we purchase loans in the secondary market. Loans and lending

September 2020 Form 10-Q
36
 

 
Risk Disclosures
mslogo3q20.jpg

commitments are either held for investment, held for sale or carried at fair value. For more information on these loan classifications, see Note 2 to the financial statements in the 2019 Form 10-K.
Total loans and lending commitments increased by approximately $13 billion since December 31, 2019, primarily due to growth within the Wealth Management business segment driven by securities-based loans and residential real estate loans. Within the Institutional Securities business segment, growth in loans and lending commitments was primarily driven by Secured lending facilities and Corporate, partially offset by a decrease in Commercial real estate.
See Notes 5, 10 and 14 to the financial statements for further information.
Beginning late in the first quarter of 2020 and following in part from the U.S. government’s enactment of the CARES Act, we have received requests from certain clients for modifications of their credit agreements with us, which in some cases include deferral of their loan payments. Requests for loan payment deferrals related to Residential real estate loans are immediately granted, while Commercial real estate loan deferrals require careful consideration prior to approval. As of September 30, 2020, the unpaid principal balance of loans with approved deferrals of principal and interest payments currently in place amounted to less than $2 billion, with approximately one-third in each of our Wealth Management business segment commercial real estate-related tailored lending portfolio, which is included within Securities-based lending and Other, our Wealth Management business segment Residential real estate loans and our Institutional Securities business segment, primarily within Commercial real estate.
In addition to these principal and interest deferrals, we are also working with clients regarding modifications of certain other terms under their original loan agreements that do not impact contractual loan payments. We have granted such relief to certain borrowers, primarily within Secured lending facilities and Corporate loans. Such modifications include agreements to modify margin calls for Secured lending facilities, typically in return for additional payments which improve loan-to-value ratios. In some cases we have agreed to temporarily not enforce certain covenants, for example debt or interest coverage ratios, typically in return for other structural enhancements.
Granting loan deferral or modification requests does not necessarily mean that we will incur credit losses and we do not believe modifications have had a material impact on the risk profile of our loan portfolio. Modifications are considered in our evaluation of overall credit risk. Generally, loans with payment deferrals remain on accrual status and loans with other modifications remain on current status.
Requests for deferrals and other modifications could continue in future periods given the ongoing uncertain global economic
 
and market conditions. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic,” and “Risk Factors” herein for further information. See also “Forward Looking Statements” in the 2019 Form 10-K. For additional information on regulatory guidance which permits certain loan modifications for borrowers impacted by COVID-19 to not be accounted for and reported as TDRs and the Firm’s accounting policies for such modifications, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein and Note 2 to the financial statements, respectively. For information on HFI loans on nonaccrual status, see “Status of Loans Held for Investment” herein and Notes 2 and 10 to the financial statements. For HFI loans modified and reported as TDRs, see Notes 2 and 10 to the financial statements.
Allowance for Credit Losses—Loans and Lending Commitments
$ in millions
 
$
590

Effect of CECL adoption
(41
)
Gross charge-offs
(59
)
Recoveries
5

Net (charge-offs) recoveries
(54
)
Provision2
757

Other
8

$
1,260

ACL—Loans
$
913

ACL—Lending commitments
347

1.
At December 31, 2019, the ACL for Loans and Lending commitments was $349 million and $241 million, respectively.
2.
In the current quarter, the provision for loan losses was $63 million and the provision for losses on lending commitments was $48 million. In the current year period, the provision for loan losses was $601 million and the provision for losses on lending commitments was $156 million.
Credit exposure arising from our loans and lending commitments is measured in accordance with our internal risk management standards. Risk factors considered in determining the aggregate allowance for loan and commitment losses include the borrower’s financial strength, industry, facility structure, loan-to-value ratio, debt service ratio, collateral and covenants. Qualitative and environmental factors such as economic and business conditions, nature and volume of the portfolio and lending terms, and volume and severity of past due loans may also be considered.
The aggregate allowance for loans and lending commitments increased in the current year period, principally reflecting the provision for credit losses within the Institutional Securities business segment primarily resulting from the continued economic impact of COVID-19. This provision was the result of risks related to vulnerable sectors and higher downgrade sensitivity, changes in asset quality trends, as well as revisions to our forecasts reflecting expected future market and macroeconomic conditions. The base scenario used in our ACL models as of September 30, 2020 was generated using a combination of industry consensus economic forecasts, forward rates, and internally developed and validated models. Given the

 
37
September 2020 Form 10-Q

 
Risk Disclosures
mslogo3q20.jpg

nature of our lending portfolio, the most sensitive model input is U.S. GDP. The base scenario, among other things, assumes a continued recovery in the last quarter of 2020 through 2021, supported by fiscal stimulus and monetary policy measures. See Note 2 to the financial statements for a discussion of the Firm’s ACL methodology under CECL.
Status of Loans Held for Investment
 
 
IS
WM
IS
WM
Accrual
99.1
%
99.8
%
99.0
%
99.9
%
Nonaccrual1
0.9
%
0.2
%
1.0
%
0.1
%
 
1.
These loans are on nonaccrual status because the loans were past due for a period of 90 days or more or payment of principal or interest was in doubt.
Institutional Securities Loans and Lending Commitments1 
 
 
Contractual Years to Maturity
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans
 
 
 
 
 
AA
$
274

$

$

$

$
274

A
874

1,062

39

229

2,204

BBB
3,958

5,726

3,314

295

13,293

BB
12,683

7,920

6,273

491

27,367

Other NIG
5,403

6,519

3,791

2,423

18,136

Unrated2
63

151

155

1,056

1,425

Total loans, net of ACL
23,255

21,378

13,572

4,494

62,699

Lending commitments
 
 
 
 
AAA

50



50

AA
4,157

1,267

1,878


7,302

A
6,310

8,290

7,901

564

23,065

BBB
5,422

15,408

15,761

310

36,901

BB
4,150

7,154

7,291

1,311

19,906

Other NIG
979

8,491

5,533

3,193

18,196

Unrated2
4

1

21

20

46

Total lending commitments
21,022

40,661

38,385

5,398

105,466

Total exposure
$
44,277

$
62,039

$
51,957

$
9,892

$
168,165

    
 
 
 
Contractual Years to Maturity
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans
 
 
 
 
 
AA
$
7

$
50

$

$
5

$
62

A
955

923

516

277

2,671

BBB
2,297

5,589

3,592

949

12,427

BB
9,031

11,189

9,452

1,449

31,121

Other NIG
4,020

5,635

2,595

1,143

13,393

Unrated2
117

82

131

1,628

1,958

Total loans, net of ACL
16,427

23,468

16,286

5,451

61,632

Lending commitments
 
 
 
 
AAA

50



50

AA
2,838

908

2,509


6,255

A
6,461

7,287

9,371

298

23,417

BBB
7,548

13,780

20,560

753

42,641

BB
2,464

5,610

8,333

1,526

17,933

Other NIG
2,193

4,741

7,062

2,471

16,467

Unrated2

9

107

7

123

Total lending commitments
21,504

32,385

47,942

5,055

106,886

Total exposure
$
37,931

$
55,853

$
64,228

$
10,506

$
168,518

 
NIG–Non-investment grade
1.
Counterparty credit ratings are internally determined by the Credit Risk Management Department (“CRM”).
2.
Unrated loans and lending commitments are primarily trading positions that are measured at fair value and risk-managed as a component of market risk. For a further discussion of our market risk, see “Market Risk” herein.
Institutional Securities Loans and Lending Commitments by Industry
$ in millions
Industry
 
 
Financials
$
41,916

$
40,992

Real estate
24,827

28,348

Industrials
15,650

13,136

Communications services
12,529

12,165

Consumer discretionary
11,253

9,589

Healthcare
10,788

14,113

Energy
10,088

9,461

Utilities
9,994

9,905

Information technology
9,808

9,201

Consumer staples
8,476

9,724

Materials
5,626

5,577

Insurance
3,975

3,755

Other
3,235

2,552

Total exposure
$
168,165

$
168,518

Sectors Currently in Focus due to COVID-19
The continuing effect on economic activity of COVID-19 and related governmental actions have impacted borrowers in many sectors and industries. While we are carefully monitoring all of our Institutional Securities business segment exposures, certain sectors are more sensitive to the current economic environment and are continuing to receive heightened focus. The sectors

September 2020 Form 10-Q
38
 

 
Risk Disclosures
mslogo3q20.jpg

currently in focus are: air travel, retail, upstream energy, lodging and leisure, and healthcare services and systems. As of September 30, 2020, exposures to these sectors are included across the Industrials, Financials, Real estate, Consumer discretionary, Energy and Healthcare industries in the previous table, and in aggregate represent approximately 10% of total Institutional Securities business segment lending exposure. The substantial majority of these exposures are either investment grade and/or secured by collateral. The future developments of COVID-19 and related government actions and their effect on the economic environment remain uncertain; therefore, the sectors impacted and the extent of the impacts may change over time. Refer to “Risk Factors” herein.
Institutional Securities Lending Activities
The Institutional Securities business segment lending activities include Corporate, Secured lending facilities, Commercial real estate and Securities-based lending and Other. Over 90% of our total lending exposure, which consists of loans and lending commitments, is investment grade and/or secured by collateral.
Corporate comprises relationship and event-driven loans and lending commitments, which typically consist of revolving lines of credit, term loans and bridge loans; may have varying terms; may be senior or subordinated; may be secured or unsecured; are generally contingent upon representations, warranties and contractual conditions applicable to the borrower; and may be syndicated, traded or hedged. For additional information on event-driven loans, see “Institutional Securities Event-Driven Loans and Lending Commitments” herein.
Secured lending facilities include loans provided to clients, which are collateralized by various assets including residential and commercial real estate mortgage loans, corporate loans, and other assets. These facilities generally provide for overcollateralization. Credit risk with respect to these loans and lending commitments arises from the failure of a borrower to perform according to the terms of the loan agreement and/or a decline in the underlying collateral value. The Firm monitors collateral levels against the requirements of lending agreements.
Commercial real estate loans are primarily senior, secured by underlying real estate and typically in term loan form. In addition, as part of certain of its trading and securitization activities, Institutional Securities may also hold residential real estate loans.
Securities-based lending and Other includes financing extended to sales and trading customers and corporate loans purchased in the secondary market.
 
Institutional Securities Event-Driven Loans and Lending Commitments
 
 
Contractual Years to Maturity
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans, net of ACL
$
1,891

$
1,185

$
710

$
1,216

$
5,002

Lending commitments
2,346

5,088

2,257

3,697

13,388

Total exposure
$
4,237

$
6,273

$
2,967

$
4,913

$
18,390

 
 
Contractual Years to Maturity
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans, net of ACL
$
1,194

$
1,024

$
839

$
390

$
3,447

Lending commitments
7,921

5,012

2,285

3,090

18,308

Total exposure
$
9,115

$
6,036

$
3,124

$
3,480

$
21,755

Event-driven loans and lending commitments are associated with a particular event or transaction, such as to support client merger, acquisition, recapitalization or project finance activities. Balances may fluctuate as such lending is related to transactions that vary in timing and size from period to period.
Institutional Securities Loans and Lending Commitments Held for Investment
 
$ in millions
Loans
Lending Commitments
Total
Corporate
$
7,628

$
65,358

$
72,986

Secured lending facilities
26,496

8,122

34,618

Commercial real estate
7,265

286

7,551

Other
1,277

1,178

2,455

Total, before ACL
$
42,666

$
74,944

$
117,610

ACL
$
(806
)
$
(342
)
$
(1,148
)
 
$ in millions
Loans
Lending Commitments
Total
Corporate
$
5,426

$
61,716

$
67,142

Secured lending facilities
24,502

6,105

30,607

Commercial real estate
7,859

425

8,284

Other
503

832

1,335

Total, before ACL
$
38,290

$
69,078

$
107,368

ACL
$
(297
)
$
(236
)
$
(533
)



 
39
September 2020 Form 10-Q

 
Risk Disclosures
mslogo3q20.jpg

Institutional Securities Allowance for Credit Losses—Loans and Lending Commitments
$ in millions
Corporate
Secured lending facilities
Commercial real estate
Other
Total
 
 
 
 
 
ACL—Loans
$
115

$
101

$
75

$
6

$
297

ACL—Lending commitments
$
201

$
27

$
7

$
1

$
236

Total
$
316

$
128

$
82

$
7

$
533

Effect of CECL adoption
(43
)
(53
)
35

3

(58
)
Gross charge-offs
(33
)

(26
)

(59
)
Recoveries
3



2

5

Net (charge-offs) recoveries
(30
)

(26
)
2

(54
)
Provision (release)1
400

155

180

(16
)
719

Other
3

1

(38
)
42

8

Total at
$
646

$
231

$
233

$
38

$
1,148

ACL—Loans
$
367

$
191

$
222

$
26

$
806

ACL—Lending commitments
279

40

11

12

342

1.
In the current quarter, the provision for loan losses was $66 million and the provision for losses on lending commitments was $47 million. In the current year period, the provision for loan losses was $562 million and the provision for losses on lending commitments was $157 million.
 
 
 
 
 
 
 
 
 
 
 
 
Institutional Securities HFI Loans—Ratios of Allowance for Credit Losses to Balance Before Allowance
 
Corporate
4.8
%
2.1
%
Secured lending facilities
0.7
%
0.4
%
Commercial real estate
3.1
%
1.0
%
Other
2.0
%
1.2
%
Total Institutional Securities loans
1.9
%
0.8
%
Wealth Management Loans and Lending Commitments
 
 
Contractual Years to Maturity
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Securities-based lending and Other
$
49,714

$
4,411

$
1,869

$
1,680

$
57,674

Residential real estate
11

4

1

33,612

33,628

Total loans, net of ACL
$
49,725

$
4,415

$
1,870

$
35,292

$
91,302

Lending commitments
11,797

2,240

326

269

14,632

Total exposure
$
61,522

$
6,655

$
2,196

$
35,561

$
105,934

 
 
Contractual Years to Maturity
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Securities-based lending and Other
$
41,863

$
3,972

$
2,783

$
1,284

$
49,902

Residential real estate
13

11


30,149

30,173

Total loans, net of ACL
$
41,876

$
3,983

$
2,783

$
31,433

$
80,075

Lending commitments
10,219

2,564

71

307

13,161

Total exposure
$
52,095

$
6,547

$
2,854

$
31,740

$
93,236

 
The principal Wealth Management business segment lending activities include securities-based lending and residential real estate loans.
Securities-based lending allows clients to borrow money against the value of qualifying securities, generally for any purpose other than purchasing, trading or carrying securities, or refinancing margin debt. For more information about our securities-based lending and residential real estate loans, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” in the 2019 Form 10-K.
For the current year period, Loans and Lending commitments associated with the Wealth Management business segment increased, driven by securities-based loans and residential real estate loans.
Wealth Management Allowance for Credit Losses—Loans and Lending Commitments
$ in millions
 
$
57

Effect of CECL adoption
17

Provision2
38

$
112

ACL—Loans
$
107

ACL—Lending commitments
5

1.
At December 31, 2019, the total ACL for Loans and Lending commitments was $52 million and $5 million, respectively.
2.
In the current quarter, the release for loan losses was $3 million and the provision for losses on lending commitments was $1 million. In the current year period the provision for loan losses was $39 million and the release for losses on lending commitments was $1 million.

At September 30, 2020, more than 75% of Wealth Management residential real estate loans were to borrowers with “Exceptional” or “Very Good” FICO scores (i.e., exceeding 740). Additionally, Wealth Management’s securities-based lending portfolio remains well-collateralized and subject to daily client margining, which includes requiring customers to deposit additional collateral, or reduce debt positions, when necessary.
Customer and Other Receivables
Margin Loans
 
$ in millions
IS
WM
Total
Customer receivables representing margin loans
$
35,604

$
9,054

$
44,658

 
$ in millions
IS
WM
Total
Customer receivables representing margin loans
$
22,216

$
9,700

$
31,916

The Institutional Securities and Wealth Management business segments provide margin lending arrangements, which allow customers to borrow against the value of qualifying securities, primarily for the purpose of purchasing additional securities, as

September 2020 Form 10-Q
40
 

 
Risk Disclosures
mslogo3q20.jpg

well as to collateralize short positions. Margin lending activities generally have lower credit risk due to the value of collateral held and their short-term nature. Amounts may fluctuate from period to period as overall client balances change as a result of market levels, client positioning and leverage.
Employee Loans
$ in millions
Currently employed by the Firm
$
2,940

N/A

No longer employed by the Firm
142

N/A

Employee loans
$
3,082

$
2,980

ACL1
(165
)
(61
)
Employee loans, net of ACL
$
2,917

$
2,919

Remaining repayment term, weighted average in years
5.1

4.8

1.
The change in ACL includes a $124 million increase due to the adoption of CECL on January 1, 2020.
Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives and are full recourse and generally require periodic repayments. The ACL as of September 30, 2020 was calculated under CECL, while the ACL at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 to the financial statements for a description of the CECL allowance methodology, including credit quality indicators, for employee loans. For additional information on employee loans, see Note 10 to the financial statements.
 
Derivatives
Fair Value of OTC Derivative Assets
 
Counterparty Credit Rating1
 
$ in millions
AAA
AA
A
BBB
NIG
Total
 
 
 
 
Less than 1 year
$
667

$
10,653

$
36,327

$
23,017

$
10,481

$
81,145

1-3 years
641

5,332

17,817

13,616

7,196

44,602

3-5 years
389

5,091

11,562

8,447

3,648

29,137

Over 5 years
4,496

34,274

87,181

64,958

16,119

207,028

Total, gross
$
6,193

$
55,350

$
152,887

$
110,038

$
37,444

$
361,912

Counterparty netting
(3,107
)
(42,447
)
(122,838
)
(83,836
)
(22,686
)
(274,914
)
Cash and securities collateral
(2,897
)
(10,830
)
(25,423
)
(20,621
)
(8,865
)
(68,636
)
Total, net
$
189

$
2,073

$
4,626

$
5,581

$
5,893

$
18,362

 
Counterparty Credit Rating1
 
$ in millions
AAA
AA
A
BBB
NIG
Total
 
 
 
 
Less than 1 year
$
371

$
9,195

$
31,789

$
22,757

$
6,328

$
70,440

1-3 years
378

5,150

17,707

11,495

9,016

43,746

3-5 years
502

4,448

9,903

6,881

3,421

25,155

Over 5 years
3,689

24,675

70,765

40,542

14,587

154,258

Total, gross
$
4,940

$
43,468

$
130,164

$
81,675

$
33,352

$
293,599

Counterparty netting
(2,172
)
(33,521
)
(103,452
)
(62,345
)
(19,514
)
(221,004
)
Cash and securities collateral
(2,641
)
(8,134
)
(22,319
)
(14,570
)
(10,475
)
(58,139
)
Total, net
$
127

$
1,813

$
4,393

$
4,760

$
3,363

$
14,456

$ in millions
Industry
 
Utilities
$
4,407

$
4,275

Financials
4,394

3,448

Industrials
1,796

914

Healthcare
1,442

991

Regional governments
966

791

Information technology
901

659

Not-for-profit organizations
796

657

Energy
775

524

Materials
590

325

Sovereign governments
549

403

Consumer staples
385

129

Consumer discretionary
371

370

Communications services
325

381

Insurance
302

214

Real estate
287

315

Other
76

60

Total
$
18,362

$
14,456


1.
Counterparty credit ratings are determined internally by CRM.

We are exposed to credit risk as a dealer in OTC derivatives. Credit risk with respect to derivative instruments arises from the possibility that a counterparty may fail to perform according to the terms of the contract. In the current year period, our exposure to credit risk arising from OTC derivatives has increased, primarily as a function of the effect of market factors and

 
41
September 2020 Form 10-Q

 
Risk Disclosures
mslogo3q20.jpg

volatility on the valuation of our positions, although exposure has declined since peaking in March 2020. For more information on derivatives, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives” in the 2019 Form 10-K and Note 7 to the financial statements.

Country Risk
Country risk exposure is the risk that events in, or that affect, a foreign country (any country other than the U.S.) might adversely affect us. We actively manage country risk exposure through a comprehensive risk management framework that combines credit and market fundamentals and allows us to effectively identify, monitor and limit country risk. For a further discussion of our country risk exposure see, “Quantitative and Qualitative Disclosures about Risk—Country and Other Risks” in the 2019 Form 10-K.
Our sovereign exposures consist of financial contracts and obligations entered into with sovereign and local governments. Our non-sovereign exposures consist of financial contracts and obligations entered into primarily with corporations and financial institutions. Index credit derivatives are included in the following country risk exposure table. Each reference entity within an index is allocated to that reference entity’s country of risk. Index exposures are allocated to the underlying reference entities in proportion to the notional weighting of each reference entity in the index, adjusted for any fair value receivable or payable for that reference entity. Where credit risk crosses multiple jurisdictions, for example, a CDS purchased from an issuer in a specific country that references bonds issued by an entity in a different country, the fair value of the CDS is reflected in the Net Counterparty Exposure row based on the country of the CDS issuer. Further, the notional amount of the CDS adjusted for the fair value of the receivable or payable is reflected in the Net Inventory row based on the country of the underlying reference entity.
Top 10 Non-U.S. Country Exposures at September 30, 2020
United Kingdom
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
1,145

$
928

$
2,073

Net counterparty exposure2
69

11,183

11,252

Loans

2,831

2,831

Lending commitments

6,607

6,607

Exposure before hedges
1,214

21,549

22,763

Hedges3
(311
)
(1,470
)
(1,781
)
Net exposure
$
903

$
20,079

$
20,982

 
Germany
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
(1,168
)
$
(14
)
$
(1,182
)
Net counterparty exposure2
214

3,280

3,494

Loans

2,092

2,092

Lending commitments
(1
)
4,428

4,427

Exposure before hedges
(955
)
9,786

8,831

Hedges3
(286
)
(867
)
(1,153
)
Net exposure
$
(1,241
)
$
8,919

$
7,678

Japan
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
2,182

$
512

$
2,694

Net counterparty exposure2
57

4,505

4,562

Loans

562

562

Exposure before hedges
2,239

5,579

7,818

Hedges3
(96
)
(228
)
(324
)
Net exposure
$
2,143

$
5,351

$
7,494

France
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
1,214

$
(334
)
$
880

Net counterparty exposure2
18

3,444

3,462

Loans

525

525

Lending commitments

3,047

3,047

Exposure before hedges
1,232

6,682

7,914

Hedges3
(6
)
(815
)
(821
)
Net exposure
$
1,226

$
5,867

$
7,093

Spain
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
(809
)
$
28

$
(781
)
Net counterparty exposure2
7

284

291

Loans

4,061

4,061

Lending commitments

620

620

Exposure before hedges
(802
)
4,993

4,191

Hedges3

(123
)
(123
)
Net exposure
$
(802
)
$
4,870

$
4,068

Australia
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
1,893

$
261

$
2,154

Net counterparty exposure2
6

637

643

Loans

392

392

Lending commitments

798

798

Exposure before hedges
1,899

2,088

3,987

Hedges3

(174
)
(174
)
Net exposure
$
1,899

$
1,914

$
3,813

India
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
1,795

$
595

$
2,390

Net counterparty exposure2

821

821

Loans

205

205

Exposure before hedges
1,795

1,621

3,416

Net exposure
$
1,795

$
1,621

$
3,416


September 2020 Form 10-Q
42
 

 
Risk Disclosures
mslogo3q20.jpg

China
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
(184
)
$
1,506

$
1,322

Net counterparty exposure2
103

481

584

Loans

772

772

Lending commitments

765

765

Exposure before hedges
(81
)
3,524

3,443

Hedges3
(82
)
(122
)
(204
)
Net exposure
$
(163
)
$
3,402

$
3,239

Canada
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
(66
)
$
330

$
264

Net counterparty exposure2
60

1,477

1,537

Loans

155

155

Lending commitments

1,380

1,380

Exposure before hedges
(6
)
3,342

3,336

Hedges3

(108
)
(108
)
Net exposure
$
(6
)
$
3,234

$
3,228

Netherlands
 
 
 
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory1
$
(5
)
$
280

$
275

Net counterparty exposure2

760

760

Loans

420

420

Lending commitments

1,768

1,768

Exposure before hedges
(5
)
3,228

3,223

Hedges3
(32
)
(210
)
(242
)
Net exposure
$
(37
)
$
3,018

$
2,981


1.
Net inventory represents exposure to both long and short single-name and index positions (i.e., bonds and equities at fair value and CDS based on a notional amount assuming zero recovery adjusted for the fair value of any receivable or payable).
2.
Net counterparty exposure (e.g., repurchase transactions, securities lending and OTC derivatives) is net of the benefit of collateral received and also is net by counterparty when legally enforceable master netting agreements are in place. For more information, seeAdditional Information—Top 10 Non-U.S. Country Exposures” herein.
3.
Amounts represent net CDS hedges (purchased and sold) on net counterparty exposure and lending executed by trading desks responsible for hedging counterparty and lending credit risk exposures. Amounts are based on the CDS notional amount assuming zero recovery adjusted for any fair value receivable or payable. For further description of the contractual terms for purchased credit protection and whether they may limit the effectiveness of our hedges, seeQuantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives” in the 2019 Form 10-K.
 
Additional Information—Top 10 Non-U.S. Country Exposures

Collateral Held against Net Counterparty Exposure1 
$ in millions
 
Country of Risk
Collateral2
 
Germany
Japan and France
$
13,464

United Kingdom
U.K., U.S. and Spain
12,093

Other
Japan, U.S. and Canada
23,884

 
1.
The benefit of collateral received is reflected in the Top 10 Non-U.S. Country Exposures at September 30, 2020.
2.
Primarily consists of cash as well as government obligations of the countries listed.
 
Country Risk Exposures Related to the U.K.
At September 30, 2020, our country risk exposures in the U.K. included net exposures of $20,982 million (as shown in the Top 10 Non-U.S. Country Exposures table) and overnight deposits of $6,168 million. The $20,079 million of exposures to non-sovereigns were diversified across both names and sectors and include $6,753 million to U.K.-focused counterparties that generate more than one-third of their revenues in the U.K., $5,163 million to geographically diversified counterparties, and $7,273 million to exchanges and clearinghouses.
Operational Risk
Operational risk refers to the risk of loss, or of damage to our reputation, resulting from inadequate or failed processes or systems, from human factors or from external events (e.g., fraud, theft, legal and compliance risks, cyber attacks or damage to physical assets). We may incur operational risk across the full scope of our business activities, including revenue-generating activities (e.g., sales and trading) and support and control groups (e.g., information technology and trade processing). For a further discussion about our operational risk, see “Quantitative and Qualitative Disclosures about Risk—Operational Risk” in the 2019 Form 10-K. In addition, for further information on market and economic conditions and their effects on risk in general, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic” and “Risk Factors” herein.
Model Risk
Model risk refers to the potential for adverse consequences from decisions based on incorrect or misused model outputs. Model risk can lead to financial loss, poor business and strategic decision making or damage to our reputation. The risk inherent in a model is a function of the materiality, complexity and uncertainty around inputs and assumptions. Model risk is generated from the use of models impacting financial statements, regulatory filings, capital adequacy assessments and the formulation of strategy. For a further discussion about our model risk, see “Quantitative and Qualitative Disclosures about Risk—Model Risk” in the 2019 Form 10-K.
Liquidity Risk
Liquidity risk refers to the risk that we will be unable to finance our operations due to a loss of access to the capital markets or difficulty in liquidating our assets. Liquidity risk also encompasses our ability (or perceived ability) to meet our financial obligations without experiencing significant business disruption or reputational damage that may threaten our viability as a going concern. For a further discussion about our liquidity risk, see “Quantitative and Qualitative Disclosures about Risk—Liquidity Risk” in the 2019 Form 10-K and “Management’s Discussion and Analysis of Financial Condition and Results of

 
43
September 2020 Form 10-Q

 
Risk Disclosures
mslogo3q20.jpg

Operations—Liquidity and Capital Resources” herein. In addition, for further information on market and economic conditions and their effects on risk in general, see “Risk Factors” herein.
Legal and Compliance Risk
Legal and compliance risk includes the risk of legal or regulatory sanctions, material financial loss, including fines, penalties, judgments, damages and/or settlements, or loss to reputation that we may suffer as a result of failure to comply with laws, regulations, rules, related self-regulatory organization standards and codes of conduct applicable to our business activities. This risk also includes contractual and commercial risk, such as the risk that a counterparty’s performance obligations will be unenforceable. It also includes compliance with AML, terrorist financing, and anti-corruption rules and regulations. For a further discussion about our legal and compliance risk, see “Quantitative and Qualitative Disclosures about Risk—Legal and Compliance Risk” in the 2019 Form 10-K.
 

September 2020 Form 10-Q
44
 



Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Morgan Stanley:
 
Results of Review of Interim Financial Information
We have reviewed the accompanying condensed consolidated balance sheet of Morgan Stanley and subsidiaries (the “Firm”) as of September 30, 2020, and the related condensed consolidated income statements, comprehensive income statements, and statements of changes in total equity for the three-month and nine-month periods ended September 30, 2020 and 2019, and the cash flow statements for the nine-month periods ended September 30, 2020 and 2019, and the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Firm as of December 31, 2019, and the related consolidated income statement, comprehensive income statement, cash flow statement and statement of changes in total equity for the year then ended (not presented herein) included in the Firm’s Annual Report on Form 10-K; and in our report dated February 27, 2020, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2019 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

 

Basis for Review Results
This interim financial information is the responsibility of the Firm’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Firm in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
 









 
45
September 2020 Form 10-Q

 
Consolidated Income Statements
(Unaudited)
mslogo3q20.jpg


 
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
in millions, except per share data
2020
2019
2020
2019
Revenues
 
 
 
 
Investment banking
$
 i 1,826

$
 i 1,635

$
 i 5,239

$
 i 4,467

Trading
 i 3,092

 i 2,608

 i 10,831

 i 8,781

Investments
 i 346

 i 87

 i 659

 i 801

Commissions and fees
 i 1,037

 i 990

 i 3,499

 i 2,935

Asset management
 i 3,664

 i 3,363

 i 10,346

 i 9,632

Other
 i 206

 i 131

( i 458
)
 i 685

Total non-interest revenues
 i 10,171

 i 8,814

 i 30,116

 i 27,301

Interest income
 i 2,056

 i 4,350

 i 7,917

 i 13,146

Interest expense
 i 570

 i 3,132

 i 3,475

 i 9,885

Net interest
 i 1,486

 i 1,218

 i 4,442

 i 3,261

Net revenues
 i 11,657

 i 10,032

 i 34,558

 i 30,562

Non-interest expenses
 
 
 
 
Compensation and benefits
 i 5,086

 i 4,427

 i 15,404

 i 13,609

Brokerage, clearing and exchange fees
 i 697

 i 637

 i 2,153

 i 1,860

Information processing and communications
 i 616

 i 557

 i 1,768

 i 1,627

Professional services
 i 542

 i 531

 i 1,526

 i 1,582

Occupancy and equipment
 i 373

 i 353

 i 1,103

 i 1,053

Marketing and business development
 i 78

 i 157

 i 273

 i 460

Other
 i 778

 i 660

 i 2,343

 i 1,803

Total non-interest expenses
 i 8,170

 i 7,322

 i 24,570

 i 21,994

Income before provision for income taxes
 i 3,487

 i 2,710

 i 9,988

 i 8,568

Provision for income taxes
 i 736

 i 492

 i 2,221

 i 1,636

Net income
$
 i 2,751

$
 i 2,218

$
 i 7,767

$
 i 6,932

Net income applicable to noncontrolling interests
 i 34

 i 45

 i 156

 i 129

Net income applicable to Morgan Stanley
$
 i 2,717

$
 i 2,173

$
 i 7,611

$
 i 6,803

Preferred stock dividends
 i 120

 i 113

 i 377

 i 376

Earnings applicable to Morgan Stanley common shareholders
$
 i 2,597

$
 i 2,060

$
 i 7,234

$
 i 6,427

Earnings per common share
 
 
 
 
Basic
$
 i 1.68

$
 i 1.28

$
 i 4.68

$
 i 3.94

Diluted
$
 i 1.66

$
 i 1.27

$
 i 4.62

$
 i 3.89

Average common shares outstanding
 
 
 
 
Basic
 i 1,542

 i 1,604

 i 1,546

 i 1,632

Diluted
 i 1,566

 i 1,627

 i 1,565

 i 1,653


September 2020 Form 10-Q
46
See Notes to Consolidated Financial Statements


 
Consolidated Comprehensive Income Statements
(Unaudited)
mslogo3q20.jpg


 
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Net income
$
 i 2,751

$
 i 2,218

$
 i 7,767

$
 i 6,932

Other comprehensive income (loss), net of tax:
 
 
 
 
Foreign currency translation adjustments
 i 110

( i 99
)
( i 1
)
( i 56
)
Change in net unrealized gains (losses) on available-for-sale securities
( i 62
)
 i 214

 i 1,558

 i 1,252

Pension, postretirement and other
 i 5

 i 3

 i 29

 i 7

Change in net debt valuation adjustment
( i 563
)
 i 337

 i 744

( i 529
)
Total other comprehensive income (loss)
$
( i 510
)
$
 i 455

$
 i 2,330

$
 i 674

Comprehensive income
$
 i 2,241

$
 i 2,673

$
 i 10,097

$
 i 7,606

Net income applicable to noncontrolling interests
 i 34

 i 45

 i 156

 i 129

Other comprehensive income (loss) applicable to noncontrolling interests
 i 28

 i 2

 i 79

( i 20
)
Comprehensive income applicable to Morgan Stanley
$
 i 2,179

$
 i 2,626

$
 i 9,862

$
 i 7,497


See Notes to Consolidated Financial Statements
47
September 2020 Form 10-Q


 
Consolidated Balance Sheets

mslogo3q20.jpg


$ in millions, except share data
(Unaudited)
At
September 30,
2020
Assets
 
 
Cash and cash equivalents
$
 i 94,772

$
 i 82,171

Trading assets at fair value ($122,933 and $128,386 were pledged to various parties)
 i 293,968

 i 297,110

Investment securities (includes $84,536 and $62,223 at fair value)
 i 130,705

 i 105,725

Securities purchased under agreements to resell (includes $15 and $4 at fair value)
 i 88,283

 i 88,224

Securities borrowed
 i 100,803

 i 106,549

Customer and other receivables
 i 72,537

 i 55,646

Loans:
 
 
Held for investment (net of allowance of $913 and $349)
 i 133,156

 i 118,060

Held for sale
 i 13,081

 i 12,577

Goodwill
 i 7,348

 i 7,143

Intangible assets (net of accumulated amortization of $3,442 and $3,204)
 i 1,880

 i 2,107

Other assets
 i 19,407

 i 20,117

Total assets
$
 i 955,940

$
 i 895,429

Liabilities
 
 
Deposits (includes $3,679 and $2,099 at fair value)
$
 i 239,253

$
 i 190,356

Trading liabilities at fair value
 i 145,016

 i 133,356

Securities sold under agreements to repurchase (includes $1,166 and $733 at fair value)
 i 41,376

 i 54,200

Securities loaned
 i 7,924

 i 8,506

Other secured financings (includes $10,185 and $7,809 at fair value)
 i 13,857

 i 14,698

Customer and other payables
 i 192,300

 i 197,834

Other liabilities and accrued expenses
 i 22,952

 i 21,155

Borrowings (includes $69,144 and $64,461 at fair value)
 i 203,444

 i 192,627

Total liabilities
 i 866,122

 i 812,732

Commitments and contingent liabilities (see Note 14)
 i 
 i 
Equity
 
 
Morgan Stanley shareholders’ equity:
 
 
Preferred stock
 i 8,520

 i 8,520

Common stock, $0.01 par value:
 
 
Shares authorized: 3,500,000,000; Shares issued: 2,038,893,979; Shares outstanding: 1,576,447,988 and 1,593,973,680
 i 20

 i 20

Additional paid-in capital
 i 24,015

 i 23,935

Retained earnings
 i 76,061

 i 70,589

Employee stock trusts
 i 2,992

 i 2,918

Accumulated other comprehensive income (loss)
( i 537
)
( i 2,788
)
Common stock held in treasury at cost, $0.01 par value (462,445,991 and 444,920,299 shares)
( i 19,685
)
( i 18,727
)
Common stock issued to employee stock trusts
( i 2,992
)
( i 2,918
)
Total Morgan Stanley shareholders’ equity
 i 88,394

 i 81,549

Noncontrolling interests
 i 1,424

 i 1,148

Total equity
 i 89,818

 i 82,697

Total liabilities and equity
$
 i 955,940

$
 i 895,429


September 2020 Form 10-Q
48
See Notes to Consolidated Financial Statements


 
Consolidated Statements of Changes in Total Equity
(Unaudited)
mslogo3q20.jpg


 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Preferred Stock
 
 
 
 
Beginning and ending balance
$
 i 8,520

$
 i 8,520

$
 i 8,520

$
 i 8,520

Common Stock
 
 
 
 
Beginning and ending balance
 i 20

 i 20

 i 20

 i 20

Additional Paid-in Capital
 
 
 
 
Beginning balance
 i 23,782

 i 23,446

 i 23,935

 i 23,794

Share-based award activity
 i 232

 i 196

 i 79

( i 154
)
Other net increases
 i 1

 i 7

 i 1

 i 9

Ending balance
 i 24,015

 i 23,649

 i 24,015

 i 23,649

Retained Earnings
 
 
 
 
Beginning balance
 i 74,015

 i 67,588

 i 70,589

 i 64,175

Cumulative adjustments for accounting changes1
 i 

 i 

( i 100
)
 i 63

Net income applicable to Morgan Stanley
 i 2,717

 i 2,173

 i 7,611

 i 6,803

Preferred stock dividends2
( i 120
)
( i 113
)
( i 377
)
( i 376
)
Common stock dividends2
( i 551
)
( i 577
)
( i 1,662
)
( i 1,594
)
Ending balance
 i 76,061

 i 69,071

 i 76,061

 i 69,071

Employee Stock Trusts
 
 
 
 
Beginning balance
 i 3,018

 i 2,889

 i 2,918

 i 2,836

Share-based award activity
( i 26
)
( i 24
)
 i 74

 i 29

Ending balance
 i 2,992

 i 2,865

 i 2,992

 i 2,865

Accumulated Other Comprehensive Income (Loss)
 
 
 
 
Beginning balance
 i 1

( i 2,051
)
( i 2,788
)
( i 2,292
)
Net change in Accumulated other comprehensive income (loss)
( i 538
)
 i 453

 i 2,251

 i 694

Ending balance
( i 537
)
( i 1,598
)
( i 537
)
( i 1,598
)
Common Stock Held In Treasury at Cost
 
 
 
 
Beginning balance
( i 19,693
)
( i 15,799
)
( i 18,727
)
( i 13,971
)
Share-based award activity
 i 38

 i 57

 i 882

 i 1,138

Repurchases of common stock and employee tax withholdings
( i 30
)
( i 1,538
)
( i 1,840
)
( i 4,447
)
Ending balance
( i 19,685
)
( i 17,280
)
( i 19,685
)
( i 17,280
)
Common Stock Issued to Employee Stock Trusts
 
 
 
 
Beginning balance
( i 3,018
)
( i 2,889
)
( i 2,918
)
( i 2,836
)
Share-based award activity
 i 26

 i 24

( i 74
)
( i 29
)
Ending balance
( i 2,992
)
( i 2,865
)
( i 2,992
)
( i 2,865
)
Non-Controlling Interests
 
 
 
 
Beginning balance
 i 1,364

 i 1,121

 i 1,148

 i 1,160

Net income applicable to non-controlling interests
 i 34

 i 45

 i 156

 i 129

Net change in Accumulated other comprehensive income (loss) applicable to non-controlling interests
 i 28

 i 2

 i 79

( i 20
)
Other net increases (decreases)
( i 2
)
 i 

 i 41

( i 101
)
Ending balance
 i 1,424

 i 1,168

 i 1,424

 i 1,168

Total Equity
$
 i 89,818

$
 i 83,550

$
 i 89,818

$
 i 83,550


1.
See Notes 2 and 17 for further information regarding cumulative adjustments for accounting changes.
2.
See Note 17 for information regarding dividends per share for each class of stock.



See Notes to Consolidated Financial Statements
49
September 2020 Form 10-Q


 
Consolidated Cash Flow Statements
(Unaudited)
mslogo3q20.jpg


 
Nine Months Ended
September 30,
$ in millions
2020
2019
Cash flows from operating activities
 
 
Net income
$
 i 7,767

$
 i 6,932

Adjustments to reconcile net income to net cash provided by (used for) operating activities:
 
 
Stock-based compensation expense
 i 802

 i 825

Depreciation and amortization
 i 2,363

 i 1,987

Provision for (Release of) credit losses on lending activities
 i 757

 i 104

Other operating adjustments
 i 663

( i 114
)
Changes in assets and liabilities:
 
 
Trading assets, net of Trading liabilities
 i 18,442

 i 17,036

Securities borrowed
 i 5,746

( i 16,088
)
Securities loaned
( i 582
)
( i 2,217
)
Customer and other receivables and other assets
( i 17,098
)
( i 5,135
)
Customer and other payables and other liabilities
( i 5,818
)
 i 22,721

Securities purchased under agreements to resell
( i 59
)
 i 5,155

Securities sold under agreements to repurchase
( i 12,824
)
 i 9,703

Net cash provided by (used for) operating activities
 i 159

 i 40,909

Cash flows from investing activities
 
 
Proceeds from (payments for):
 
 
Other assets—Premises, equipment and software, net
( i 905
)
( i 1,460
)
Changes in loans, net
( i 13,592
)
( i 10,079
)
Investment securities:
 
 
Purchases
( i 41,147
)
( i 35,078
)
Proceeds from sales
 i 7,220

 i 13,561

Proceeds from paydowns and maturities
 i 11,240

 i 8,183

Other investing activities
( i 254
)
( i 848
)
Net cash provided by (used for) investing activities
( i 37,438
)
( i 25,721
)
Cash flows from financing activities
 
 
Net proceeds from (payments for):
 
 
Other secured financings
 i 229

( i 587
)
Deposits
 i 48,734

( i 7,084
)
Proceeds from issuance of Borrowings
 i 42,169

 i 23,697

Payments for:
 
 
Borrowings
( i 38,151
)
( i 30,391
)
Repurchases of common stock and employee tax withholdings
( i 1,840
)
( i 4,447
)
Cash dividends
( i 2,008
)
( i 2,082
)
Other financing activities
( i 208
)
( i 286
)
Net cash provided by (used for) financing activities
 i 48,925

( i 21,180
)
Effect of exchange rate changes on cash and cash equivalents
 i 955

( i 1,548
)
Net increase (decrease) in cash and cash equivalents
 i 12,601

( i 7,540
)
Cash and cash equivalents, at beginning of period
 i 82,171

 i 87,196

Cash and cash equivalents, at end of period
$
 i 94,772

$
 i 79,656

Supplemental Disclosure of Cash Flow Information
 
 
Cash payments for:
 
 
Interest
$
 i 3,747

$
 i 9,760

Income taxes, net of refunds
 i 1,675

 i 1,603


September 2020 Form 10-Q
50
See Notes to Consolidated Financial Statements


 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
1.  i Introduction and Basis of Presentation
The Firm
Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments—Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley” or the “Firm” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form 10-Q.
A description of the clients and principal products and services of each of the Firm’s business segments is as follows:
Institutional Securities provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in the equity and fixed income businesses. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research.
Wealth Management provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services.
Investment Management provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors and
 
corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors.
 i 
Basis of Financial Information
The financial statements are prepared in accordance with U.S. GAAP, which requires the Firm to make estimates and assumptions regarding the valuations of certain financial instruments, the valuations of goodwill and intangible assets, the outcome of legal and tax matters, deferred tax assets, ACL, and other matters that affect its financial statements and related disclosures. The Firm believes that the estimates utilized in the preparation of its financial statements are prudent and reasonable. Actual results could differ materially from these estimates.
Certain reclassifications have been made to prior periods to conform to the current presentation. The Notes are an integral part of the Firm's financial statements. The Firm has evaluated subsequent events for adjustment to or disclosure in these financial statements through the date of this report and has not identified any recordable or disclosable events not otherwise reported in these financial statements or the notes thereto.
The accompanying financial statements should be read in conjunction with the Firm’s financial statements and notes thereto included in the 2019 Form 10-K. Certain footnote disclosures included in the 2019 Form 10-K have been condensed or omitted from these financial statements as they are not required for interim reporting under U.S. GAAP. The financial statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for the fair presentation of the results for the interim period. The results of operations for interim periods are not necessarily indicative of results for the entire year.
 i 
Consolidation
The financial statements include the accounts of the Firm, its wholly owned subsidiaries and other entities in which the Firm has a controlling financial interest, including certain VIEs (see Note 15). Intercompany balances and transactions have been eliminated. For consolidated subsidiaries that are not wholly owned, the third-party holdings of equity interests are referred to as noncontrolling interests. The net income attributable to noncontrolling interests for such subsidiaries is presented as Net income applicable to noncontrolling interests in the income statements. The portion of shareholders’ equity that is attributable to noncontrolling interests for such subsidiaries is presented as noncontrolling interests, a component of Total equity, in the balance sheets.
For a discussion of the Firm’s significant regulated U.S. and international subsidiaries and its involvement with VIEs, see Note 1 to the financial statements in the 2019 Form 10-K.

 
51
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

2.  i Significant Accounting Policies
For a detailed discussion about the Firm’s significant accounting policies and for further information on accounting updates adopted in the prior year, see Note 2 to the financial statements in the 2019 Form 10-K.
During the nine months ended September 30, 2020 (“current year period”), there were no significant revisions to the Firm’s significant accounting policies, other than for the accounting updates adopted.
 i 
Accounting Updates Adopted in 2020
Reference Rate Reform
The Firm adopted the Reference Rate Reform accounting update in the current year period. There was no impact to the Firm’s financial statements upon initial adoption.
This accounting update provides optional accounting relief to entities with contracts, hedge accounting relationships or other transactions that reference LIBOR or other interest rate benchmarks for which the referenced rate is expected to be discontinued or replaced. The Firm is applying the accounting relief as relevant contract and hedge accounting relationship modifications are made during the course of the reference rate reform transition period. The optional relief generally allows for contract modifications solely related to the replacement of the reference rate to be accounted for as a continuation of the existing contract instead of as an extinguishment of the contract, and would therefore not trigger certain accounting impacts that would otherwise be required. It also allows entities to change certain critical terms of existing hedge accounting relationships that are affected by reference rate reform, and these changes would not require de-designating the hedge accounting relationship. The optional relief ends December 31, 2022.
Financial Instruments—Credit Losses
The Firm adopted the Financial InstrumentsCredit Losses accounting update on January 1, 2020.
This accounting update impacted the impairment model for certain financial assets measured at amortized cost by requiring a CECL methodology to estimate expected credit losses over the entire life of the financial asset, recorded at inception or purchase. CECL replaced the loss model previously applicable to loans held for investment, HTM securities and other receivables carried at amortized cost, such as employee loans.
The update also eliminated the concept of other-than-temporary impairment for AFS securities and instead requires impairments on AFS securities to be recognized in earnings through an allowance when the fair value is less than amortized cost and a credit loss exists, and through a permanent reduction of the
 
amortized cost basis when the securities are expected to be sold before recovery of amortized cost.

For certain portfolios, we determined that there are de minimus or zero expected credit losses, for example, for lending and financing transactions, such as Securities borrowed, Securities purchased under agreements to resell and certain other portfolios where collateral arrangements are being followed. Also, we have zero expected credit losses for certain financial assets based on the credit quality of the borrower or issuer, such as U.S. government and agency securities.

At transition on January 1, 2020, the adoption of this accounting standard resulted in an increase in the allowance for credit losses of $ i 131 million with a corresponding reduction in Retained earnings of $ i 100 million, net of tax. The adoption impact was primarily attributable to a $ i 124 million increase in the allowance for credit losses on employee loans.

The following discussion highlights changes to the Firm’s accounting policies as a result of this adoption.
Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures
Allowance for Credit Losses
The ACL for financial instruments measured at amortized cost and certain off-balance sheet exposures (e.g., HFI loans and lending commitments, HTM securities, customer and other receivables and certain guarantees) represents an estimate of expected credit losses over the entire life of the financial instrument.
Factors considered by management when determining the ACL include payment status, fair value of collateral, expected payments of principal and interest, as well as internal or external information relating to past events, current conditions and reasonable and supportable forecasts. The Firm’s three forecasts include assumptions about certain macroeconomic variables including, but not limited to, U.S. gross domestic product, equity market indices, unemployment rates, as well as commercial real estate and home price indices. At the conclusion of the Firm’s reasonable and supportable forecast period of 13 quarters, there is a gradual reversion back to historical averages.
The ACL is measured on a collective basis when similar risk characteristics exist for multiple instruments considering all available information relevant to assessing the collectability of cash flows. Generally, the Firm applies a probability of default/loss given default model for instruments that are collectively assessed, under which the ACL is calculated as the product of probability of default, loss given default and exposure at default. These parameters are forecast for each collective group of assets using a scenario-based statistical model and at the conclusion of the Firm’s reasonable and supportable forecast period, the parameters gradually revert back to historical averages.

September 2020 Form 10-Q
52
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

If the instrument does not share similar risk characteristics with other instruments, including when it is probable that the Firm will be unable to collect the full payment of principal and interest on the instrument when due, the ACL is measured on an individual basis. The Firm generally applies a discounted cash flow method for instruments that are individually assessed.

The Firm may also elect to use an approach that considers the fair value of the collateral when measuring the ACL if the loan is collateral dependent (i.e., repayment of the loan is expected to be provided substantially by the sale or operation of the underlying collateral and the borrower is experiencing financial difficulty).

Additionally, the Firm can elect to use an approach to measure the ACL using the fair value of collateral where the borrower is required to, and reasonably expected to, continually adjust and replenish the amount of collateral securing the instrument to reflect changes in the fair value of such collateral. The Firm has elected to use this approach for certain securities-based loans, customer receivables representing margin loans, Securities purchased under agreements to resell and Securities borrowed.
Credit quality indicators considered in developing the ACL include:
Corporate loans, Secured lending facilities, Commercial real estate loans and securities, and Other loans: Internal risk ratings developed by the Credit Risk Management Department which are refreshed at least annually, and more frequently as necessary. These ratings generally correspond to external ratings published by S&P. The Firm also considers transaction structure, including type of collateral, collateral terms, and position of the obligation within the capital structure. In addition, for Commercial real estate, the Firm considers property type and location, net operating income, LTV ratios, among others, as well as commercial real estate price and credit spread indices and capitalization rates.
Residential real estate loans: Loan origination Fair Isaac Corporation (“FICO”) credit scores as determined by independent credit agencies in the United States and loan-to-value (“LTV”) ratios.
Employee loans: Employment status, which includes those currently employed by the Firm and for which the Firm can deduct any unpaid amounts due to it through certain compensation arrangements; and those no longer employed by the Firm where such compensation arrangements are no longer applicable.
 
For Securities-based loans, the Firm generally measures the ACL based on the fair value of collateral.
Qualitative and environmental factors such as economic and business conditions, the nature and volume of the portfolio, and lending terms and the volume and severity of past due loans are also considered in the ACL calculations.
 
Presentation of ACL and Provision for Credit Losses
 
ACL
Provision for
credit losses
Instruments measured at amortized cost (e.g., HFI loans, HTM securities and customer and other receivables)
Contra asset
Other revenue
Employee loans
Contra asset
Compensation and benefits expense
Off-balance sheet instruments (e.g., HFI lending commitments and certain guarantees)
Other liabilities and accrued expenses
Other expense
Troubled Debt Restructurings (“TDRs”)
The Firm may modify the terms of certain loans for economic or legal reasons related to a borrower’s financial difficulties by granting one or more concessions that the Firm would not otherwise consider. Such modifications are accounted for and reported as a TDR, except for certain modifications related to the Coronavirus Disease (“COVID-19”) as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. A loan that has been modified in a TDR is generally considered to be impaired and is evaluated individually. TDRs are also generally classified as nonaccrual and may be returned to accrual status only after the Firm expects repayment of the remaining contractual principal and interest and there is sustained repayment performance for a reasonable period.
Nonaccrual
The Firm places financial instruments on nonaccrual status if principal or interest is past due for a period of 90 days or more or payment of principal or interest is in doubt unless the obligation is well-secured and in the process of collection, or in certain cases when related to COVID-19 as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. For any instrument placed on nonaccrual status, the Firm reverses any unpaid interest accrued with an offsetting reduction to Interest income. Principal and interest payments received on nonaccrual instruments are applied to principal if there is doubt regarding the ultimate collectability of principal. If collection of the principal is not in doubt, interest income is realized on a cash basis. If neither principal nor interest collection is in doubt and the instruments are brought current, instruments are generally placed on accrual status and interest income is recognized using the effective interest method.
Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19
In the first quarter of 2020, the Firm elected to apply the guidance issued by Congress in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) as well as by the U.S. banking agencies stating that certain concessions granted to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of COVID-19, generally would not be considered TDRs.

 
53
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Additionally, these loans generally would not be considered nonaccrual status unless collectability concerns exist despite the modification provided. For loans remaining on accrual status, the Firm elected to continue recognizing interest income during the modification periods.
ACL Write-offs
The Firm writes-off a financial instrument in the period that it is deemed uncollectible and records a reduction in the ACL and the balance of the financial instrument in the balance sheet. However, for accrued interest receivable balances that are separately recorded from the related financial instruments, the Firm's nonaccrual policy requires that accrued interest receivable be written off against Interest income when the related financial instrument is placed in nonaccrual status. Accordingly, the Firm elected not to measure an ACL for accrued interest receivables. However, in the case of loans which are modified as a result of COVID-19 and remain on accrual status due to the relief noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19,” accrued interest receivable balances are assessed for any required ACL.
Available-for-Sale (“AFS”) Investment Securities

AFS securities are reported at fair value in the balance sheets. Interest income, including amortization of premiums and accretion of discounts, is included in Interest income in the Income statements. Unrealized gains are recorded in OCI and unrealized losses are recorded either in OCI or in Other revenues as described below.

AFS securities in an unrealized loss position are first evaluated to determine whether there is an intent to sell or it is more likely than not the Firm will be required to sell before recovery of the amortized cost basis. If so, the entire unrealized loss is recognized in Other revenues, as any previously established ACL is written off and the amortized cost basis is written down to the fair value of the security.

For all other AFS securities in an unrealized loss position, any portion of unrealized losses representing a credit loss is recognized in Other revenues and as an increase to the ACL for AFS securities, with the remainder of unrealized losses recognized in OCI. When considering whether a credit loss exists, relevant information as discussed in Note 2 of the 2019 Form 10-K is considered, except that with the adoption of Financial Instruments—Credit Losses in 2020, the length of time the fair value has been less than the amortized cost basis is no longer considered.
Presentation of ACL and Provision for Credit Losses
 
ACL
Provision for
credit losses
AFS securities
Contra Investment securities
Other revenue
 
Nonaccrual & ACL Write-Offs on AFS Securities
AFS securities follow the same nonaccrual and write-off guidance as discussed in “Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures” herein, except as set forth in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19.”
 i 
Goodwill
The Firm completed its annual goodwill impairment testing as of July 1, 2020. The Firm’s impairment testing did not indicate any goodwill impairment, as each of the Firm’s reporting units with goodwill had a fair value that was in excess of its carrying value.
3.  i Acquisitions
Acquisition of E*TRADE
On October 2, 2020, the Firm completed the acquisition of  i 100% of E*TRADE Financial Corporation (“E*TRADE”) in a stock-for-stock transaction, which is expected to increase the scale and breadth of the Wealth Management business segment. Given the recency of the closing, the purchase accounting analysis is still preliminary, however, the transaction is expected to result in the addition of approximately $ i 77 billion in assets, inclusive of approximately $ i 5 billion of Goodwill and $ i 3 billion of Intangible assets. Total consideration for the transaction was approximately $ i 11.9 billion, which principally consists of the $ i 11 billion fair value of  i 233 million common shares issued from Common stock held in treasury, at an exchange ratio of  i 1.0432 per E*TRADE common share. In addition, the Firm issued Series M and Series N preferred shares with a fair value of approximately $ i 0.7 billion in exchange for E*TRADE’s existing preferred stock.
Planned Acquisition of Eaton Vance
On October 8, 2020, the Firm entered into a definitive agreement under which it will acquire Eaton Vance Corp. (“Eaton Vance”) in a cash and stock transaction valued, as of the announcement, at approximately $ i 7 billion, based on the closing price of the Firm’s common stock and the number of Eaton Vance’s fully diluted shares outstanding on October 7, 2020. Under the terms of the agreement, Eaton Vance common stockholders will receive $ i 28.25 in cash and  i 0.5833 Morgan Stanley common shares for each Eaton Vance common share. In addition, Eaton Vance common shareholders will receive a one-time special cash dividend of $ i 4.25 per share to be paid pre-closing by Eaton Vance. The acquisition is subject to customary closing conditions, and is expected to close in the second quarter of 2021.

September 2020 Form 10-Q
54
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

4.  i Cash and Cash Equivalents
Cash and cash equivalents consist of Cash and due from banks and Interest bearing deposits with banks. Cash equivalents are highly liquid investments with remaining maturities of three months or less from the acquisition date that are readily convertible to cash and are not held for trading purposes.
 i 
$ in millions
Cash and due from banks
$
 i 13,840

$
 i 6,763

Interest bearing deposits with banks
 i 80,932

 i 75,408

Total Cash and cash equivalents
$
 i 94,772

$
 i 82,171

Restricted cash
$
 i 37,186

$
 i 32,512


 / 
Cash and cash equivalents also include Restricted cash such as cash segregated in compliance with federal or other regulations, including minimum reserve requirements set by the Federal Reserve Bank and other central banks, and the Firm's initial margin deposited with clearing organizations.
5.  i Fair Values
Recurring Fair Value Measurements
 i 
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 
$ in millions
Level 1
Level 2
Level 3
Netting1
Total
Assets at fair value
 
 
 
 
 
Trading assets:
 
 
 
 
 
U.S. Treasury and agency securities
$
 i 41,488

$
 i 27,033

$
 i 122

$

$
 i 68,643

Other sovereign government obligations
 i 31,171

 i 5,909

 i 10


 i 37,090

State and municipal securities
 i 

 i 1,479

 i 


 i 1,479

MABS
 i 

 i 999

 i 443


 i 1,442

Loans and lending commitments2
 i 

 i 3,982

 i 4,351


 i 8,333

Corporate and other debt
 i 

 i 27,158

 i 2,727


 i 29,885

Corporate equities3
 i 102,975

 i 655

 i 135


 i 103,765

Derivative and other contracts:
 
 
 
 
Interest rate
 i 2,784

 i 239,900

 i 1,114


 i 243,798

Credit
 i 

 i 9,138

 i 768


 i 9,906

Foreign exchange
 i 16

 i 67,016

 i 152


 i 67,184

Equity
 i 1,244

 i 65,115

 i 1,127


 i 67,486

Commodity and other
 i 3,022

 i 12,031

 i 3,480


 i 18,533

Netting1
( i 5,913
)
( i 304,977
)
( i 1,060
)
( i 59,715
)
( i 371,665
)
Total derivative and other contracts
 i 1,153

 i 88,223

 i 5,581

( i 59,715
)
 i 35,242

Investments4
 i 664

 i 144

 i 821


 i 1,629

Physical commodities
 i 

 i 2,615

 i 


 i 2,615

Total trading assets4
 i 177,451

 i 158,197

 i 14,190

( i 59,715
)
 i 290,123

Investment securities—AFS
 i 46,946

 i 37,590

 i 


 i 84,536

Securities purchased under agreements to resell
 i 

 i 15

 i 


 i 15

Total assets at fair value
$
 i 224,397

$
 i 195,802

$
 i 14,190

$
( i 59,715
)
$
 i 374,674


 / 
 
 
$ in millions
Level 1
Level 2
Level 3
Netting1
Total
Liabilities at fair value
 
 
 
 
 
Deposits
$
 i 

$
 i 3,574

$
 i 105

$

$
 i 3,679

Trading liabilities:
 
 
 
 
 
U.S. Treasury and agency securities
 i 11,311

 i 462

 i 1


 i 11,774

Other sovereign government obligations
 i 25,589

 i 1,513

 i 


 i 27,102

Corporate and other debt
 i 

 i 8,623

 i 2


 i 8,625

Corporate equities3
 i 59,950

 i 344

 i 57


 i 60,351

Derivative and other contracts:
 
 
 
 
Interest rate
 i 2,942

 i 226,788

 i 478


 i 230,208

Credit
 i 

 i 9,602

 i 652


 i 10,254

Foreign exchange
 i 17

 i 65,390

 i 53


 i 65,460

Equity
 i 1,219

 i 75,900

 i 3,272


 i 80,391

Commodity and other
 i 3,025

 i 10,304

 i 1,676


 i 15,005

Netting1
( i 5,913
)
( i 304,977
)
( i 1,060
)
( i 52,204
)
( i 364,154
)
Total derivative and other contracts
 i 1,290

 i 83,007

 i 5,071

( i 52,204
)
 i 37,164

Total trading liabilities
 i 98,140

 i 93,949

 i 5,131

( i 52,204
)
 i 145,016

Securities sold under agreements to repurchase
 i 

 i 718

 i 448


 i 1,166

Other secured financings
 i 

 i 9,876

 i 309


 i 10,185

Borrowings
 i 

 i 65,063

 i 4,081


 i 69,144

Total liabilities at fair value
$
 i 98,140

$
 i 173,180

$
 i 10,074

$
( i 52,204
)
$
 i 229,190

 
$ in millions
Level 1
Level 2
Level 3
Netting1
Total
Assets at fair value
 
 
 
 
 
Trading assets:
 
 
 
 
 
U.S. Treasury and agency securities
$
 i 36,866

$
 i 28,992

$
 i 22

$

$
 i 65,880

Other sovereign government obligations
 i 23,402

 i 4,347

 i 5


 i 27,754

State and municipal securities
 i 

 i 2,790

 i 1


 i 2,791

MABS
 i 

 i 1,690

 i 438


 i 2,128

Loans and lending commitments2
 i 

 i 6,253

 i 5,073


 i 11,326

Corporate and other debt
 i 

 i 22,124

 i 1,396


 i 23,520

Corporate equities3
 i 123,942

 i 652

 i 97


 i 124,691

Derivative and other contracts:
 
 
 
Interest rate
 i 1,265

 i 182,977

 i 1,239


 i 185,481

Credit
 i 

 i 6,658

 i 654


 i 7,312

Foreign exchange
 i 15

 i 64,260

 i 145


 i 64,420

Equity
 i 1,219

 i 48,927

 i 922


 i 51,068

Commodity and other
 i 1,079

 i 7,255

 i 2,924


 i 11,258

Netting1
( i 2,794
)
( i 235,947
)
( i 993
)
( i 47,804
)
( i 287,538
)
Total derivative and other contracts
 i 784

 i 74,130

 i 4,891

( i 47,804
)
 i 32,001

Investments4
 i 481

 i 252

 i 858


 i 1,591

Physical commodities
 i 

 i 1,907

 i 


 i 1,907

Total trading assets4
 i 185,475

 i 143,137

 i 12,781

( i 47,804
)
 i 293,589

Investment securities—AFS
 i 32,902

 i 29,321

 i 


 i 62,223

Securities purchased under agreements to resell
 i 

 i 4

 i 


 i 4

Total assets at fair value
$
 i 218,377

$
 i 172,462

$
 i 12,781

$
( i 47,804
)
$
 i 355,816


September 2020 Form 10-Q
55
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
$ in millions
Level 1
Level 2
Level 3
Netting1
Total
Liabilities at fair value
 
 
 
 
 
Deposits
$
 i 

$
 i 1,920

$
 i 179

$

$
 i 2,099

Trading liabilities:
 
 
 
 
 
U.S. Treasury and agency securities
 i 11,191

 i 34

 i 


 i 11,225

Other sovereign government obligations
 i 21,837

 i 1,332

 i 1


 i 23,170

Corporate and other debt
 i 

 i 7,410

 i 


 i 7,410

Corporate equities3
 i 63,002

 i 79

 i 36


 i 63,117

Derivative and other contracts:
 
 
 
 
Interest rate
 i 1,144

 i 171,025

 i 462


 i 172,631

Credit
 i 

 i 7,391

 i 530


 i 7,921

Foreign exchange
 i 6

 i 67,473

 i 176


 i 67,655

Equity
 i 1,200

 i 49,062

 i 2,606


 i 52,868

Commodity and other
 i 1,194

 i 7,118

 i 1,312


 i 9,624

Netting1
( i 2,794
)
( i 235,947
)
( i 993
)
( i 42,531
)
( i 282,265
)
Total derivative and other contracts
 i 750

 i 66,122

 i 4,093

( i 42,531
)
 i 28,434

Total trading liabilities
 i 96,780

 i 74,977

 i 4,130

( i 42,531
)
 i 133,356

Securities sold under agreements to repurchase
 i 

 i 733

 i 


 i 733

Other secured financings
 i 

 i 7,700

 i 109


 i 7,809

Borrowings
 i 

 i 60,373

 i 4,088


 i 64,461

Total liabilities at fair value
$
 i 96,780

$
 i 145,703

$
 i 8,506

$
( i 42,531
)
$
 i 208,458

MABSMortgage- and asset-backed securities
1.
For positions with the same counterparty that cross over the levels of the fair value hierarchy, both counterparty netting and cash collateral netting are included in the column titled “Netting.” Positions classified within the same level that are with the same counterparty are netted within that level. For further information on derivative instruments and hedging activities, see Note 7.
2.
For a further breakdown by type, see the following Detail of Loans and Lending Commitments at Fair Value table.
3.
For trading purposes, the Firm holds or sells short equity securities issued by entities in diverse industries and of varying sizes.
4.
Amounts exclude certain investments that are measured based on NAV per share, which are not classified in the fair value hierarchy. For additional disclosure about such investments, see “Net Asset Value Measurements” herein.
 i 
Detail of Loans and Lending Commitments at Fair Value1 
$ in millions
Corporate
$
 i 14

$
 i 20

Secured lending facilities
 i 445

 i 951

Commercial Real Estate
 i 769

 i 2,098

Residential Real Estate
 i 824

 i 1,192

Securities-based lending and Other loans
 i 6,281

 i 7,065

Total
$
 i 8,333

$
 i 11,326


 / 
1.
Loans previously classified as corporate have been further disaggregated; prior period balances have been revised to conform with current period presentation.
 i 
Unsettled Fair Value of Futures Contracts1   
$ in millions
Customer and other receivables, net
$
 i 589

$
 i 365

 / 
1.
These contracts are primarily Level 1, actively traded, valued based on quoted prices from the exchange and are excluded from the previous recurring fair value tables.
 
For a description of the valuation techniques applied to the Firm’s major categories of assets and liabilities measured at fair value on a recurring basis, see Note 3 to the financial statements in the 2019 Form 10-K. During the current quarter, there were no significant revisions made to the Firm’s valuation techniques.
 i  i 
Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
U.S. Treasury and agency securities
Beginning balance
$
 i 97

$
 i 5

$
 i 22

$
 i 54

Realized and unrealized gains (losses)
( i 1
)
 i 

 i 

 i 

Purchases
 i 109

 i 11

 i 133

 i 18

Sales
( i 36
)
 i 

( i 42
)
( i 54
)
Net transfers
( i 47
)
 i 2

 i 9

 i 

Ending balance
$
 i 122

$
 i 18

$
 i 122

$
 i 18

Unrealized gains (losses)
$
( i 1
)
$
 i 

$
 i 

$
 i 

Other sovereign government obligations
Beginning balance
$
 i 11

$
 i 10

$
 i 5

$
 i 17

Realized and unrealized gains (losses)
( i 1
)
( i 3
)
 i 

( i 2
)
Purchases
 i 1

 i 2

 i 8

 i 13

Sales
( i 1
)
( i 2
)
( i 3
)
( i 6
)
Net transfers
 i 

 i 5

 i 

( i 10
)
Ending balance
$
 i 10

$
 i 12

$
 i 10

$
 i 12

Unrealized gains (losses)
$
 i 

$
( i 3
)
$
 i 

$
( i 2
)
State and municipal securities
Beginning balance
$
 i 

$
 i 16

$
 i 1

$
 i 148

Sales
 i 

( i 2
)
 i 

( i 43
)
Net transfers
 i 

( i 13
)
( i 1
)
( i 104
)
Ending balance
$
 i 

$
 i 1

$
 i 

$
 i 1

Unrealized gains (losses)
$
 i 

$
 i 

$
 i 

$
 i 

MABS
Beginning balance
$
 i 379

$
 i 480

$
 i 438

$
 i 354

Realized and unrealized gains (losses)
 i 13

( i 10
)
( i 60
)
( i 9
)
Purchases
 i 13

 i 5

 i 172

 i 66

Sales
( i 54
)
( i 58
)
( i 162
)
( i 157
)
Settlements
 i 

 i 

 i 

( i 39
)
Net transfers
 i 92

( i 16
)
 i 55

 i 186

Ending balance
$
 i 443

$
 i 401

$
 i 443

$
 i 401

Unrealized gains (losses)
$
 i 8

$
( i 8
)
$
( i 35
)
$
( i 38
)
Loans and lending commitments
Beginning balance
$
 i 4,068

$
 i 5,604

$
 i 5,073

$
 i 6,870

Realized and unrealized gains (losses)
 i 20

( i 51
)
( i 161
)
 i 3

Purchases and originations
 i 846

 i 852

 i 1,926

 i 1,934

Sales
( i 725
)
( i 464
)
( i 1,139
)
( i 1,541
)
Settlements
( i 285
)
( i 811
)
( i 1,907
)
( i 2,130
)
Net transfers1
 i 427

( i 261
)
 i 559

( i 267
)
Ending balance
$
 i 4,351

$
 i 4,869

$
 i 4,351

$
 i 4,869

Unrealized gains (losses)
$
 i 27

$
( i 55
)
$
( i 137
)
$
 i 283


 / 
 / 

September 2020 Form 10-Q
56
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Corporate and other debt
Beginning balance
$
 i 2,686

$
 i 1,364

$
 i 1,396

$
 i 1,076

Realized and unrealized gains (losses)
( i 107
)
 i 157

( i 184
)
 i 269

Purchases
 i 451

 i 341

 i 2,217

 i 632

Sales
( i 325
)
( i 474
)
( i 425
)
( i 587
)
Settlements
 i 

 i 

( i 311
)
( i 7
)
Net transfers
 i 22

 i 2

 i 34

 i 7

Ending balance
$
 i 2,727

$
 i 1,390

$
 i 2,727

$
 i 1,390

Unrealized gains (losses)
$
( i 96
)
$
 i 114

$
( i 186
)
$
 i 217

Corporate equities
Beginning balance
$
 i 83

$
 i 98

$
 i 97

$
 i 95

Realized and unrealized gains (losses)
 i 32

 i 1

 i 

( i 41
)
Purchases
 i 32

 i 5

 i 42

 i 44

Sales
( i 27
)
( i 16
)
( i 27
)
( i 268
)
Net transfers
 i 15

 i 15

 i 23

 i 273

Ending balance
$
 i 135

$
 i 103

$
 i 135

$
 i 103

Unrealized gains (losses)
$
 i 39

$
 i 7

$
 i 14

$
( i 38
)
Investments
Beginning balance
$
 i 759

$
 i 785

$
 i 858

$
 i 757

Realized and unrealized gains (losses)
 i 55

( i 15
)
( i 6
)
 i 19

Purchases
 i 7

 i 7

 i 37

 i 28

Sales
( i 16
)
( i 7
)
( i 37
)
( i 43
)
Net transfers
 i 16

 i 15

( i 31
)
 i 24

Ending balance
$
 i 821

$
 i 785

$
 i 821

$
 i 785

Unrealized gains (losses)
$
 i 44

$
( i 12
)
$
( i 19
)
$
 i 22

Net derivatives: Interest rate
Beginning balance
$
 i 760

$
 i 816

$
 i 777

$
 i 618

Realized and unrealized gains (losses)
( i 147
)
( i 40
)
( i 95
)
 i 143

Purchases
 i 36

 i 69

 i 153

 i 132

Issuances
( i 15
)
( i 11
)
( i 41
)
( i 22
)
Settlements
( i 31
)
 i 2

 i 36

 i 16

Net transfers
 i 33

( i 48
)
( i 194
)
( i 99
)
Ending balance
$
 i 636

$
 i 788

$
 i 636

$
 i 788

Unrealized gains (losses)
$
( i 139
)
$
 i 120

$
( i 37
)
$
 i 214

Net derivatives: Credit
Beginning balance
$
 i 131

$
( i 138
)
$
 i 124

$
 i 40

Realized and unrealized gains (losses)
( i 16
)
( i 183
)
 i 11

 i 36

Purchases
 i 17

 i 44

 i 66

 i 103

Issuances
( i 51
)
( i 19
)
( i 101
)
( i 162
)
Settlements
 i 10

 i 389

 i 61

 i 90

Net transfers
 i 25

 i 12

( i 45
)
( i 2
)
Ending balance
$
 i 116

$
 i 105

$
 i 116

$
 i 105

Unrealized gains (losses)
$
( i 16
)
$
 i 20

$
 i 2

$
 i 41

 
 
 
 
 

 
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Net derivatives: Foreign exchange
Beginning balance
$
 i 17

$
( i 29
)
$
( i 31
)
$
 i 75

Realized and unrealized gains (losses)
 i 86

 i 67

 i 202

( i 83
)
Purchases
 i 

 i 

 i 3

 i 

Issuances
( i 4
)
 i 

( i 5
)
 i 

Settlements
( i 9
)
 i 5

( i 27
)
 i 

Net transfers
 i 9

 i 9

( i 43
)
 i 60

Ending balance
$
 i 99

$
 i 52

$
 i 99

$
 i 52

Unrealized gains (losses)
$
 i 75

$
 i 79

$
 i 136

$
 i 26

Net derivatives: Equity
Beginning balance
$
( i 1,884
)
$
( i 1,715
)
$
( i 1,684
)
$
( i 1,485
)
Realized and unrealized gains (losses)
 i 3

( i 61
)
 i 75

 i 59

Purchases
 i 19

 i 36

 i 192

 i 75

Issuances
( i 181
)
( i 207
)
( i 706
)
( i 227
)
Settlements
( i 151
)
( i 56
)
( i 167
)
( i 173
)
Net transfers
 i 49

 i 622

 i 145

 i 370

Ending balance
$
( i 2,145
)
$
( i 1,381
)
$
( i 2,145
)
$
( i 1,381
)
Unrealized gains (losses)
$
 i 32

$
( i 86
)
$
( i 143
)
$
 i 81

Net derivatives: Commodity and other
Beginning balance
$
 i 2,087

$
 i 1,861

$
 i 1,612

$
 i 2,052

Realized and unrealized gains (losses)
( i 29
)
 i 120

 i 373

 i 35

Purchases
 i 1

 i 126

 i 26

 i 145

Issuances
( i 40
)
( i 36
)
( i 65
)
( i 71
)
Settlements
( i 181
)
( i 107
)
( i 101
)
( i 307
)
Net transfers
( i 34
)
 i 10

( i 41
)
 i 120

Ending balance
$
 i 1,804

$
 i 1,974

$
 i 1,804

$
 i 1,974

Unrealized gains (losses)
$
( i 251
)
$
 i 33

$
( i 6
)
$
( i 89
)
Deposits
Beginning balance
$
 i 90

$
 i 138

$
 i 179

$
 i 27

Realized and unrealized losses (gains)
 i 4

 i 5

 i 8

 i 16

Issuances
 i 

 i 23

 i 

 i 70

Settlements
( i 2
)
( i 8
)
( i 13
)
( i 12
)
Net transfers
 i 13

( i 13
)
( i 69
)
 i 44

Ending balance
$
 i 105

$
 i 145

$
 i 105

$
 i 145

Unrealized losses (gains)
$
 i 4

$
 i 5

$
 i 8

$
 i 16

Nonderivative trading liabilities
Beginning balance
$
 i 74

$
 i 36

$
 i 37

$
 i 16

Realized and unrealized losses (gains)
( i 6
)
( i 7
)
( i 21
)
( i 37
)
Purchases
( i 7
)
( i 13
)
( i 23
)
( i 31
)
Sales
 i 5

 i 6

 i 23

 i 36

Settlements
 i 

 i 

 i 3

 i 

Net transfers
( i 6
)
 i 18

 i 41

 i 56

Ending balance
$
 i 60

$
 i 40

$
 i 60

$
 i 40

Unrealized losses (gains)
$
( i 4
)
$
( i 7
)
$
( i 21
)
$
( i 37
)


 
57
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Securities sold under agreements to repurchase
Beginning balance
$
 i 440

$
 i 

$
 i 

$
 i 

Realized and unrealized losses (gains)
 i 8

 i 

( i 22
)
 i 

Issuances
 i 

 i 

 i 470

 i 

Ending balance
$
 i 448

$
 i 

$
 i 448

$
 i 

Unrealized losses (gains)
$
 i 8

$
 i 

$
( i 22
)
$
 i 

Other secured financings
 
 
Beginning balance
$
 i 300

$
 i 154

$
 i 109

$
 i 208

Realized and unrealized losses (gains)
 i 11

( i 1
)
( i 1
)
 i 5

Issuances
 i 3

 i 

 i 10

 i 

Settlements
( i 5
)
 i 

( i 208
)
( i 8
)
Net transfers
 i 

( i 43
)
 i 399

( i 95
)
Ending balance
$
 i 309

$
 i 110

$
 i 309

$
 i 110

Unrealized losses (gains)
$
 i 11

$
( i 1
)
$
( i 1
)
$
 i 5

Borrowings
Beginning balance
$
 i 4,135

$
 i 3,939

$
 i 4,088

$
 i 3,806

Realized and unrealized losses (gains)
( i 32
)
 i 88

( i 284
)
 i 498

Issuances
 i 194

 i 201

 i 992

 i 610

Settlements
( i 70
)
( i 260
)
( i 346
)
( i 438
)
Net transfers
( i 146
)
( i 430
)
( i 369
)
( i 938
)
Ending balance
$
 i 4,081

$
 i 3,538

$
 i 4,081

$
 i 3,538

Unrealized losses (gains)
$
( i 33
)
$
 i 91

$
( i 282
)
$
 i 459

Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA
 i 22

( i 23
)
( i 124
)
 i 68


1.
Net transfers in the current year period reflect the largely offsetting impacts of transfers in of $ i 857 million of equity margin loans and transfers out of $ i 707 million of equity margin loans. The loans were transferred into Level 3 in the first quarter as the significance of the margin loan rate input increased as a result of reduced liquidity, and transferred out of Level 3 in the second quarter as liquidity conditions improved reducing the significance of the input.
Level 3 instruments may be hedged with instruments classified in Level 1 and Level 2. The realized and unrealized gains or losses for assets and liabilities within the Level 3 category presented in the previous tables do not reflect the related realized and unrealized gains or losses on hedging instruments that have been classified by the Firm within the Level 1 and/or Level 2 categories.
The unrealized gains (losses) during the period for assets and liabilities within the Level 3 category may include changes in fair value during the period that were attributable to both observable and unobservable inputs. Total realized and unrealized gains (losses) are primarily included in Trading revenues in the income statements.
Additionally, in the previous tables, consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements.

 
Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements
 i 
Valuation Techniques and Unobservable Inputs
 
Balance / Range (Average)1
$ in millions, except inputs
Assets Measured at Fair Value on a Recurring Basis
U.S. Treasury and agency securities
$
 i 122

$
 i 22

Comparable pricing:
 
 
Bond price
102 to 108 points (104 points)

N/M

MABS
$
 i 443

$
 i 438

Comparable pricing:
 
Bond price
0 to 80 points (47 points)

0 to 96 points (47 points)

Loans and lending commitments
$
 i 4,351

$
 i 5,073

Margin loan model:
 
 
Discount rate
N/A

1% to 9% (2%)

Volatility skew
N/A

15% to 80% (28%)

Credit Spread
N/A

9 to 39 bps (19 bps)

Margin loan rate
1% to 5% (3%)

N/A

Comparable pricing:
 
Loan price
70 to 103 points (96 points)

69 to 100 points (93 points)

Corporate and other debt
$
 i 2,727

$
 i 1,396

Comparable pricing:
 
Bond price
10 to 103 points (94 points)

11 to 108 points (84 points)

Discounted cash flow:
 
Recovery rate
51% to 62% (53% / 51%)

 i 35
%
Option model:
 
 
At the money volatility
 i 21
%
 i 21
%
Corporate equities
$
 i 135

$
 i 97

Comparable pricing:
 
Equity price
 i 100
%
 i 100
%
Investments
$
 i 821

$
 i 858

Discounted cash flow:
 
WACC
10% to 21% (15%)

8% to 17% (15%)

Exit multiple
7 to 17 times (11 times)

7 to 16 times (11 times)

Market approach:
 
 
EBITDA multiple
8 to 29 times (11 times)

7 to 24 times (11 times)

Comparable pricing:
 
Equity price
50% to 100% (98%)

75% to 100% (99%)

Net derivative and other contracts:
 
Interest rate
$
 i 636

$
 i 777

Option model:
 
 
IR volatility skew
0% to 162% (62% / 75%)

24% to 156% (63% / 59%)

IR curve correlation
59% to 97% (87% / 92%)

47% to 90% (72% / 72%)

Bond volatility
4% to 32% (13% / 8%)

4% to 15% (13% / 14%)

Inflation volatility
25% to 64% (44% / 42%)

24% to 63% (44% / 41%)

IR curve
 i 1
%
 i 1
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 / 

September 2020 Form 10-Q
58
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
Balance / Range (Average)1
$ in millions, except inputs
Credit
$
 i 116

$
 i 124

Credit default swap model:
 
Cash-synthetic basis
6 points

6 points

Bond price
0 to 95 points (52 points)

0 to 104 points (45 points)

Credit spread
20 to 435 bps (79 bps)

9 to 469 bps (81 bps)

Funding spread
71 to 138 bps (116 bps)

47 to 117 bps (84 bps)

Correlation model:
 
 
Credit correlation
29% to 56% (35%)

29% to 62% (36%)

Foreign exchange2
$
 i 99

$
( i 31
)
Option model:
 
 
IR - FX correlation
13% to 59% (37% / 37%)

32% to 56% (46% / 46%)

IR volatility skew
0% to 162% (62% / 75%)

24% to 156% (63% / 59%)

IR curve
8% to 9% (8% / 8%)

10% to 11% (10% / 10%)

Foreign exchange volatility skew
-7% to -5% (-6% / -6%)

N/A

Contingency probability
95% (95%)

85% to 95% (94% / 95%)

Equity2
$
( i 2,145
)
$
( i 1,684
)
Option model:
 
 
At the money volatility
16% to 92% (42%)

9% to 90% (36%)

Volatility skew
-2% to 0% (-1%)

-2% to 0% (-1%)

Equity correlation
5% to 96% (70%)

5% to 98% (70%)

FX correlation
-60% to 60% (-17%)

-79% to 60% (-37%)

IR correlation
-7% to 44% (20% / 18%)

-11% to 44% (18% / 16%)

Commodity and other
$
 i 1,804

$
 i 1,612

Option model:
 
 
Forward power price
$-1 to $116 ($28) per MWh

$3 to $182 ($28) per MWh

Commodity volatility
8% to 95% (19%)

7% to 183% (18%)

Cross-commodity correlation
43% to 99% (92%)

43% to 99% (93%)

Liabilities Measured at Fair Value on a Recurring Basis
Deposits
$
 i 105

$
 i 179

Option Model:
 
 
Equity at the money volatility
7% to 23% (7%)

16% to 37% (20%)

Corporate equities
$
 i 57

$
 i 36

Comparable pricing:


Equity price
100% (100%)

N/M

Securities sold under agreements to repurchase
$
 i 448

$
 i 

Discounted cash flow:

Funding spread
105 to 130 bps (114 bps)

N/A

Other secured financings
$
 i 309

$
 i 109

Discounted cash flow:
 
Funding spread
110 bps (110 bps)

111 to 124 bps (117 bps)

Comparable pricing:
 
Loan price
25 to 101 points (68 points)

N/A

 
 
 
 
 
 
 
 
 
 
 
Balance / Range (Average)1
$ in millions, except inputs
Borrowings
$
 i 4,081

$
 i 4,088

Option model:
 
 
At the money volatility
6% to 70% (23%)

5% to 44% (21%)

Volatility skew
-2% to 0% (0%)

-2% to 0% (0%)

Equity correlation
37% to 98% (81%)

38% to 94% (78%)

Equity - FX correlation
-72% to 13% (-28%)

-75% to 26% (-25%)

IR - FX Correlation
-28% to 6% (-6% / -6%)

-26% to 10% (-7% / -7%)

Nonrecurring Fair Value Measurement
Loans
$
 i 2,088

$
 i 1,500

Corporate loan model:
 
Credit spread
52 bps to 668 bps (380 bps)

69 to 446 bps (225 bps)

Warehouse model:
 
 
Credit spread
191 bps to 580 bps (379 bps)

287 to 318 bps (297 bps)

Points—Percentage of par
IR—Interest rate
FX—Foreign exchange
1.
A single amount is disclosed for range and average when there is no significant difference between the minimum, maximum and average. Amounts represent weighted averages except where simple averages and the median of the inputs are more relevant.
2.
Includes derivative contracts with multiple risks (i.e., hybrid products).
The previous tables provide information on the valuation techniques, significant unobservable inputs, and the ranges and averages for each major category of assets and liabilities measured at fair value on a recurring and nonrecurring basis with a significant Level 3 balance. The level of aggregation and breadth of products cause the range of inputs to be wide and not evenly distributed across the inventory of financial instruments. Further, the range of unobservable inputs may differ across firms in the financial services industry because of diversity in the types of products included in each firm’s inventory. Generally, there are no predictable relationships between multiple significant unobservable inputs attributable to a given valuation technique.
Other than as follows, during the current year period, there were no significant revisions made to the descriptions of the Firm’s significant unobservable inputs. For margin loans, the margin loan rate is the annualized rate that reflects the possibility of losses as a result of movements in the price of the underlying margin loan collateral. The rate is calibrated from the previously disclosed discount rate, credit spread and/or volatility measures. For a description of the Firm’s significant unobservable inputs and qualitative information about the effect of hypothetical changes in the values of those inputs, see Note 3 to the financial statements in the 2019 Form 10-K.


 
59
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Net Asset Value Measurements
 i 
Fund Interests
 
$ in millions
Carrying
Value
Commitment
Carrying
Value
Commitment
Private equity
$
 i 2,400

$
 i 614

$
 i 2,078

$
 i 450

Real estate
 i 1,383

 i 140

 i 1,349

 i 150

Hedge1
 i 62

 i 

 i 94

 i 4

Total
$
 i 3,845

$
 i 754

$
 i 3,521

$
 i 604

 / 
1.
Investments in hedge funds may be subject to initial period lock-up or gate provisions, which restrict an investor from withdrawing from the fund during a certain initial period or restrict the redemption amount on any redemption date, respectively.
Amounts in the previous table represent the Firm’s carrying value of general and limited partnership interests in fund investments, as well as any related performance-based fees in the form of carried interest. The carrying amounts are measured based on the NAV of the fund taking into account the distribution terms applicable to the interest held. This same measurement applies whether the fund investments are accounted for under the equity method or fair value.
For a description of the Firm’s investments in private equity funds, real estate funds and hedge funds, which are measured based on NAV, see Note 3 to the financial statements in the 2019 Form 10-K.
See Note 14 for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received. See Note 20 for information regarding unrealized carried interest at risk of reversal. 
Nonredeemable Funds by Contractual Maturity
 
Carrying Value at September 30, 2020
$ in millions
Private Equity
Real Estate
Less than 5 years
$
 i 1,551

$
 i 415

5-10 years
 i 765

 i 374

Over 10 years
 i 84

 i 594

Total
$
 i 2,400

$
 i 1,383


Nonrecurring Fair Value Measurements    
 i 
Carrying and Fair Values
 
 
Fair Value
$ in millions
Level 2
Level 31
Total
Assets
 
 
 
Loans
$
 i 4,827

$
 i 2,088

$
 i 6,915

Other assets—Other investments
 i 

 i 18

 i 18

Total
$
 i 4,827

$
 i 2,106

$
 i 6,933

Liabilities
 
 
 
Other liabilities and accrued expenses—Lending commitments
$
 i 221

$
 i 69

$
 i 290

Total
$
 i 221

$
 i 69

$
 i 290

 / 
 
 
 
Fair Value
$ in millions
Level 2
Level 31
Total
Assets
 
 
 
Loans
$
 i 1,543

$
 i 1,500

$
 i 3,043

Other assets—Other investments
 i 

 i 113

 i 113

Total
$
 i 1,543

$
 i 1,613

$
 i 3,156

Liabilities
 
 
 
Other liabilities and accrued expenses—Lending commitments
$
 i 132

$
 i 69

$
 i 201

Total
$
 i 132

$
 i 69

$
 i 201

 
1.
For significant Level 3 balances, refer to “Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements” section herein for details of the significant unobservable inputs used for nonrecurring fair value measurement.
Gains (Losses) from Fair Value Remeasurements1   
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Assets
 
 
 
 
Loans2
$
( i 43
)
$
( i 27
)
$
( i 467
)
$
( i 12
)
Intangibles
( i 1
)
 i 

( i 1
)
 i 

Other assets—Other investments3
( i 2
)
( i 3
)
( i 54
)
( i 8
)
Other assets—Premises, equipment and software4
( i 29
)
( i 4
)
( i 35
)
( i 8
)
Total
$
( i 75
)
$
( i 34
)
$
( i 557
)
$
( i 28
)
Liabilities
 
 


Other liabilities and accrued expenses—Lending commitments2
$
 i 25

$
( i 19
)
$
( i 54
)
$
 i 82

Total
$
 i 25

$
( i 19
)
$
( i 54
)
$
 i 82

1.
Gains and losses for Loans and Other assets—Other investments are classified in Other revenues. For other items, gains and losses are recorded in Other revenues if the item is held for sale; otherwise, they are recorded in Other expenses.
2.
Nonrecurring changes in the fair value of loans and lending commitments were calculated as follows: for the held-for-investment category, based on the value of the underlying collateral; and for the held-for-sale category, based on recently executed transactions, market price quotations, valuation models that incorporate market observable inputs where possible, such as comparable loan or debt prices and CDS spread levels adjusted for any basis difference between cash and derivative instruments, or default recovery analysis where such transactions and quotations are unobservable.
3.
Losses related to Other assets—Other investments were determined using techniques that included discounted cash flow models, methodologies that incorporate multiples of certain comparable companies and recently executed transactions.
4.
Losses related to Other assets—Premises, equipment and software generally include impairments as well as write-offs related to the disposal of certain assets.

September 2020 Form 10-Q
60
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 i 
Financial Instruments Not Measured at Fair Value
 
 
Carrying
Value
Fair Value
$ in millions
Level 1
Level 2
Level 3
Total
Financial assets
 
 
 
 
Cash and cash equivalents
$
 i 94,772

$
 i 94,772

$
 i 

$
 i 

$
 i 94,772

Investment securities—HTM
 i 46,169

 i 30,893

 i 17,200

 i 861

 i 48,954

Securities purchased under agreements to resell
 i 88,268

 i 

 i 86,756

 i 1,538

 i 88,294

Securities borrowed
 i 100,803

 i 

 i 100,804

 i 

 i 100,804

Customer and other receivables1
 i 68,541

 i 

 i 65,624

 i 2,903

 i 68,527

Loans2
 i 146,237

 i 

 i 25,942

 i 121,217

 i 147,159

Other assets
 i 466

 i 

 i 466

 i 

 i 466

Financial liabilities
 
 
 
Deposits
$
 i 235,574

$
 i 

$
 i 235,924

$
 i 

$
 i 235,924

Securities sold under agreements to repurchase
 i 40,210

 i 

 i 39,876

 i 375

 i 40,251

Securities loaned
 i 7,924

 i 

 i 7,921

 i 

 i 7,921

Other secured financings
 i 3,672

 i 

 i 3,672

 i 

 i 3,672

Customer and other payables1
 i 189,754

 i 

 i 189,754

 i 

 i 189,754

Borrowings
 i 134,300

 i 

 i 138,925

 i 5

 i 138,930

 
Commitment
Amount
 
 
 
 
Lending commitments3
$
 i 118,966

$
 i 

$
 i 965

$
 i 406

$
 i 1,371

 / 
 

 
 
Carrying
Value
Fair Value
$ in millions
Level 1
Level 2
Level 3
Total
Financial assets
 
 
 
 
Cash and cash equivalents
$
 i 82,171

$
 i 82,171

$
 i 

$
 i 

$
 i 82,171

Investment securities—HTM
 i 43,502

 i 30,661

 i 12,683

 i 789

 i 44,133

Securities purchased under agreements to resell
 i 88,220

 i 

 i 86,794

 i 1,442

 i 88,236

Securities borrowed
 i 106,549

 i 

 i 106,551

 i 

 i 106,551

Customer and other receivables1
 i 51,134

 i 

 i 48,215

 i 2,872

 i 51,087

Loans2
 i 130,637

 i 

 i 22,293

 i 108,059

 i 130,352

Other assets
 i 495

 i 

 i 495

 i 

 i 495

Financial liabilities
 
 
 
Deposits
$
 i 188,257

$
 i 

$
 i 188,639

$
 i 

$
 i 188,639

Securities sold under agreements to repurchase
 i 53,467

 i 

 i 53,486

 i 

 i 53,486

Securities loaned
 i 8,506

 i 

 i 8,506

 i 

 i 8,506

Other secured financings
 i 6,889

 i 

 i 6,800

 i 92

 i 6,892

Customer and other payables1
 i 195,035

 i 

 i 195,035

 i 

 i 195,035

Borrowings
 i 128,166

 i 

 i 133,563

 i 10

 i 133,573

 
Commitment
Amount
 
 
 
 
Lending commitments3
$
 i 119,004

$
 i 

$
 i 748

$
 i 338

$
 i 1,086

1.
Accrued interest and dividend receivables and payables have been excluded. Carrying value approximates fair value for these receivables and payables.
2.
Amounts include loans measured at fair value on a nonrecurring basis.
3.
Represents Lending commitments accounted for as Held for Investment and Held for Sale. For a further discussion on lending commitments, see Note 14.
The previous tables exclude certain financial instruments such as equity method investments and all non-financial assets and liabilities such as the value of the long-term relationships with the Firm’s deposit customers.


 
61
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

6.  i Fair Value Option
The Firm has elected the fair value option for certain eligible instruments that are risk managed on a fair value basis to mitigate income statement volatility caused by measurement basis differences between the elected instruments and their associated risk management transactions or to eliminate complexities of applying certain accounting models.
Borrowings Measured at Fair Value on a Recurring Basis
$ in millions
Business Unit Responsible for Risk Management
Equity
$
 i 31,673

$
 i 30,214

Interest rates
 i 28,986

 i 27,298

Commodities
 i 5,097

 i 4,501

Credit
 i 1,257

 i 1,246

Foreign exchange
 i 2,131

 i 1,202

Total
$
 i 69,144

$
 i 64,461


Net Revenues from Borrowings under the Fair Value Option
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Trading revenues
$
( i 1,455
)
$
( i 795
)
$
( i 1,447
)
$
( i 5,888
)
Interest expense
 i 77

 i 93

 i 241

 i 280

Net revenues1
$
( i 1,532
)
$
( i 888
)
$
( i 1,688
)
$
( i 6,168
)
1.
Amounts do not reflect any gains or losses from related economic hedges.
Gains (losses) from changes in fair value are recorded in Trading revenues and are mainly attributable to movements in the reference price or index, interest rates or foreign exchange rates.
 
Gains (Losses) Due to Changes in Instrument-Specific Credit Risk
 
Three Months Ended September 30,
 
2020
2019
$ in millions
Trading
Revenues
OCI
Trading
Revenues
OCI
Loans and other debt1
$
 i 56

$
 i 

$
( i 3
)
$
 i 

Lending commitments
( i 3
)
 i 

 i 

 i 

Deposits
 i 

( i 19
)
 i 

 i 1

Borrowings
( i 8
)
( i 720
)
( i 2
)
 i 442

 
Nine Months Ended September 30,
 
2020
2019
$ in millions
Trading
Revenues
OCI
Trading
Revenues
OCI
Loans and other debt1
$
( i 183
)
$
 i 

$
 i 148

$
 i 

Lending commitments
( i 2
)
 i 

( i 2
)
 i 

Deposits
 i 

( i 10
)
 i 

( i 2
)
Borrowings
( i 14
)
 i 991

( i 9
)
( i 702
)
$ in millions
Cumulative pre-tax DVA gain (loss) recognized in AOCI
$
( i 1,017
)
$
( i 1,998
)
1.
Loans and other debt instrument-specific credit gains (losses) were determined by excluding the non-credit components of gains and losses.
Difference Between Contractual Principal and Fair Value1   
$ in millions
Loans and other debt2
$
 i 13,552

$
 i 13,037

Nonaccrual loans2
 i 11,411

 i 10,849

Borrowings3
( i 2,103
)
( i 1,665
)
1.
Amounts indicate contractual principal greater than or (less than) fair value.
2.
The majority of the difference between principal and fair value amounts for loans and other debt relates to distressed debt positions purchased at amounts well below par.
3.
Excludes borrowings where the repayment of the initial principal amount fluctuates based on changes in a reference price or index.
The previous tables exclude non-recourse debt from consolidated VIEs, liabilities related to transfers of financial assets treated as collateralized financings, pledged commodities and other liabilities that have specified assets attributable to them.
Fair Value Loans on Nonaccrual Status  i 
$ in millions
Nonaccrual loans
$
 i 1,119

$
 i 1,100

Nonaccrual loans 90 or more days past due
$
 i 238

$
 i 330


 / 

September 2020 Form 10-Q
62
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

7.  i Derivative Instruments and Hedging Activities
Fair Values of Derivative Contracts
 
Assets
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
 
 
 
Interest rate
$
 i 1,109

$
 i 4

$
 i 

$
 i 1,113

Foreign exchange
 i 63

 i 9

 i 

 i 72

Total
 i 1,172

 i 13

 i 

 i 1,185

Not designated as accounting hedges
 
 
Interest rate
 i 232,894

 i 9,261

 i 530

 i 242,685

Credit
 i 6,889

 i 3,017

 i 

 i 9,906

Foreign exchange
 i 65,734

 i 1,299

 i 79

 i 67,112

Equity
 i 28,255

 i 

 i 39,231

 i 67,486

Commodity and other
 i 13,378

 i 

 i 5,155

 i 18,533

Total
 i 347,150

 i 13,577

 i 44,995

 i 405,722

Total gross derivatives
$
 i 348,322

$
 i 13,590

$
 i 44,995

$
 i 406,907

Amounts offset
 
 
 
 
Counterparty netting
( i 263,488
)
( i 11,426
)
( i 42,320
)
( i 317,234
)
Cash collateral netting
( i 52,608
)
( i 1,823
)
 i 

( i 54,431
)
Total in Trading assets
$
 i 32,226

$
 i 341

$
 i 2,675

$
 i 35,242

Amounts not offset1
 
 
 
 
Financial instruments collateral
( i 14,117
)
 i 

 i 

( i 14,117
)
Other cash collateral
( i 88
)
 i 

 i 

( i 88
)
Net amounts
$
 i 18,021

$
 i 341

$
 i 2,675

$
 i 21,037

Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
$
 i 2,848


 i 
 
Liabilities
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
 
 
 
Interest rate
$
 i 

$
 i 

$
 i 

$
 i 

Foreign exchange
 i 92

 i 40

 i 

 i 132

Total
 i 92

 i 40

 i 

 i 132

Not designated as accounting hedges
 
 
Interest rate
 i 222,102

 i 7,258

 i 848

 i 230,208

Credit
 i 6,638

 i 3,616

 i 

 i 10,254

Foreign exchange
 i 63,885

 i 1,405

 i 38

 i 65,328

Equity
 i 38,518

 i 

 i 41,873

 i 80,391

Commodity and other
 i 9,910

 i 

 i 5,095

 i 15,005

Total
 i 341,053

 i 12,279

 i 47,854

 i 401,186

Total gross derivatives
$
 i 341,145

$
 i 12,319

$
 i 47,854

$
 i 401,318

Amounts offset
 
 
 
 
Counterparty netting
( i 263,488
)
( i 11,426
)
( i 42,320
)
( i 317,234
)
Cash collateral netting
( i 46,148
)
( i 772
)
 i 

( i 46,920
)
Total in Trading liabilities
$
 i 31,509

$
 i 121

$
 i 5,534

$
 i 37,164

Amounts not offset1
 
 
 
 
Financial instruments collateral
( i 9,085
)
 i 

( i 2,240
)
( i 11,325
)
Other cash collateral
( i 62
)
( i 3
)
 i 

( i 65
)
Net amounts
$
 i 22,362

$
 i 118

$
 i 3,294

$
 i 25,774

Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
 i 5,282



 / 
 
 i 
 
Assets
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
 
 
 
Interest rate
$
 i 673

$
 i 

$
 i 

$
 i 673

Foreign exchange
 i 41

 i 1

 i 

 i 42

Total
 i 714

 i 1

 i 

 i 715

Not designated as accounting hedges
 
 
Interest rate
 i 179,450

 i 4,839

 i 519

 i 184,808

Credit
 i 4,895

 i 2,417

 i 

 i 7,312

Foreign exchange
 i 62,957

 i 1,399

 i 22

 i 64,378

Equity
 i 27,621

 i 

 i 23,447

 i 51,068

Commodity and other
 i 9,306

 i 

 i 1,952

 i 11,258

Total
 i 284,229

 i 8,655

 i 25,940

 i 318,824

Total gross derivatives
$
 i 284,943

$
 i 8,656

$
 i 25,940

$
 i 319,539

Amounts offset
 
 
 
 
Counterparty netting
( i 213,710
)
( i 7,294
)
( i 24,037
)
( i 245,041
)
Cash collateral netting
( i 41,222
)
( i 1,275
)
 i 

( i 42,497
)
Total in Trading assets
$
 i 30,011

$
 i 87

$
 i 1,903

$
 i 32,001

Amounts not offset1
 
 
 
 
Financial instruments collateral
( i 15,596
)
 i 

 i 

( i 15,596
)
Other cash collateral
( i 46
)
 i 

 i 

( i 46
)
Net amounts
$
 i 14,369

$
 i 87

$
 i 1,903

$
 i 16,359

Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
$
 i 1,900


 / 
 
Liabilities
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
 
 
 
Interest rate
$
 i 1

$
 i 

$
 i 

$
 i 1

Foreign exchange
 i 121

 i 38

 i 

 i 159

Total
 i 122

 i 38

 i 

 i 160

Not designated as accounting hedges
 
 
Interest rate
 i 168,597

 i 3,597

 i 436

 i 172,630

Credit
 i 4,798

 i 3,123

 i 

 i 7,921

Foreign exchange
 i 65,965

 i 1,492

 i 39

 i 67,496

Equity
 i 30,135

 i 

 i 22,733

 i 52,868

Commodity and other
 i 7,713

 i 

 i 1,911

 i 9,624

Total
 i 277,208

 i 8,212

 i 25,119

 i 310,539

Total gross derivatives
$
 i 277,330

$
 i 8,250

$
 i 25,119

$
 i 310,699

Amounts offset
 
 
 
 
Counterparty netting
( i 213,710
)
( i 7,294
)
( i 24,037
)
( i 245,041
)
Cash collateral netting
( i 36,392
)
( i 832
)
 i 

( i 37,224
)
Total in Trading liabilities
$
 i 27,228

$
 i 124

$
 i 1,082

$
 i 28,434

Amounts not offset1
 
 
 
 
Financial instruments collateral
( i 7,747
)
 i 

( i 287
)
( i 8,034
)
Other cash collateral
( i 14
)
 i 

 i 

( i 14
)
Net amounts
$
 i 19,467

$
 i 124

$
 i 795

$
 i 20,386

Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
$
 i 3,680


1.
Amounts relate to master netting agreements and collateral agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.

 
63
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

See Note 5 for information related to the unsettled fair value of futures contracts not designated as accounting hedges, which are excluded from the previous tables.
 i 
Notionals of Derivative Contracts
 
Assets
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
 i 6

$
 i 120

$
 i 

$
 i 126

Foreign exchange
 i 6

 i 1

 i 

 i 7

Total
 i 12

 i 121

 i 

 i 133

Not designated as accounting hedges
Interest rate
 i 4,234

 i 6,726

 i 409

 i 11,369

Credit
 i 136

 i 124

 i 

 i 260

Foreign exchange
 i 2,941

 i 102

 i 10

 i 3,053

Equity
 i 466

 i 

 i 416

 i 882

Commodity and other
 i 118

 i 

 i 79

 i 197

Total
 i 7,895

 i 6,952

 i 914

 i 15,761

Total gross derivatives
$
 i 7,907

$
 i 7,073

$
 i 914

$
 i 15,894

 
Liabilities
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
 i 

$
 i 64

$
 i 

$
 i 64

Foreign exchange
 i 6

 i 2

 i 

 i 8

Total
 i 6

 i 66

 i 

 i 72

Not designated as accounting hedges
Interest rate
 i 4,108

 i 6,596

 i 668

 i 11,372

Credit
 i 143

 i 128

 i 

 i 271

Foreign exchange
 i 2,943

 i 100

 i 8

 i 3,051

Equity
 i 473

 i 

 i 579

 i 1,052

Commodity and other
 i 91

 i 

 i 76

 i 167

Total
 i 7,758

 i 6,824

 i 1,331

 i 15,913

Total gross derivatives
$
 i 7,764

$
 i 6,890

$
 i 1,331

$
 i 15,985














 / 
 



 
 
Assets
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
 i 14

$
 i 94

$
 i 

$
 i 108

Foreign exchange
 i 2

 i 

 i 

 i 2

Total
 i 16

 i 94

 i 

 i 110

Not designated as accounting hedges
Interest rate
 i 4,230

 i 7,398

 i 732

 i 12,360

Credit
 i 136

 i 79

 i 

 i 215

Foreign exchange
 i 2,667

 i 91

 i 10

 i 2,768

Equity
 i 429

 i 

 i 419

 i 848

Commodity and other
 i 99

 i 

 i 61

 i 160

Total
 i 7,561

 i 7,568

 i 1,222

 i 16,351

Total gross derivatives
$
 i 7,577

$
 i 7,662

$
 i 1,222

$
 i 16,461

 
Liabilities
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
 i 

$
 i 71

$
 i 

$
 i 71

Foreign exchange
 i 9

 i 2

 i 

 i 11

Total
 i 9

 i 73

 i 

 i 82

Not designated as accounting hedges
Interest rate
 i 4,185

 i 6,866

 i 666

 i 11,717

Credit
 i 153

 i 84

 i 

 i 237

Foreign exchange
 i 2,841

 i 91

 i 14

 i 2,946

Equity
 i 455

 i 

 i 515

 i 970

Commodity and other
 i 85

 i 

 i 61

 i 146

Total
 i 7,719

 i 7,041

 i 1,256

 i 16,016

Total gross derivatives
$
 i 7,728

$
 i 7,114

$
 i 1,256

$
 i 16,098


The Firm believes that the notional amounts of derivative contracts generally overstate its exposure. In most circumstances, notional amounts are used only as a reference point from which to calculate amounts owed between the parties to the contract. Furthermore, notional amounts do not reflect the benefit of legally enforceable netting arrangements or risk mitigating transactions.
For a discussion of the Firm's derivative instruments and hedging activities, see Note 5 to the financial statements in the 2019 Form 10-K.

September 2020 Form 10-Q
64
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 i 
Gains (Losses) on Accounting Hedges
 
Three Months Ended
Nine Months Ended
 
September 30,
September 30,
$ in millions
2020
2019
2020
2019
Fair value hedges—Recognized in Interest income
 
Interest rate contracts
$
 i 12

$
( i 7
)
$
( i 68
)
$
( i 26
)
Investment Securities—AFS
( i 11
)
 i 8

 i 78

 i 27

Fair value hedges—Recognized in Interest expense
 
Interest rate contracts
$
( i 1,004
)
$
 i 1,999

$
 i 5,908

$
 i 6,046

Deposits1
 i 62

 i 

( i 153
)
 i 

Borrowings
 i 915

( i 1,996
)
( i 5,844
)
( i 6,111
)
Net investment hedges—Foreign exchange contracts
 
Recognized in OCI
$
( i 260
)
$
 i 251

$
 i 54

$
 i 201

Forward points excluded from hedge effectiveness testing—Recognized in Interest income
( i 6
)
 i 30

 i 19

 i 107


 / 
 i 
Fair Value Hedges—Hedged Items 
$ in millions
Investment Securities—AFS
 
 
Amortized cost basis currently or previously hedged
$
 i 2,146

$
 i 917

Basis adjustments included in amortized cost2
$
 i 74

$
 i 14

Deposits1
 
 
Carrying amount currently or previously hedged
$
 i 18,241

$
 i 5,435

Basis adjustments included in carrying amount2
$
 i 146

$
( i 7
)
Borrowings
 
 
Carrying amount currently or previously hedged
$
 i 107,653

$
 i 102,456

Basis adjustments included in carrying amountOutstanding hedges
$
 i 7,697

$
 i 2,593

Basis adjustments included in carrying amountTerminated hedges
$
( i 762
)
$
 i 


1.
The Firm began designating interest rate swaps as fair value hedges of certain Deposits in the fourth quarter of 2019.
 / 
2.
Hedge accounting basis adjustments are primarily related to outstanding hedges.
 i 
Net Derivative Liabilities and Collateral Posted
$ in millions
Net derivative liabilities with credit risk-related contingent features
$
 i 27,659

$
 i 21,620

Collateral posted
 i 23,426

 i 17,392


The previous table presents the aggregate fair value of certain derivative contracts that contain credit risk-related contingent features that are in a net liability position for which the Firm has posted collateral in the normal course of business.
 / 
 
Incremental Collateral and Termination Payments upon Potential Future Ratings Downgrade
$ in millions
One-notch downgrade
$
 i 246

Two-notch downgrade
 i 315

Bilateral downgrade agreements included in the amounts above1
$
 i 487

 
1.
Amount represents arrangements between the Firm and other parties where upon the downgrade of one party, the downgraded party must deliver collateral to the other party. These bilateral downgrade arrangements are used by the Firm to manage the risk of counterparty downgrades.
The additional collateral or termination payments that may be called in the event of a future credit rating downgrade vary by contract and can be based on ratings by either or both of Moody’s Investors Service, Inc. (“Moody’s”) and S&P Global Ratings. The previous table shows the future potential collateral amounts and termination payments that could be called or required by counterparties or exchange and clearing organizations in the event of one-notch or two-notch downgrade scenarios based on the relevant contractual downgrade triggers.
 i 
Maximum Potential Payout/Notional of Credit Protection Sold1 
 
Years to Maturity at September 30, 2020
$ in billions
< 1
1-3
3-5
Over 5
Total
Single-name CDS
 
 
 
 
 
Investment grade
$
 i 10

$
 i 16

$
 i 31

$
 i 13

$
 i 70

Non-investment grade
 i 6

 i 10

 i 15

 i 4

 i 35

Total
$
 i 16

$
 i 26

$
 i 46

$
 i 17

$
 i 105

Index and basket CDS
 
 
 
Investment grade
$
 i 3

$
 i 11

$
 i 44

$
 i 35

$
 i 93

Non-investment grade
 i 6

 i 6

 i 25

 i 20

 i 57

Total
$
 i 9

$
 i 17

$
 i 69

$
 i 55

$
 i 150

Total CDS sold
$
 i 25

$
 i 43

$
 i 115

$
 i 72

$
 i 255

Other credit contracts
 i 

 i 

 i 

 i 

 i 

Total credit protection sold
$
 i 25

$
 i 43

$
 i 115

$
 i 72

$
 i 255

CDS protection sold with identical protection purchased
$
 i 222

 
Years to Maturity at December 31, 2019
$ in billions
< 1
1-3
3-5
Over 5
Total
Single-name CDS
 
 
 
 
 
Investment grade
$
 i 16

$
 i 17

$
 i 33

$
 i 9

$
 i 75

Non-investment grade
 i 9

 i 9

 i 16

 i 1

 i 35

Total
$
 i 25

$
 i 26

$
 i 49

$
 i 10

$
 i 110

Index and basket CDS
 
 
 
Investment grade
$
 i 4

$
 i 7

$
 i 46

$
 i 11

$
 i 68

Non-investment grade
 i 7

 i 4

 i 17

 i 10

 i 38

Total
$
 i 11

$
 i 11

$
 i 63

$
 i 21

$
 i 106

Total CDS sold
$
 i 36

$
 i 37

$
 i 112

$
 i 31

$
 i 216

Other credit contracts
 i 

 i 

 i 

 i 

 i 

Total credit protection sold
$
 i 36

$
 i 37

$
 i 112

$
 i 31

$
 i 216

CDS protection sold with identical protection purchased
$
 i 187

 / 

 
65
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Fair Value Asset (Liability) of Credit Protection Sold1 
$ in millions
Single-name CDS
 
 
Investment grade
$
 i 764

$
 i 1,057

Non-investment grade
( i 969
)
( i 540
)
Total
$
( i 205
)
$
 i 517

Index and basket CDS
 
 
Investment grade
$
 i 994

$
 i 1,052

Non-investment grade
( i 2,546
)
 i 134

Total
$
( i 1,552
)
$
 i 1,186

Total CDS sold
$
( i 1,757
)
$
 i 1,703

Other credit contracts
( i 4
)
( i 17
)
Total credit protection sold
$
( i 1,761
)
$
 i 1,686

 
1.
Investment grade/non-investment grade determination is based on the internal credit rating of the reference obligation. Internal credit ratings serve as the Credit Risk Management Department’s assessment of credit risk and the basis for a comprehensive credit limits framework used to control credit risk. The Firm uses quantitative models and judgment to estimate the various risk parameters related to each obligor.
Protection Purchased with CDS
 
Notional
$ in billions
Single name
$
 i 115

$
 i 118

Index and basket
 i 143

 i 103

Tranched index and basket
 i 18

 i 15

Total
$
 i 276

$
 i 236

 
Fair Value Asset (Liability)
$ in millions
Single name
$
 i 72

$
( i 723
)
Index and basket
 i 1,276

( i 1,139
)
Tranched index and basket
 i 61

( i 450
)
Total
$
 i 1,409

$
( i 2,312
)
 
The Firm enters into credit derivatives, principally CDS, under which it receives or provides protection against the risk of default on a set of debt obligations issued by a specified reference entity or entities. A majority of the Firm’s counterparties for these derivatives are banks, broker-dealers, and insurance and other financial institutions.

The fair value amounts as shown in the previous tables are prior to cash collateral or counterparty netting. For further information on credit derivatives and other contracts, see Note 5 to the financial statements in the 2019 Form 10-K.








 
8.  i Investment Securities
 i 
AFS and HTM Securities
 
$ in millions
Amortized
Cost1
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair 
Value
AFS securities
 
 
 
 
U.S. government and agency securities:
 
 
U.S. Treasury securities
$
 i 45,796

$
 i 1,150

$
 i 

$
 i 46,946

U.S. agency securities2
 i 26,887

 i 769

 i 6

 i 27,650

Total U.S. government and agency securities
 i 72,683

 i 1,919

 i 6

 i 74,596

Corporate and other debt:
 
 
 
 
Agency CMBS
 i 4,653

 i 355

 i 1

 i 5,007

Corporate bonds
 i 1,756

 i 43

 i 1

 i 1,798

State and municipal securities
 i 1,682

 i 60

 i 18

 i 1,724

FFELP student loan ABS3
 i 1,455

 i 

 i 44

 i 1,411

Total corporate and other debt
 i 9,546

 i 458

 i 64

 i 9,940

Total AFS securities
 i 82,229

 i 2,377

 i 70

 i 84,536

HTM securities
 
 
 
 
U.S. government and agency securities:
 
 
U.S. Treasury securities
 i 28,754

 i 2,138

 i 

 i 30,892

U.S. agency securities2
 i 16,598

 i 610

 i 7

 i 17,201

Total U.S. government and agency securities
 i 45,352

 i 2,748

 i 7

 i 48,093

Corporate and other debt:
 
 
 
 
Non-agency CMBS
 i 817

 i 45

 i 1

 i 861

Total HTM securities
 i 46,169

 i 2,793

 i 8

 i 48,954

Total investment securities
$
 i 128,398

$
 i 5,170

$
 i 78

$
 i 133,490


 / 

September 2020 Form 10-Q
66
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
$ in millions
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair 
Value
AFS securities
 
 
 
 
U.S. government and agency securities:
 
 
U.S. Treasury securities
$
 i 32,465

$
 i 224

$
 i 111

$
 i 32,578

U.S. agency securities2
 i 20,725

 i 249

 i 100

 i 20,874

Total U.S. government and agency securities
 i 53,190

 i 473

 i 211

 i 53,452

Corporate and other debt:
 
 
 
 
Agency CMBS
 i 4,810

 i 55

 i 57

 i 4,808

Corporate bonds
 i 1,891

 i 17

 i 1

 i 1,907

State and municipal securities
 i 481

 i 22

 i 

 i 503

FFELP student loan ABS3
 i 1,580

 i 1

 i 28

 i 1,553

Total corporate and other debt
 i 8,762

 i 95

 i 86

 i 8,771

Total AFS securities
 i 61,952

 i 568

 i 297

 i 62,223

HTM securities
 
 
 
 
U.S. government and agency securities:
 
 
U.S. Treasury securities
 i 30,145

 i 568

 i 52

 i 30,661

U.S. agency securities2
 i 12,589

 i 151

 i 57

 i 12,683

Total U.S. government and agency securities
 i 42,734

 i 719

 i 109

 i 43,344

Corporate and other debt:
 
 
 
 
Non-agency CMBS
 i 768

 i 22

 i 1

 i 789

Total HTM securities
 i 43,502

 i 741

 i 110

 i 44,133

Total investment securities
$
 i 105,454

$
 i 1,309

$
 i 407

$
 i 106,356

1.
Amounts are net of any ACL.
2.
U.S. agency securities consist mainly of agency-issued debt, agency mortgage pass-through pool securities and CMOs.
3.
Underlying loans are backed by a guarantee, ultimately from the U.S. Department of Education, of at least  i 95% of the principal balance and interest outstanding.
In the first quarter of 2020, the Firm transferred certain municipal securities from Trading assets into AFS securities as a result of a change in intent due to the severe deterioration in liquidity for these instruments. These securities had a fair value of $ i 441 million at the end of the first quarter of 2020.
 
 i 
Investment Securities in an Unrealized Loss Position
 
$ in millions
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
U.S. government and agency securities:
 
 
U.S. Treasury securities
 
 
 
 
Less than12 months
$
 i 

$
 i 

$
 i 4,793

$
 i 28

12 months or longer
 i 

 i 

 i 7,904

 i 83

Total
 i 

 i 

 i 12,697

 i 111

U.S. agency securities
 
 
 
 
Less than12 months
 i 1,198

 i 3

 i 2,641

 i 20

12 months or longer
 i 1,294

 i 3

 i 7,697

 i 80

Total
 i 2,492

 i 6

 i 10,338

 i 100

Total U.S. government and agency securities:
 
 
Less than12 months
 i 1,198

 i 3

 i 7,434

 i 48

12 months or longer
 i 1,294

 i 3

 i 15,601

 i 163

Total
 i 2,492

 i 6

 i 23,035

 i 211

Corporate and other debt:
 
 
 
 
Agency CMBS
 
 
 
 
Less than12 months
 i 17

 i 

 i 2,294

 i 26

12 months or longer
 i 189

 i 1

 i 681

 i 31

Total
 i 206

 i 1

 i 2,975

 i 57

Corporate bonds
 
 
 
 
Less than12 months
 i 127

 i 

 i 194

 i 1

12 months or longer
 i 21

 i 1

 i 44

 i 

Total
 i 148

 i 1

 i 238

 i 1

State and municipal securities
 
 
 
Less than12 months
 i 606

 i 18

 i 

 i 

Total
 i 606

 i 18

 i 

 i 

FFELP student loan ABS
 
 
 
Less than12 months
 i 322

 i 1

 i 91

 i 

12 months or longer
 i 1,089

 i 43

 i 1,165

 i 28

Total
 i 1,411

 i 44

 i 1,256

 i 28

Total Corporate and other debt:
 
 
Less than12 months
 i 1,072

 i 19

 i 2,579

 i 27

12 months or longer
 i 1,299

 i 45

 i 1,890

 i 59

Total
 i 2,371

 i 64

 i 4,469

 i 86

Total AFS securities in an unrealized loss position
 
Less than12 months
 i 2,270

 i 22

 i 10,013

 i 75

12 months or longer
 i 2,593

 i 48

 i 17,491

 i 222

Total
$
 i 4,863

$
 i 70

$
 i 27,504

$
 i 297


 / 
For AFS securities, the Firm believes there are no securities in an unrealized loss position that have credit losses after performing the analysis described in Note 2. Additionally, the Firm does not intend to sell the securities and is not likely to be required to sell the securities prior to recovery of the amortized cost basis. Furthermore, the securities have not experienced credit losses as they are predominantly investment grade and the Firm expects to recover the amortized cost basis.
As of September 30, 2020, the HTM securities net carrying amount reflects an ACL of $ i 24 million related to Non-agency CMBS. See Note 2 for a description of the ACL methodology

 
67
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

used beginning in 2020 following the Firm’s adoption of CECL and see Note 2 to the financial statements in the 2019 Form 10-K for prior period credit loss considerations. There were  i no HTM securities in an unrealized loss position as of December 31, 2019 that were other-than-temporarily impaired. As of September 30, 2020, and December 31, 2019, Non-Agency CMBS HTM securities were predominantly on accrual status and investment grade.
See Note 15 for additional information on securities issued by VIEs, including U.S. agency mortgage-backed securities, non-agency CMBS and FFELP student loan ABS.
 i 
Investment Securities by Contractual Maturity
 
$ in millions
Amortized
Cost
1
Fair
Value
Annualized
Average
Yield
AFS securities
 
 
 
U.S. government and agency securities:
U.S. Treasury securities:
 
 
 
Due within 1 year
$
 i 15,671

$
 i 15,741

 i 0.9
%
After 1 year through 5 years
 i 27,523

 i 28,399

 i 1.5
%
After 5 years through 10 years
 i 2,602

 i 2,806

 i 1.7
%
Total
 i 45,796

 i 46,946

 
U.S. agency securities:
 
 
 
Due within 1 year
 i 215

 i 215

 i 0.8
%
After 1 year through 5 years
 i 70

 i 71

 i 1.6
%
After 5 years through 10 years
 i 1,235

 i 1,274

 i 1.8
%
After 10 years
 i 25,367

 i 26,090

 i 1.9
%
Total
 i 26,887

 i 27,650

 
Total U.S. government and agency securities
 i 72,683

 i 74,596

 i 1.5
%
Corporate and other debt:
 
 
 
Agency CMBS:
 
 
 
Due within 1 year
 i 44

 i 45

 i 2.5
%
After 1 year through 5 years
 i 535

 i 547

 i 1.8
%
After 5 years through 10 years
 i 3,399

 i 3,728

 i 2.5
%
After 10 years
 i 675

 i 687

 i 1.8
%
Total
 i 4,653

 i 5,007

 
Corporate bonds:
 
 
 
Due within 1 year
 i 210

 i 213

 i 2.5
%
After 1 year through 5 years
 i 1,269

 i 1,301

 i 2.6
%
After 5 years through 10 years
 i 266

 i 273

 i 2.7
%
After 10 years
 i 11

 i 11

 i 1.7
%
Total
 i 1,756

 i 1,798

 
State and municipal securities:
 
 
 
Due within 1 year
 i 3

 i 3

 i 1.8
%
After 1 year through 5 years
 i 16

 i 16

 i 2.2
%
After 5 years through 10 years
 i 103

 i 109

 i 2.6
%
After 10 Years
 i 1,560

 i 1,596

 i 2.7
%
Total
 i 1,682

 i 1,724

 
 
 
 
 
 / 
 
 
$ in millions
Amortized
Cost
1
Fair
Value
Annualized
Average
Yield
FFELP student loan ABS:
 
 
 
After 1 year through 5 years
 i 93

 i 88

 i 0.8
%
After 5 years through 10 years
 i 257

 i 241

 i 0.8
%
After 10 years
 i 1,105

 i 1,082

 i 1.2
%
Total
 i 1,455

 i 1,411

 
Total corporate and other debt
 i 9,546

 i 9,940

 i 2.3
%
Total AFS securities
 i 82,229

 i 84,536

 i 1.6
%
 
 
 
 
HTM securities
 
 
 
U.S. government and agency securities:
U.S. Treasury securities:
 
 
 
Due within 1 year
$
 i 3,065

$
 i 3,095

 i 2.6
%
After 1 year through 5 years
 i 16,991

 i 17,880

 i 2.0
%
After 5 years through 10 years
 i 7,616

 i 8,572

 i 2.2
%
After 10 years
 i 1,082

 i 1,345

 i 2.5
%
Total
 i 28,754

 i 30,892

 
U.S. agency securities:
 
 
 
After 5 years through 10 years
 i 279

 i 288

 i 1.9
%
After 10 years
 i 16,319

 i 16,913

 i 2.0
%
Total
 i 16,598

 i 17,201

 
Total U.S. government and agency securities
 i 45,352

 i 48,093

 i 2.2
%
Corporate and other debt:
 
 
 
Non-agency CMBS:
 
 
 
Due within 1 year
 i 110

 i 109

 i 4.6
%
After 1 year through 5 years
 i 77

 i 78

 i 3.7
%
After 5 years through 10 years
 i 576

 i 616

 i 3.8
%
After 10 years
 i 54

 i 58

 i 3.8
%
Total corporate and other debt
 i 817

 i 861

 i 3.9
%
Total HTM securities
 i 46,169

 i 48,954

 i 2.2
%
Total investment securities
$
 i 128,398

$
 i 133,490

 i 1.8
%
1.
Amounts are net of any ACL.
 i 
Gross Realized Gains (Losses) on Sales of AFS Securities
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Gross realized gains
$
 i 55

$
 i 27

$
 i 120

$
 i 99

Gross realized (losses)
 i 

( i 1
)
( i 14
)
( i 10
)
Total1
$
 i 55

$
 i 26

$
 i 106

$
 i 89

 
 / 
1.
Realized gains and losses are recognized in Other revenues in the income statements.

September 2020 Form 10-Q
68
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

9.  i Collateralized Transactions
 i 
Offsetting of Certain Collateralized Transactions
 
$ in millions
Gross
Amounts
Amounts
Offset
Net
Amounts
Presented
Amounts
Not Offset1
Net
Amounts
Assets
 
 
 
 
 
Securities purchased under agreements to resell
$
 i 199,725

$
( i 111,442
)
$
 i 88,283

$
( i 86,057
)
$
 i 2,226

Securities borrowed
 i 104,642

( i 3,839
)
 i 100,803

( i 97,169
)
 i 3,634

Liabilities
 
 
 
 
 
Securities sold under agreements to repurchase
$
 i 152,760

$
( i 111,384
)
$
 i 41,376

$
( i 35,742
)
$
 i 5,634

Securities loaned
 i 11,821

( i 3,897
)
 i 7,924

( i 7,725
)
 i 199

Net amounts for which master netting agreements are not in place or may not be legally enforceable
Securities purchased under agreements to resell
$
 i 2,117

Securities borrowed
 
 
 i 601

Securities sold under agreements to repurchase
 
 i 4,698

Securities loaned
 
 
 
 
 i 149

 
$ in millions
Gross
Amounts
Amounts
Offset
Net
Amounts
Presented
Amounts
Not Offset1
Net
Amounts
Assets
 
 
 
 
 
Securities purchased under agreements to resell
$
 i 247,545

$
( i 159,321
)
$
 i 88,224

$
( i 85,200
)
$
 i 3,024

Securities borrowed
 i 109,528

( i 2,979
)
 i 106,549

( i 101,850
)
 i 4,699

Liabilities
 
 
 
 
 
Securities sold under agreements to repurchase
$
 i 213,519

$
( i 159,319
)
$
 i 54,200

$
( i 44,549
)
$
 i 9,651

Securities loaned
 i 11,487

( i 2,981
)
 i 8,506

( i 8,324
)
 i 182

Net amounts for which master netting agreements are not in place or may not be legally enforceable
Securities purchased under agreements to resell
$
 i 2,255

Securities borrowed
 
 
 i 1,181

Securities sold under agreements to repurchase
 
 i 8,033

Securities loaned
 
 
 
 
 i 101

 / 
1.
Amounts relate to master netting agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.
For further discussion of the Firm’s collateralized transactions, see Note 7 to the financial statements in the 2019 Form 10-K. For information related to offsetting of derivatives, see Note 7.
 
 i 
Gross Secured Financing Balances by Remaining Contractual Maturity
 
$ in millions
Overnight
and Open
Less than
30 Days
30-90
Days
Over
90 Days
Total
Securities sold under agreements to repurchase
$
 i 69,210

$
 i 37,965

$
 i 13,144

$
 i 32,441

$
 i 152,760

Securities loaned
 i 5,752

 i 278

 i 1,169

 i 4,622

 i 11,821

Total included in the offsetting disclosure
$
 i 74,962

$
 i 38,243

$
 i 14,313

$
 i 37,063

$
 i 164,581

Trading liabilities—
Obligation to return securities received as collateral
 i 21,753

 i 

 i 

 i 

 i 21,753

Total
$
 i 96,715

$
 i 38,243

$
 i 14,313

$
 i 37,063

$
 i 186,334

 
$ in millions
Overnight
and Open
Less than
30 Days
30-90
Days
Over
90 Days
Total
Securities sold under agreements to repurchase
$
 i 67,158

$
 i 81,300

$
 i 26,904

$
 i 38,157

$
 i 213,519

Securities loaned
 i 2,378

 i 3,286

 i 516

 i 5,307

 i 11,487

Total included in the offsetting disclosure
$
 i 69,536

$
 i 84,586

$
 i 27,420

$
 i 43,464

$
 i 225,006

Trading liabilities—
Obligation to return securities received as collateral
 i 23,877

 i 

 i 

 i 

 i 23,877

Total
$
 i 93,413

$
 i 84,586

$
 i 27,420

$
 i 43,464

$
 i 248,883

Gross Secured Financing Balances by Class of Collateral Pledged
$ in millions
Securities sold under agreements to repurchase
U.S. Treasury and agency securities
$
 i 55,759

$
 i 68,895

State and municipal securities
 i 864

 i 905

Other sovereign government obligations
 i 70,281

 i 109,414

ABS
 i 1,945

 i 2,218

Corporate and other debt
 i 4,923

 i 6,066

Corporate equities
 i 18,256

 i 25,563

Other
 i 732

 i 458

Total
$
 i 152,760

$
 i 213,519

Securities loaned
 
 
Other sovereign government obligations
$
 i 4,254

$
 i 3,026

Corporate equities
 i 7,034

 i 8,422

Other
 i 533

 i 39

Total
$
 i 11,821

$
 i 11,487

Total included in the offsetting disclosure
$
 i 164,581

$
 i 225,006

Trading liabilities—Obligation to return securities received as collateral
Corporate equities
$
 i 21,724

$
 i 23,873

Other
 i 29

 i 4

Total
$
 i 21,753

$
 i 23,877

Total
$
 i 186,334

$
 i 248,883


 / 

 
69
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 i 
Carrying Value of Assets Loaned or Pledged without Counterparty Right to Sell or Repledge
$ in millions
Trading assets
$
 i 34,952

$
 i 41,201

Loans, before ACL
 i 

 i 750

Total
$
 i 34,952

$
 i 41,951


 / 
The Firm pledges certain of its trading assets and loans to collateralize securities sold under agreements to repurchase, securities loaned, other secured financings and derivatives and to cover customer short sales. Counterparties may or may not have the right to sell or repledge the collateral.
Pledged financial instruments that can be sold or repledged by the secured party are identified as Trading assets (pledged to various parties) in the balance sheets.
 i 
Fair Value of Collateral Received with Right to Sell or Repledge 
$ in millions
Collateral received with right to sell
or repledge
$
 i 609,445

$
 i 679,280

Collateral that was sold or repledged1
 i 455,883

 i 539,412

 / 
1.
Does not include securities used to meet federal regulations for the Firm’s U.S. broker-dealers.
 i 
Securities Segregated for Regulatory Purposes
$ in millions
Segregated securities1
$
 i 27,679

$
 i 25,061

 / 
1.
Securities segregated under federal regulations for the Firm’s U.S. broker-dealers are sourced from Securities purchased under agreements to resell and Trading assets in the balance sheets.
The Firm receives collateral in the form of securities in connection with securities purchased under agreements to resell, securities borrowed, securities-for-securities transactions, derivative transactions, customer margin loans and securities-based lending. In many cases, the Firm is permitted to sell or repledge this collateral to secure securities sold under agreements to repurchase, to enter into securities lending and derivative transactions or for delivery to counterparties to cover short positions.
 i 
Customer Margin Lending
$ in millions
Customer receivables representing margin loans
$
 i 44,658

$
 i 31,916


 / 
The Firm provides margin lending arrangements which allow customers to borrow against the value of qualifying securities. Receivables under margin lending arrangements are included within Customer and other receivables in the balance sheets.
 
Under these agreements and transactions, the Firm receives collateral, which includes U.S. government and agency securities, other sovereign government obligations, corporate and other debt, and corporate equities. Customer receivables generated from margin lending activities are collateralized by customer-owned securities held by the Firm. The Firm monitors required margin levels and established credit terms daily and, pursuant to such guidelines, requires customers to deposit additional collateral, or reduce positions, when necessary.
For a further discussion of the Firm’s margin lending activities, see Note 7 to the financial statements in the 2019 Form 10-K.
Other Secured Financings
The Firm has additional secured liabilities. For a further discussion of other secured financings, see Note 13.
10.  i Loans, Lending Commitments and Related Allowance for Credit Losses
As of September 30, 2020, the Firm’s loan portfolio consists of the following types of loans:
Corporate.    Corporate includes revolving lines of credit, term loans and bridge loans made to corporate entities for a variety of purposes.
Secured lending facilities.    Secured lending facilities include loans provided to clients, which are collateralized by various assets including residential and commercial real estate mortgage loans, corporate loans, and other assets.
Residential Real Estate.    Residential real estate loans mainly include non-conforming loans and HELOC.
Commercial Real Estate.    Commercial real estate loans include owner-occupied loans and income-producing loans.
Securities-based lending and Other.    Securities-based lending includes loans which allow clients to borrow money against the value of qualifying securities for any suitable purpose other than purchasing, trading, or carrying securities or refinancing margin debt. The majority of these loans are structured as revolving lines of credit. Other primarily includes certain loans originated in the tailored lending business within the Wealth Management business segment.

September 2020 Form 10-Q
70
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 i 
Loans by Type1 
 
$ in millions
Loans Held
for Investment
Loans Held
for Sale
Total Loans
Corporate
$
 i 7,628

$
 i 8,552

$
 i 16,180

Secured lending facilities
 i 26,496

 i 3,521

 i 30,017

Commercial real estate
 i 7,265

 i 891

 i 8,156

Residential real estate
 i 33,674

 i 49

 i 33,723

Securities-based lending and Other loans
 i 59,006

 i 68

 i 59,074

Total loans
 i 134,069

 i 13,081

 i 147,150

ACL
( i 913
)
 i 

( i 913
)
Total loans, net
$
 i 133,156

$
 i 13,081

$
 i 146,237

Fixed rate loans, net
 
 
$
 i 31,342

Floating or adjustable rate loans, net
 
 i 114,895

Loans to non-U.S. borrowers, net
 
 i 23,591

 
$ in millions
Loans Held
for Investment
Loans Held
for Sale
Total Loans
Corporate
$
 i 5,426

$
 i 6,192

$
 i 11,618

Secured lending facilities
 i 24,502

 i 4,200

 i 28,702

Commercial real estate
 i 7,859

 i 2,049

 i 9,908

Residential real estate
 i 30,184

 i 13

 i 30,197

Securities-based lending and Other loans
 i 50,438

 i 123

 i 50,561

Total loans
 i 118,409

 i 12,577

 i 130,986

ACL
( i 349
)
 
( i 349
)
Total loans, net
$
 i 118,060

$
 i 12,577

$
 i 130,637

Fixed rate loans, net
 
 
$
 i 22,716

Floating or adjustable rate loans, net
 
 i 107,921

Loans to non-U.S. borrowers, net
 
 i 21,617


1.
Loans previously classified as corporate have been further disaggregated; prior period balances have been revised to conform with current period presentation.

 / 
 i 
Loans Held for Investment before Allowance by Origination Year
 
 
Corporate
$ in millions
Investment Grade
Non-Investment Grade
Total
Revolving Loans
$
 i 1,556

$
 i 4,264

$
 i 5,820

2020
 i 582

 i 176

 i 758

2019
 i 279

 i 159

 i 438

2018
 i 195

 i 

 i 195

2017
 i 

 i 64

 i 64

2016
 i 114

 i 

 i 114

Prior
 i 127

 i 112

 i 239

Total
$
 i 2,853

$
 i 4,775

$
 i 7,628


 / 
 
 
 
Secured lending facilities
$ in millions
Investment Grade
Non-Investment Grade
Total
Revolving Loans
$
 i 4,457

$
 i 14,832

$
 i 19,289

2020
 i 206

 i 378

 i 584

2019
 i 297

 i 2,000

 i 2,297

2018
 i 1,063

 i 1,449

 i 2,512

2017
 i 245

 i 570

 i 815

2016
 i 

 i 620

 i 620

Prior
 i 

 i 379

 i 379

Total
$
 i 6,268

$
 i 20,228

$
 i 26,496

 
 
Commercial real estate
$ in millions
Investment Grade
Non-Investment Grade
Total
2020
$
 i 17

$
 i 744

 i 761

2019
 i 637

 i 2,318

 i 2,955

2018
 i 601

 i 1,053

 i 1,654

2017
 i 188

 i 629

 i 817

2016
 i 235

 i 451

 i 686

Prior
 i 

 i 392

 i 392

Total
$
 i 1,678

$
 i 5,587

$
 i 7,265

 
 
Residential real estate
 
by FICO Scores
 
by LTV Ratio
 
Total
$ in millions
≥ 740
680-739
≤ 679
 
≤ 80%
> 80%
 
Revolving Loans
$
 i 89

$
 i 34

$
 i 5

 
$
 i 128

$
 i 

 
$
 i 128

2020
 i 6,438

 i 1,337

 i 138

 
 i 7,487

 i 426

 
 i 7,913

2019
 i 5,791

 i 1,306

 i 175

 
 i 6,812

 i 460

 
 i 7,272

2018
 i 2,442

 i 685

 i 83

 
 i 2,952

 i 258

 
 i 3,210

2017
 i 2,875

 i 732

 i 93

 
 i 3,436

 i 264

 
 i 3,700

2016
 i 3,524

 i 953

 i 134

 
 i 4,305

 i 306

 
 i 4,611

Prior
 i 4,814

 i 1,716

 i 310

 
 i 6,094

 i 746

 
 i 6,840

Total
$
 i 25,973

$
 i 6,763

$
 i 938

 
$
 i 31,214

$
 i 2,460

 
$
 i 33,674

 
 
Securities-based lending1
Other2
 
$ in millions
Investment Grade
Non-Investment Grade
Total
Revolving Loans
$
 i 47,251

$
 i 4,238

$
 i 684

$
 i 52,173

2020
 i 

 i 860

 i 431

 i 1,291

2019
 i 18

 i 1,106

 i 674

 i 1,798

2018
 i 232

 i 334

 i 456

 i 1,022

2017
 i 

 i 663

 i 116

 i 779

2016
 i 

 i 579

 i 113

 i 692

Prior
 i 16

 i 1,068

 i 167

 i 1,251

Total
$
 i 47,517

$
 i 8,848

$
 i 2,641

$
 i 59,006

1. Securities-based loans are subject to collateral maintenance provisions, and at September 30, 2020, these loans are predominantly over-collateralized. For more information on the ACL methodology related to securities-based loans, see Note 2.
2. Other loans primarily include certain loans originated in the tailored lending business within the Wealth Management business segment.


 
71
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Past Due Status of Loans Held for Investment before Allowance
 
$ in millions
Current
Past Due1
Total
Corporate
$
 i 7,628

$
 i 

$
 i 7,628

Secured lending facilities
 i 26,496

 i 

 i 26,496

Commercial real estate
 i 7,264

 i 1

 i 7,265

Residential real estate
 i 33,476

 i 198

 i 33,674

Securities-based lending and Other loans
 i 58,881

 i 125

 i 59,006

Total
$
 i 133,745

$
 i 324

$
 i 134,069

1.
The majority of the amounts are past due for a period of 90 days or more.

Nonaccrual Loans Held for Investment before Allowance
$ in millions
Corporate
$
 i 184

$
 i 299

Commercial real estate
 i 185

 i 85

Residential real estate
 i 92

 i 94

Securities-based lending and Other loans
 i 133

 i 5

Total1
$
 i 594

$
 i 483

Nonaccrual loans without an ACL
$
 i 91

$
 i 120

1.
Includes all HFI loans that are 90 days or more past due.

See Note 2 for a description of the ACL calculated under the CECL methodology, including credit quality indicators, used for HFI loans beginning in 2020.
 i 
Troubled Debt Restructurings
$ in millions
Loans, before ACL
$
 i 166

$
 i 92

Lending commitments
 i 32

 i 32

ACL on Loans and Lending commitments
 i 32

 i 16


 / 
Troubled debt restructurings typically include modifications of interest rates, collateral requirements, other loan covenants and payment extensions. See Note 2 for further information on TDR guidance issued by Congress in the CARES Act as well as by the U.S. banking agencies.
For a discussion of the Firm’s ACL methodology under the prior incurred loss model, including credit quality indicators, used for HFI loans as of December 31, 2019, and a further discussion of the Firm’s loans, see Notes 2 and 8 in the 2019 Form 10-K.
 
 i 
Allowance for Credit Losses Rollforward—Loans
$ in millions
Corporate
Secured lending facilities
CRE
Residential real estate
SBL and Other
Total
$
 i 115

$
 i 101

$
 i 75

$
 i 25

$
 i 33

$
 i 349

Effect of CECL adoption
( i 2
)
( i 42
)
 i 34

 i 21

( i 2
)
 i 9

Gross charge-offs
( i 33
)
 i 

( i 26
)
 i 

 i 

( i 59
)
Recoveries
 i 3

 i 

 i 

 i 

 i 2

 i 5

Net (charge-offs) recoveries
( i 30
)
 i 

( i 26
)
 i 

 i 2

( i 54
)
Provision (release)1
 i 281

 i 131

 i 173

 i 12

 i 4

 i 601

Other
 i 3

 i 1

( i 34
)
 i 

 i 38

 i 8

$
 i 367

$
 i 191

$
 i 222

$
 i 58

$
 i 75

$
 i 913

$ in millions
Corporate
Secured lending facilities
CRE
Residential real estate
SBL and Other
Total
$
 i 62

$
 i 60

$
 i 67

$
 i 20

$
 i 29

$
 i 238

Gross charge-offs
 i 

 i 

 i 

( i 1
)
 i 

( i 1
)
Provision (release)1
 i 40

 i 28

( i 6
)
 i 5

 i 1

 i 68

Other
( i 6
)
( i 1
)
( i 1
)
 i 

 i 

( i 8
)
$
 i 96

$
 i 87

$
 i 60

$
 i 24

$
 i 30

$
 i 297

1.
The provision for loan losses was $ i 63 million in the current quarter and $ i 34 million in the prior year quarter.
Allowance for Credit Losses Rollforward—Lending Commitments
$ in millions
Corporate
Secured lending facilities
CRE
Residential real estate
SBL and Other
Total
$
 i 201

$
 i 27

$
 i 7

$
 i 

$
 i 6

$
 i 241

Effect of CECL adoption
( i 41
)
( i 11
)
 i 1

 i 2

( i 1
)
( i 50
)
Provision (release)1
 i 119

 i 24

 i 7

( i 1
)
 i 7

 i 156

Other
 i 

 i 

( i 4
)
 i 

 i 4

 i 

$
 i 279

$
 i 40

$
 i 11

$
 i 1

$
 i 16

$
 i 347

$ in millions
Corporate
Secured lending facilities
CRE
Residential real estate
SBL and Other
Total
$
 i 178

$
 i 16

$
 i 3

$
 i 

$
 i 6

$
 i 203

Provision (release)1
 i 27

 i 7

 i 2

 i 

 i 

 i 36

Other
( i 4
)
 i 

 i 

 i 

( i 1
)
( i 5
)
$
 i 201

$
 i 23

$
 i 5

$
 i 

$
 i 5

$
 i 234

CRE—Commercial real estate
SBL—Securities-based lending
 / 
1.
The provision (release) for lending commitments was $ i 48 million in the current quarter and $ i 16 million in the prior year quarter.
The aggregate allowance for loans and lending commitments increased in the current year period, principally reflecting the

September 2020 Form 10-Q
72
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

provision for credit losses within the Institutional Securities business segment primarily resulting from the continued economic impact of COVID-19. This provision was the result of risks related to vulnerable sectors and higher downgrade sensitivity, changes in asset quality trends, as well as revisions to our forecasts reflecting expected future market and macroeconomic conditions. The base scenario used in our ACL models as of September 30, 2020 was generated using a combination of industry consensus economic forecasts, forward rates, and internally developed and validated models. Given the nature of our lending portfolio, the most sensitive model input is U.S. GDP. The base scenario, among other things, assumes a continued recovery in the last quarter of 2020 through 2021, supported by fiscal stimulus and monetary policy measures. For a further discussion of the Firm’s loans as well as the Firm’s allowance methodology prior to the adoption of CECL, refer to Notes 2 and 8 to the financial statements in the 2019 Form 10-K. See Note 5 for further information regarding Loans and lending commitments held at fair value. See Note 14 for details of current commitments to lend in the future.
 i 
Employee Loans
$ in millions
Currently employed by the Firm1
$
 i 2,940

N/A

No longer employed by the Firm2
 i 142

N/A

Employee loans
$
 i 3,082

$
 i 2,980

ACL3
( i 165
)
( i 61
)
Employee loans, net of ACL
$
 i 2,917

$
 i 2,919

Remaining repayment term, weighted average in years
 i 5.1

 i 4.8

1.
These loans are predominantly current.
2.
These loans are predominantly past due for a period of 90 days or more.
 / 
3.
The change in ACL includes a $ i 124 million increase due to the adoption of CECL in the first quarter of 2020.
Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives, are full recourse and generally require periodic repayments, and are due in full upon termination of employment with the Firm. These loans are recorded in Customer and other receivables in the balance sheets. The ACL as of September 30, 2020 was calculated under the CECL methodology, while the ACL at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 for a description of the CECL allowance methodology, including credit quality indicators, for employee loans.
 
11.  i Other Assets—Equity Method Investments
 i 
Equity Method Investments
$ in millions
Investments
$
 i 2,338

$
 i 2,363

 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Income (loss)1
$
 i 10

$
( i 13
)
$
( i 24
)
$
( i 39
)

 / 
1.
The current year period includes an impairment of the Investment Management business segment’s investment in a third-party asset manager.
Equity method investments, other than investments in certain fund interests, are summarized above and are included in Other assets in the balance sheets with related income or loss included in Other revenues in the income statements. See “Net Asset Value Measurements—Fund Interests” in Note 5 for the carrying value of certain of the Firm’s fund interests, which are comprised of general and limited partnership interests, as well as any related carried interest.
 i 
Japanese Securities Joint Venture
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Income (loss) from investment in MUMSS
$
 i 15

$
( i 4
)
$
 i 46

$
 i 5


 / 
For more information on Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (“MUMSS”) and other relationships with Mitsubishi UFJ Financial Group, Inc., see Note 10 to the financial statements in the 2019 Form 10-K.

12.  i Deposits
 i 
Deposits
$ in millions
Savings and demand deposits
$
 i 202,577

$
 i 149,465

Time deposits
 i 36,676

 i 40,891

Total
$
 i 239,253

$
 i 190,356

Deposits subject to FDIC insurance
$
 i 173,173

$
 i 149,966

Time deposits that equal or exceed the FDIC insurance limit
$
 i 20

$
 i 12


 / 
 

 
73
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 i 
Time Deposit Maturities
$ in millions
2020
$
 i 5,457

2021
 i 17,986

2022
 i 4,984

2023
 i 4,086

2024
 i 2,784

Thereafter
 i 1,379

Total
$
 i 36,676


 / 
   
13.  i Borrowings and Other Secured Financings
 i 
Borrowings
$ in millions
Original maturities of one year or less
$
 i 4,553

$
 i 2,567

Original maturities greater than one year
Senior
$
 i 187,717

$
 i 179,519

Subordinated
 i 11,174

 i 10,541

Total
$
 i 198,891

$
 i 190,060

Total borrowings
$
 i 203,444

$
 i 192,627

Weighted average stated maturity, in years1
 i 7.4

 i 6.9


 / 
1.
Only includes borrowings with original maturities greater than one year.
 
 i 
Other Secured Financings
$ in millions
At
Original maturities:
 
 
One year or less
$
 i 9,141

$
 i 7,103

Greater than one year
 i 4,716

 i 7,595

Total
$
 i 13,857

$
 i 14,698

Transfers of assets accounted for as secured financings
$
 i 1,108

$
 i 1,115



 / 
1.
Prior period balances have been conformed to the current presentation.
Other secured financings include the liabilities related to certain ELNs, transfers of financial assets that are accounted for as financings rather than sales, pledged commodities, consolidated VIEs where the Firm is deemed to be the primary beneficiary and other secured borrowings. These liabilities are generally payable from the cash flows of the related assets accounted for as Trading assets. See Note 15 for further information on other secured financings related to VIEs and securitization activities.
For transfers of assets that fail to meet accounting criteria for a sale, the Firm continues to record the assets and recognizes the associated liabilities in the balance sheets.

 
14.  i Commitments, Guarantees and Contingencies
 i 
Commitments
 
Years to Maturity at September 30, 2020
 
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Lending:
 
 
 
 
Corporate
$
 i 14,707

$
 i 36,048

$
 i 37,002

$
 i 4,888

$
 i 92,645

Secured lending facilities
 i 5,554

 i 3,693

 i 1,302

 i 133

 i 10,682

Commercial and Residential real estate
 i 137

 i 226

 i 38

 i 260

 i 661

Securities-based lending and Other
 i 12,421

 i 2,934

 i 369

 i 386

 i 16,110

Forward-starting secured financing receivables
 i 81,340

 i 

 i 

 i 

 i 81,340

Central counterparty1
 i 300

 i 

 i 

 i 9,329

 i 9,629

Underwriting
 i 675

 i 

 i 

 i 

 i 675

Investment activities
 i 947

 i 241

 i 41

 i 286

 i 1,515

Letters of credit and other financial guarantees
 i 172

 i 1

 i 

 i 3

 i 176

Total
$
 i 116,253

$
 i 43,143

$
 i 38,752

$
 i 15,285

$
 i 213,433

Lending commitments participated to third parties
$
 i 8,647

Forward-starting secured financing receivables settled within three business days
$
 i 72,771


 / 
1.
Beginning in the first quarter of 2020, commitments to central counterparties are presented separately; these commitments were previously included in Corporate Lending commitments and Forward-starting secured financing receivables depending on the type of agreement. These commitments relate to the Firm’s membership in certain clearinghouses and are contingent upon the default of a clearinghouse member or other stress events.
Since commitments associated with these instruments may expire unused, the amounts shown do not necessarily reflect the actual future cash funding requirements.
For a further description of these commitments, refer to Note 13 to the financial statements in the 2019 Form 10-K.

September 2020 Form 10-Q
74
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Guarantees
 i 
Maximum Potential Payout/Notional of Obligations under Guarantee Arrangements
 
Years to Maturity at September 30, 2020
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Credit derivatives
$
 i 25,206

$
 i 42,799

$
 i 114,950

$
 i 72,312

$
 i 255,267

Other credit contracts
 i 

 i 190

 i 

 i 104

 i 294

Non-credit derivatives
 i 1,531,263

 i 1,122,139

 i 367,428

 i 779,686

 i 3,800,516

Standby letters of credit and other financial guarantees issued1
 i 1,082

 i 1,475

 i 758

 i 3,967

 i 7,282

Market value guarantees
 i 92

 i 28

 i 

 i 

 i 120

Liquidity facilities
 i 4,342

 i 

 i 

 i 

 i 4,342

Whole loan sales guarantees
 i 1

 i 

 i 9

 i 23,176

 i 23,186

Securitization representations and warranties
 i 

 i 

 i 

 i 67,024

 i 67,024

General partner guarantees
 i 59

 i 161

 i 12

 i 115

 i 347

Client clearing guarantees
 i 92

 i 

 i 

 i 

 i 92

$ in millions
Carrying Amount Asset (Liability)
Credit derivatives2
$
( i 1,757
)
Other credit contracts
( i 4
)
Non-credit derivatives2
( i 88,369
)
Standby letters of credit and other financial guarantees issued1
 i 113

Market value guarantees
 i 

Liquidity facilities
 i 6

Whole loan sales guarantees
 i 

Securitization representations and warranties3
( i 42
)
General partner guarantees
( i 66
)
Client clearing guarantees
 i 


1.
These amounts include certain issued standby letters of credit participated to third parties, totaling $ i 0.6 billion of notional and collateral/recourse, due to the nature of the Firm’s obligations under these arrangements. As of September 30, 2020, the carrying amount of standby letters of credit and other financial guarantees issued includes an allowance for credit losses of $ i 86 million.
2.
The carrying amounts of derivative contracts that meet the accounting definition of a guarantee are shown on a gross basis. For further information on derivatives contracts, see Note 7.
 / 
3.
Primarily related to residential mortgage securitizations.

The Firm has obligations under certain guarantee arrangements, including contracts and indemnification agreements, that contingently require the Firm to make payments to the guaranteed party based on changes in an underlying measure (such as an interest or foreign exchange rate, security or commodity price, an index, or the occurrence or non-occurrence of a specified event) related to an asset, liability or equity security of a guaranteed party. Also included as guarantees are contracts that contingently require the Firm to make payments to the guaranteed party based on another entity’s failure to perform under an agreement, as well as indirect guarantees of the indebtedness of others.
 
Client Clearing Guarantees. In the first quarter of 2020, FICC’s sponsored clearing model was updated such that the Firm could be responsible for liquidation of a sponsored member’s account and guarantees any resulting loss to the FICC in the event the sponsored member fails to fully pay any net liquidation amount due from the sponsored member to the FICC. Accordingly, the Firm’s maximum potential payout amount as of September 30, 2020 reflects the total of the estimated net liquidation amounts for sponsored member accounts.
For more information on the nature of the obligations and related business activities for our guarantees, see Note 13 to the financial statements in the 2019 Form 10-K.
Other Guarantees and Indemnities
In the normal course of business, the Firm provides guarantees and indemnifications in a variety of transactions. These provisions generally are standard contractual terms. Certain of these guarantees and indemnifications related to indemnities, exchange and clearinghouse member guarantees and merger and acquisition guarantees are described in Note 13 to the financial statements in the 2019 Form 10-K.
In addition, in the ordinary course of business, the Firm guarantees the debt and/or certain trading obligations (including obligations associated with derivatives, foreign exchange contracts and the settlement of physical commodities) of certain subsidiaries. These guarantees generally are entity or product specific and are required by investors or trading counterparties. The activities of the Firm’s subsidiaries covered by these guarantees (including any related debt or trading obligations) are included in the financial statements.
Finance Subsidiary
The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary.

Contingencies
Legal
In addition to the matters described in the following paragraphs, in the normal course of business, the Firm has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with its activities as a global diversified financial services institution. Certain of the actual or threatened legal actions include claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages. In some cases, the entities that would otherwise be the primary defendants in such cases are bankrupt or are in financial distress. These actions have included, but are not limited to, residential mortgage and credit crisis-related matters.

 
75
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

While the Firm has identified below any individual proceedings where the Firm believes a material loss to be reasonably possible and reasonably estimable, there can be no assurance that material losses will not be incurred from claims that have not yet been asserted or are not yet determined to be probable or possible and reasonably estimable losses.
The Firm contests liability and/or the amount of damages as appropriate in each pending matter. Where available information indicates that it is probable a liability had been incurred at the date of the financial statements and the Firm can reasonably estimate the amount of that loss, the Firm accrues the estimated loss by a charge to income.
In many proceedings and investigations, however, it is inherently difficult to determine whether any loss is probable or even possible or to estimate the amount of any loss. In addition, even where a loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is not always possible to reasonably estimate the size of the possible loss or range of loss.
For certain legal proceedings and investigations, the Firm cannot reasonably estimate such losses, particularly for proceedings and investigations where the factual record is being developed or contested or where plaintiffs or government entities seek substantial or indeterminate damages, restitution, disgorgement or penalties. Numerous issues may need to be resolved, including through potentially lengthy discovery and determination of important factual matters, determination of issues related to class certification and the calculation of damages or other relief, and by addressing novel or unsettled legal questions relevant to the proceedings or investigations in question, before a loss or additional loss or range of loss or additional range of loss can be reasonably estimated for a proceeding or investigation.
For certain other legal proceedings and investigations, the Firm can estimate reasonably possible losses, additional losses, ranges of loss or ranges of additional loss in excess of amounts accrued but does not believe, based on current knowledge and after consultation with counsel, that such losses will have a material adverse effect on the Firm’s financial statements as a whole, other than the matters referred to in the following paragraphs.
On July 15, 2010, China Development Industrial Bank (“CDIB”) filed a complaint against the Firm, styled China Development Industrial Bank v. Morgan Stanley & Co. Incorporated et al., which is pending in the Supreme Court of the State of New York, New York County (“Supreme Court of NY”). The complaint relates to a $ i 275 million CDS referencing the super senior portion of the STACK 2006-1 CDO. The complaint asserts claims for common law fraud, fraudulent inducement and fraudulent concealment and alleges that the Firm misrepresented the risks of the STACK 2006-1 CDO to
 
CDIB, and that the Firm knew that the assets backing the CDO were of poor quality when it entered into the CDS with CDIB. The complaint seeks compensatory damages related to the approximately $ i 228 million that CDIB alleges it has already lost under the CDS, rescission of CDIB’s obligation to pay an additional $ i 12 million, punitive damages, equitable relief, fees and costs. On February 28, 2011, the court denied the Firm’s motion to dismiss the complaint. On December 21, 2018, the court denied the Firm’s motion for summary judgment and granted in part the Firm’s motion for sanctions relating to spoliation of evidence. On January 24, 2019, CDIB filed a notice of appeal from the court’s December 21, 2018 order, and on January 25, 2019, the Firm filed a notice of appeal from the same order. On March 7, 2019, the court denied the relief that CDIB sought in a motion to clarify and resettle the portion of the court’s December 21, 2018 order granting spoliation sanctions. On May 21, 2020, the Appellate Division, First Department (“First Department”), modified the Supreme Court of NY’s order to deny the Firm’s motion for sanctions relating to spoliation of evidence and otherwise affirmed the denial of the Firm’s motion for summary judgment. On June 19, 2020, the Firm moved for leave to appeal the First Department’s decision to the New York Court of Appeals (“Court of Appeals”), which the First Department denied on July 24, 2020. Based on currently available information, the Firm believes it could incur a loss in this action of up to approximately $ i 240 million plus pre- and post-judgment interest, fees and costs.
On September 23, 2014, Financial Guaranty Insurance Company (“FGIC”) filed a complaint against the Firm in the Supreme Court of NY styled Financial Guaranty Insurance Company v. Morgan Stanley ABS Capital I Inc. et al. relating to the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4. The complaint asserts claims for breach of contract and fraudulent inducement and alleges, among other things, that the loans in the trust breached various representations and warranties and defendants made untrue statements and material omissions to induce FGIC to issue a financial guaranty policy on certain classes of certificates that had an original balance of approximately $ i 876 million. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential and punitive damages, attorneys’ fees and interest. On January 23, 2017, the court denied the Firm’s motion to dismiss the complaint. On September 13, 2018, the First Department affirmed in part and reversed in part the lower court’s order denying the Firm’s motion to dismiss. On December 20, 2018, the First Department denied plaintiff’s motion for leave to appeal its decision to the Court of Appeals or, in the alternative, for re-argument. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $ i 277 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and FGIC that the Firm did not repurchase, plus pre- and post- judgment interest, fees and costs, as well as claim payments that FGIC has

September 2020 Form 10-Q
76
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

made and will make in the future. In addition, plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.
On January 23, 2015, Deutsche Bank National Trust Company, in its capacity as trustee, filed a complaint against the Firm styled Deutsche Bank National Trust Company solely in its capacity as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as Successor-by-Merger to Morgan Stanley Mortgage Capital Inc., and Morgan Stanley ABS Capital I Inc., pending in the Supreme Court of NY. The complaint asserts claims for breach of contract and alleges, among other things, that the loans in the trust, which had an original principal balance of approximately $ i 1.05 billion, breached various representations and warranties. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential, rescissory, equitable and punitive damages, attorneys’ fees, costs and other related expenses, and interest. On December 11, 2015, the court granted in part and denied in part the Firm’s motion to dismiss the complaint. On October 19, 2018, the court granted the Firm’s motion for leave to amend its answer and to stay the case pending resolution of Deutsche Bank National Trust Company’s appeal to the Court of Appeals in another case, styled Deutsche Bank National Trust Company v. Barclays Bank PLC, regarding the applicable statute of limitations. On January 17, 2019, the First Department reversed the trial court’s order to the extent that it had granted in part the Firm’s motion to dismiss the complaint. On June 4, 2019, the First Department granted the Firm’s motion for leave to appeal to the Court of Appeals. On March 19, 2020, the Firm filed a motion for partial summary judgment. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $ i 277 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and a monoline insurer that the Firm did not repurchase, plus pre- and post-judgment interest, fees and costs, but plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.
Tax
In matters styled Case number 15/3637 and Case number 15/4353, the Dutch Tax Authority (“Dutch Authority”) is challenging in the Dutch courts, the prior set-off by the Firm of approximately  i 124 million (approximately $ i 145 million) plus accrued interest of withholding tax credits against the Firm’s corporation tax liabilities for the tax years 2007 to 2013. The Dutch Authority alleges that the Firm was not entitled to receive the withholding tax credits on the basis, inter alia, that a Firm subsidiary did not hold legal title to certain securities subject to withholding tax on the relevant dates. The Dutch Authority has also alleged that the Firm failed to provide certain information to the Dutch Authority and keep adequate books and records. On April 26, 2018, the District Court in Amsterdam issued a decision dismissing the Dutch Authority’s claims with respect
 
to certain of the tax years in dispute. On May 12, 2020, the Court of Appeal in Amsterdam granted the Dutch Authority’s appeal in matters re-styled Case number 18/00318 and Case number 18/00319. On June 22, 2020, the Firm filed an appeal against the decision of the Court of Appeal in Amsterdam before the Dutch High Court.
15.  i Variable Interest Entities and Securitization Activities
 i 
Consolidated VIE Assets and Liabilities by Type of Activity
 
$ in millions
VIE Assets
VIE Liabilities
VIE Assets
VIE Liabilities 
OSF
$
 i 672

$
 i 429

$
 i 696

$
 i 391

MABS1
 i 447

 i 108

 i 265

 i 4

Other2
 i 942

 i 42

 i 987

 i 66

Total
$
 i 2,061

$
 i 579

$
 i 1,948

$
 i 461

OSF—Other structured financings
1.
Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets and may be in loan or security form. The value of assets is determined based on the fair value of the liabilities and the interests owned by the Firm in such VIEs as the fair values for the liabilities and interests owned are more observable.
2.
Other primarily includes operating entities, investment funds and structured transactions.
 
Consolidated VIE Assets and Liabilities by Balance Sheet Caption
$ in millions
Assets
 
 
Cash and cash equivalents
$
 i 284

$
 i 488

Trading assets at fair value
 i 1,376

 i 943

Customer and other receivables
 i 8

 i 18

Intangible assets
 i 101

 i 111

Other assets
 i 292

 i 388

Total
$
 i 2,061

$
 i 1,948

Liabilities
 
 
Other secured financings
$
 i 536

$
 i 422

Other liabilities and accrued expenses
 i 43

 i 39

Total
$
 i 579

$
 i 461

Noncontrolling interests
$
 i 275

$
 i 192


 / 
 
Consolidated VIE assets and liabilities are presented in the previous tables after intercompany eliminations. Generally, most assets owned by consolidated VIEs cannot be removed unilaterally by the Firm and are not available to the Firm while the related liabilities issued by consolidated VIEs are non-recourse to the Firm. However, in certain consolidated VIEs, the Firm either has the unilateral right to remove assets or provides additional recourse through derivatives such as total return swaps, guarantees or other forms of involvement.
In general, the Firm’s exposure to loss in consolidated VIEs is limited to losses that would be absorbed on the VIE net assets recognized in its financial statements, net of amounts absorbed by third-party variable interest holders.

 
77
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 i 
Non-consolidated VIEs
 
$ in millions
MABS1
CDO
MTOB
OSF
Other2
VIE assets (UPB)
$
 i 136,362

$
 i 3,744

$
 i 6,404

$
 i 2,190

$
 i 50,040

Maximum exposure to loss3
 
 
Debt and equity interests
$
 i 16,821

$
 i 390

$
 i 

$
 i 1,059

$
 i 10,581

Derivative and other contracts
 i 

 i 

 i 4,342

 i 

 i 3,853

Commitments, guarantees and other
 i 810

 i 

 i 

 i 

 i 685

Total
$
 i 17,631

$
 i 390

$
 i 4,342

$
 i 1,059

$
 i 15,119

Carrying value of variable interests—Assets
 
 
Debt and equity interests
$
 i 16,821

$
 i 390

$
 i 

$
 i 1,059

$
 i 10,581

Derivative and other contracts
 i 

 i 

 i 6

 i 

 i 621

Total
$
 i 16,821

$
 i 390

$
 i 6

$
 i 1,059

$
 i 11,202

Additional VIE assets owned4
 
 
 
$
 i 11,832

Carrying value of variable interests—Liabilities
 
 
Derivative and other contracts
$
 i 

$
 i 

$
 i 1

$
 i 

$
 i 114

Total
$
 i 

$
 i 

$
 i 1

$
 i 

$
 i 114

 
 
$ in millions
MABS1
CDO
MTOB
OSF
Other2
VIE assets (UPB)
$
 i 125,603

$
 i 2,976

$
 i 6,965

$
 i 2,288

$
 i 51,305

Maximum exposure to loss3
 
 
Debt and equity interests
$
 i 16,314

$
 i 240

$
 i 

$
 i 1,009

$
 i 11,977

Derivative and other contracts
 i 

 i 

 i 4,599

 i 

 i 2,995

Commitments, guarantees and other
 i 631

 i 

 i 

 i 

 i 266

Total
$
 i 16,945

$
 i 240

$
 i 4,599

$
 i 1,009

$
 i 15,238

Carrying value of variable interestsAssets
 
 
Debt and equity interests
$
 i 16,314

$
 i 240

$
 i 

$
 i 1,008

$
 i 11,977

Derivative and other contracts
 i 

 i 

 i 6

 i 

 i 388

Total
$
 i 16,314

$
 i 240

$
 i 6

$
 i 1,008

$
 i 12,365

Additional VIE assets owned4
 
 
 
$
 i 11,453

Carrying value of variable interests—Liabilities
 
 
Derivative and other contracts
$
 i 

$
 i 

$
 i 

$
 i 

$
 i 444


MTOB—Municipal tender option bonds
1.
Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets. and may be in loan or security form.
2.
Other primarily includes exposures to commercial real estate property and investment funds.
3.
Where notional amounts are utilized in quantifying the maximum exposure related to derivatives, such amounts do not reflect changes in fair value recorded by the Firm.
4.
Additional VIE assets owned represents the carrying value of total exposure to non-consolidated VIEs for which the maximum exposure to loss is less than specific thresholds, primarily interests issued by securitization SPEs. The Firm’s maximum exposure to loss generally equals the fair value of the assets owned. These assets are primarily included in Trading assets and Investment securities and are measured at fair value (see Note 5). The Firm does not provide additional support in these transactions through contractual facilities, guarantees or similar derivatives.

 / 
 
The majority of the VIEs included in the previous tables are sponsored by unrelated parties; examples of the Firm’s involvement with these VIEs include its secondary market-making activities and the securities held in its Investment securities portfolio (see Note 8).
The Firm’s maximum exposure to loss is dependent on the nature of the Firm’s variable interest in the VIE and is limited to the notional amounts of certain liquidity facilities and other credit support, total return swaps and written put options, as well as the fair value of certain other derivatives and investments the Firm has made in the VIE.
The Firm’s maximum exposure to loss in the previous tables does not include the offsetting benefit of hedges or any reductions associated with the amount of collateral held as part of a transaction with the VIE or any party to the VIE directly against a specific exposure to loss.
Liabilities issued by VIEs generally are non-recourse to the Firm.
 i 
Detail of Mortgage- and Asset-Backed Securitization Assets
 
$ in millions
UPB
Debt and
Equity
Interests
UPB
Debt and
Equity
Interests
Residential mortgages
$
 i 20,056

$
 i 3,264

$
 i 30,353

$
 i 3,993

Commercial mortgages
 i 59,111

 i 3,940

 i 53,892

 i 3,881

U.S. agency collateralized mortgage obligations
 i 52,335

 i 8,021

 i 36,366

 i 6,365

Other consumer or commercial loans
 i 4,860

 i 1,596

 i 4,992

 i 2,075

Total
$
 i 136,362

$
 i 16,821

$
 i 125,603

$
 i 16,314


 / 
 i 
Transferred Assets with Continuing Involvement
 
$ in millions
RML
CML
U.S. Agency
CMO
CLN and
Other1
SPE assets (UPB)2
$
 i 7,225

$
 i 81,900

$
 i 22,951

$
 i 12,223

Retained interests
Investment grade
$
 i 47

$
 i 794

$
 i 745

$
 i 

Non-investment grade
 i 16

 i 221

 i 

 i 89

Total
$
 i 63

$
 i 1,015

$
 i 745

$
 i 89

Interests purchased in the secondary market
Investment grade
$
 i 1

$
 i 129

$
 i 26

$
 i 

Non-investment grade
 i 24

 i 60

 i 

 i 

Total
$
 i 25

$
 i 189

$
 i 26

$
 i 

Derivative assets
$
 i 

$
 i 

$
 i 

$
 i 500

Derivative liabilities
 i 

 i 

 i 

 i 127

 / 

September 2020 Form 10-Q
78
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
$ in millions
RML
CML
U.S. Agency
CMO
CLN and
Other1
SPE assets (UPB)2
$
 i 9,850

$
 i 86,203

$
 i 19,132

$
 i 8,410

Retained interests
Investment grade
$
 i 29

$
 i 720

$
 i 2,376

$
 i 1

Non-investment grade
 i 17

 i 254

 i 

 i 92

Total
$
 i 46

$
 i 974

$
 i 2,376

$
 i 93

Interests purchased in the secondary market
Investment grade
$
 i 6

$
 i 197

$
 i 77

$
 i 

Non-investment grade
 i 75

 i 51

 i 

 i 

Total
$
 i 81

$
 i 248

$
 i 77

$
 i 

Derivative assets
$
 i 

$
 i 

$
 i 

$
 i 339

Derivative liabilities
 i 

 i 

 i 

 i 145

 
Fair Value At September 30, 2020
$ in millions
Level 2
Level 3
Total
Retained interests
 
 
 
Investment grade
$
 i 771

$
 i 22

$
 i 793

Non-investment grade
 i 5

 i 72

 i 77

Total
$
 i 776

$
 i 94

$
 i 870

Interests purchased in the secondary market
Investment grade
$
 i 154

$
 i 2

$
 i 156

Non-investment grade
 i 66

 i 18

 i 84

Total
$
 i 220

$
 i 20

$
 i 240

Derivative assets
$
 i 495

$
 i 5

$
 i 500

Derivative liabilities
 i 126

 i 1

 i 127

 
Fair Value at December 31, 2019
$ in millions
Level 2
Level 3
Total
Retained interests
 
 
 
Investment grade
$
 i 2,401

$
 i 4

$
 i 2,405

Non-investment grade
 i 6

 i 97

 i 103

Total
$
 i 2,407

$
 i 101

$
 i 2,508

Interests purchased in the secondary market
Investment grade
$
 i 278

$
 i 2

$
 i 280

Non-investment grade
 i 68

 i 58

 i 126

Total
$
 i 346

$
 i 60

$
 i 406

Derivative assets
$
 i 337

$
 i 2

$
 i 339

Derivative liabilities
 i 144

 i 1

 i 145



RML—Residential mortgage loans
CML—Commercial mortgage loans
1.
Amounts include CLO transactions managed by unrelated third parties.
2.
Amounts include assets transferred by unrelated transferors.
The previous tables include transactions with SPEs in which the Firm, acting as principal, transferred financial assets with continuing involvement and received sales treatment. The transferred assets are carried at fair value prior to securitization, and any changes in fair value are recognized in the income statements. The Firm may act as underwriter of the beneficial interests issued by these securitization vehicles, for which Investment banking revenues are recognized. The Firm may retain interests in the securitized financial assets as one or more tranches of the securitization. These retained interests are generally carried at fair value in the balance sheets with changes in fair value recognized in the income statements. Fair value for these interests is measured using techniques that are consistent
 
with the valuation techniques applied to the Firm’s major categories of assets and liabilities as described in Note 2 in the 2019 Form 10-K and Note 5 herein. Further, as permitted by applicable guidance, certain transfers of assets where the Firm’s only continuing involvement is a derivative are only reported in the following Assets Sold with Retained Exposure table.
 i 
Proceeds from New Securitization Transactions and Sales of Loans
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
New transactions1
$
 i 12,969

$
 i 8,651

$
 i 30,629

$
 i 20,897

Retained interests
 i 1,991

 i 902

 i 7,215

 i 4,424

Sales of corporate loans to CLO SPEs1, 2
 i 234

 i 

 i 373

 i 


1.
Net gains on new transactions and sales of corporate loans to CLO entities at the time of the sale were not material for all periods presented.
 / 
2.
Sponsored by non-affiliates.
The Firm has provided, or otherwise agreed to be responsible for, representations and warranties regarding certain assets transferred in securitization transactions sponsored by the Firm (see Note 14).
 i 
Assets Sold with Retained Exposure
$ in millions
Gross cash proceeds from sale of assets1
$
 i 31,800

$
 i 38,661

Fair value
 
 
Assets sold
$
 i 32,006

$
 i 39,137

Derivative assets recognized
in the balance sheets
 i 631

 i 647

Derivative liabilities recognized
in the balance sheets
 i 423

 i 152


 / 
1.
The carrying value of assets derecognized at the time of sale approximates gross cash proceeds.
The Firm enters into transactions in which it sells securities, primarily equities and contemporaneously enters into bilateral OTC derivatives with the purchasers of the securities, through which it retains exposure to the sold securities.
For a discussion of the Firm’s VIEs, the determination and structure of VIEs and securitization activities, see Note 14 to the financial statements in the 2019 Form 10-K.
16.  i Regulatory Requirements
Regulatory Capital Framework and Requirements
For a discussion of the Firm’s regulatory capital framework, see Note 15 to the financial statements in the 2019 Form 10-K.
The Firm is required to maintain minimum risk-based and leverage-based capital ratios under regulatory capital requirements. A summary of the calculations of regulatory capital and RWA follows.

 
79
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios. At September 30, 2020 and December 31, 2019, the Firm’s ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively.
In the current year period, the U.S. banking agencies have adopted an interim final rule altering, for purposes of the regulatory capital rules, the required adoption time period for CECL. As of September 30, 2020, the risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period in accordance with the interim final rule.
In addition to the minimum risk-based capital ratio requirements, the Firm is subject to the following Common Equity Tier 1 buffers:
 
A greater than  i 2.5% capital conservation buffer;

The G-SIB capital surcharge, currently at  i 3%; and

Up to a  i 2.5% CCyB, currently set by U.S. banking agencies at zero.
 i 
The Firm’s Regulatory Capital and Capital Ratios
 
$ in millions
Required
Ratio1
Amount
Ratio
Risk-based capital
 
 
 
Common Equity Tier 1
capital
 i 10.0
%
$
 i 71,157

 i 16.9
%
Tier 1 capital
 i 11.5
%
 i 79,905

 i 19.0
%
Total capital
 i 13.5
%
 i 89,763

 i 21.4
%
Total RWA
 
 i 420,081

 
$ in millions
 
Required
Ratio1
Leverage-based capital
 
 
 
Adjusted average assets2
 
 
$
 i 962,435

Tier 1 leverage ratio
 
 i 4.0
%
 i 8.3
%
Supplementary leverage exposure3,4
 
 
$
 i 1,084,348

SLR3
 
 i 5.0
%
 i 7.4
%

 
 / 
 
 
$ in millions
Required
Ratio1
Amount
Ratio
Risk-based capital
 
 
 
Common Equity Tier 1 capital
 i 10.0
%
$
 i 64,751

 i 16.4
%
Tier 1 capital
 i 11.5
%
 i 73,443

 i 18.6
%
Total capital
 i 13.5
%
 i 82,708

 i 21.0
%
Total RWA
 
 i 394,177

 
$ in millions
 
Required
Ratio1
Leverage-based capital
 
 
 
Adjusted average assets2
 
 
$
 i 889,195

Tier 1 leverage ratio
 
 i 4.0
%
 i 8.3
%
Supplementary leverage
 exposure3,4
 
 
$
 i 1,155,177

SLR3
 
 i 5.0
%
 i 6.4
%
 
1.
Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the Firm’s ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.
2.
Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in the Firm’s own capital instruments, certain defined tax assets and other capital deductions.
3.
Based on a Federal Reserve interim final rule in effect until March 31, 2021, the Firm’s SLR and Supplementary leverage exposure as of September 30, 2020 reflect the exclusion of U.S. Treasury securities and deposits at Federal Reserve Banks.
4.
Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures.
 
U.S. Bank Subsidiaries’ Regulatory Capital and Capital Ratios
The OCC establishes capital requirements for the Firm’s U.S. bank subsidiaries, which as of September 30, 2020 include Morgan Stanley Bank, N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) (collectively, the “U.S. Bank Subsidiaries), and evaluates their compliance with such capital requirements. Regulatory capital requirements for the U.S. Bank Subsidiaries are calculated in a similar manner to the Firm’s regulatory capital requirements, although G-SIB capital surcharge requirements do not apply to the U.S. Bank Subsidiaries.
The OCC’s regulatory capital framework includes Prompt Corrective Action (“PCA”) standards, including “well-capitalized” PCA standards that are based on specified regulatory capital ratio minimums. For the Firm to remain an FHC, the U.S. Bank Subsidiaries must remain well-capitalized

September 2020 Form 10-Q
80
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

in accordance with the OCC’s PCA standards. In addition, failure by the U.S. Bank Subsidiaries to meet minimum capital requirements may result in certain mandatory and discretionary actions by regulators that, if undertaken, could have a direct material effect on the U.S. Bank Subsidiaries’ and the Firm’s financial statements.
At September 30, 2020 and December 31, 2019, the U.S. Bank Subsidiaries’ risk-based capital ratios are based on the Standardized Approach rules. At September 30, 2020, the risk-based and leverage-based capital amounts and ratios are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period.
 i 
MSBNA’s Regulatory Capital
 
$ in millions
Well-Capitalized
Requirement
Required
Ratio1
Amount
Ratio
Risk-based capital
 
 
 
 
Common Equity Tier 1
capital
 i 6.5
%
 i 7.0
%
$
 i 17,764

 i 19.7
%
Tier 1 capital
 i 8.0
%
 i 8.5
%
 i 17,764

 i 19.7
%
Total capital
 i 10.0
%
 i 10.5
%
 i 18,442

 i 20.4
%
Leverage-based capital
 
 
 
 
Tier 1 leverage
 i 5.0
%
 i 4.0
%
$
 i 17,764

 i 10.7
%
SLR
 i 6.0
%
 i 3.0
%
 i 17,764

 i 8.5
%
 
$ in millions
Well-Capitalized
Requirement
Required
Ratio1
Amount
Ratio
Risk-based capital
 
 
 
 
Common Equity Tier 1 capital
 i 6.5
%
 i 7.0
%
$
 i 15,919

 i 18.5
%
Tier 1 capital
 i 8.0
%
 i 8.5
%
 i 15,919

 i 18.5
%
Total capital
 i 10.0
%
 i 10.5
%
 i 16,282

 i 18.9
%
Leverage-based capital
 
 
 
 
Tier 1 leverage
 i 5.0
%
 i 4.0
%
$
 i 15,919

 i 11.3
%
SLR
 i 6.0
%
 i 3.0
%
 i 15,919

 i 8.7
%

 / 
 i 
MSPBNA’s Regulatory Capital
 
$ in millions
Well-Capitalized
Requirement
Required
Ratio1
Amount
Ratio
Risk-based capital
 
 
 
 
Common Equity Tier 1 capital
 i 6.5
%
 i 7.0
%
$
 i 8,528

 i 23.4
%
Tier 1 capital
 i 8.0
%
 i 8.5
%
 i 8,528

 i 23.4
%
Total capital
 i 10.0
%
 i 10.5
%
 i 8,611

 i 23.6
%
Leverage-based capital
 
 
 
 
Tier 1 leverage
 i 5.0
%
 i 4.0
%
$
 i 8,528

 i 8.2
%
SLR
 i 6.0
%
 i 3.0
%
 i 8,528

 i 7.8
%
 
 / 
 
 
$ in millions
Well-Capitalized
Requirement
Required
Ratio1
Amount
Ratio
Risk-based capital
 
 
 
 
Common Equity Tier 1 capital
 i 6.5
%
 i 7.0
%
$
 i 7,962

 i 24.8
%
Tier 1 capital
 i 8.0
%
 i 8.5
%
 i 7,962

 i 24.8
%
Total capital
 i 10.0
%
 i 10.5
%
 i 8,016

 i 25.0
%
Leverage-based capital
 
 
 
 
Tier 1 leverage
 i 5.0
%
 i 4.0
%
$
 i 7,962

 i 9.9
%
SLR
 i 6.0
%
 i 3.0
%
 i 7,962

 i 9.4
%

1.
Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the U.S. Bank Subsidiaries' ability to make capital distributions, including the payment of dividends.

U.S. Broker-Dealer Regulatory Capital Requirements
 i 
MS&Co. Regulatory Capital
$ in millions
Net capital
$
 i 14,183

$
 i 13,708

Excess net capital
 i 10,217

 i 10,686


 / 
MS&Co. is a registered U.S. broker-dealer and registered futures commission merchant and, accordingly, is subject to the minimum net capital requirements of the SEC and the CFTC. MS&Co. has consistently operated with capital in excess of its regulatory capital requirements.
As an Alternative Net Capital broker-dealer, and in accordance with Securities Exchange Act of 1934 (“Exchange Act”) Rule 15c3-1, Appendix E, MS&Co. is subject to minimum net capital and tentative net capital requirements. In addition, MS&Co. must notify the SEC if its tentative net capital falls below certain levels. At September 30, 2020 and December 31, 2019, MS&Co. has exceeded its net capital requirement and has tentative net capital in excess of the minimum and notification requirements.
 i 
MSSB Regulatory Capital
$ in millions
Net capital
$
 i 2,758

$
 i 3,387

Excess net capital
 i 2,581

 i 3,238


 / 
MSSB is a registered U.S. broker-dealer and introducing broker for the futures business and, accordingly, is subject to the minimum net capital requirements of the SEC. MSSB has consistently operated with capital in excess of its regulatory capital requirements.
Other Regulated Subsidiaries
MSIP, a London-based broker-dealer subsidiary, is subject to the capital requirements of the PRA, and MSMS, a Tokyo-based broker-dealer subsidiary, is subject to the capital requirements

 
81
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

of the Financial Services Agency. MSIP and MSMS have consistently operated with capital in excess of their respective regulatory capital requirements.
Certain other U.S. and non-U.S. subsidiaries of the Firm are subject to various securities, commodities and banking regulations, and capital adequacy requirements promulgated by the regulatory and exchange authorities of the countries in which they operate. These subsidiaries have consistently operated with capital in excess of their local capital adequacy requirements.
17.  i Total Equity
Preferred Stock
 
Shares
Outstanding
 
Carrying Value
$ in millions, except per share data
Liquidation
Preference
per Share
Series
 
 
 
A
 i 44,000

$
 i 25,000

$
 i 1,100

$
 i 1,100

C1
 i 519,882

 i 1,000

 i 408

 i 408

E
 i 34,500

 i 25,000

 i 862

 i 862

F
 i 34,000

 i 25,000

 i 850

 i 850

H
 i 52,000

 i 25,000

 i 1,300

 i 1,300

I
 i 40,000

 i 25,000

 i 1,000

 i 1,000

J
 i 60,000

 i 25,000

 i 1,500

 i 1,500

K
 i 40,000

 i 25,000

 i 1,000

 i 1,000

L
 i 20,000

 i 25,000

 i 500

 i 500

Total
$
 i 8,520

$
 i 8,520

Shares authorized
 i 30,000,000
 
1.
Series C preferred stock is held by MUFG.
For a description of Series A through Series L preferred stock issuances, see Note 16 to the financial statements in the 2019 Form 10-K. The preferred stock has a preference over the common stock upon liquidation. The Firm’s preferred stock qualifies as and is included in Tier 1 capital in accordance with regulatory capital requirements (see Note 16).
 i 
Common Shares Outstanding for Basic and Diluted EPS
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
in millions
2020
2019
2020
2019
Weighted average common shares outstanding, basic
 i 1,542

 i 1,604

 i 1,546

 i 1,632

Effect of dilutive Stock options, RSUs and PSUs
 i 24

 i 23

 i 19

 i 21

Weighted average common shares outstanding and common stock equivalents, diluted
 i 1,566

 i 1,627

 i 1,565

 i 1,653

Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS)
 i 

 i 

 i 7

 i 2


 / 
 
 
 i 
Share Repurchases
 
Three Months Ended September 30,
Nine Months Ended September 30,
$ in millions
2020
2019
2020
2019
Repurchases of common stock under the Firm's Share Repurchase Program
$
 i 

$
 i 1,500

$
 i 1,347

$
 i 3,860


 / 
On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs. On June 25, 2020, the Federal Reserve published summary results of CCAR and announced that large BHCs, including the Firm, generally would be restricted in making share repurchases during the current quarter, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020.
A portion of common stock repurchases was conducted under a sales plan with MUFG, whereby MUFG sold shares of the Firm’s common stock to the Firm, as part of the Firm’s Share Repurchase Program. The sales plan is only intended to maintain MUFG’s ownership percentage below  i 24.9% in order to comply with MUFG’s passivity commitments to the Board of Governors of the Federal Reserve System and has no impact on the strategic alliance between MUFG and the Firm, including the joint ventures in Japan.
 i  i 
Dividends
$ in millions, except per
share data
Three Months Ended
September 30, 2020
Three Months Ended
September 30, 2019
Per Share1
Total
Per Share1
Total
Preferred Stock Series
 
 
 
 
A
$
 i 256

$
 i 11

$
 i 256

$
 i 11

C
 i 25

 i 13

 i 25

 i 13

E
 i 445

 i 15

 i 445

 i 15

F
 i 430

 i 15

 i 430

 i 15

G2
 i 

 i 

 i 414

 i 8

H3
 i 248

 i 13

 i 378

 i 20

I
 i 398

 i 16

 i 398

 i 16

J4
 i 261

 i 16

 i 

 i 

K
 i 366

 i 15

 i 366

 i 15

L
 i 305

 i 6

 i 

 i 

Total Preferred stock
 
$
 i 120

 
$
 i 113

Common stock
 i 0.35

$
 i 551

$
 i 0.35

$
 i 577

 
 / 
 / 

September 2020 Form 10-Q
82
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

$ in millions, except per
share data
Nine Months Ended
September 30, 2020
Nine Months Ended
September 30, 2019
Per Share1
Total
Per Share1
Total
Preferred Stock Series
 
 
 
 
A
$
 i 761

$
 i 33

$
 i 758

$
 i 33

C
 i 75

 i 39

 i 75

 i 39

E
 i 1,336

 i 45

 i 1,336

 i 45

F
 i 1,289

 i 44

 i 1,289

 i 45

G2
 i 

 i 

 i 1,242

 i 24

H3
 i 897

 i 47

 i 1,059

 i 55

I
 i 1,195

 i 48

 i 1,195

 i 48

J4
 i 955

 i 58

 i 694

 i 42

K
 i 1,097

 i 45

 i 1,097

 i 45

L
 i 914

 i 18

 i 

 i 

Total Preferred stock
 
$
 i 377

 
$
 i 376

Common stock
 i 1.05

$
 i 1,662

$
 i 0.95

$
 i 1,594


1.
Common and Preferred Stock dividends are payable quarterly, unless otherwise noted.
2.
Series G preferred stock was redeemed during the first quarter of 2020. For further information, see Note 16 to the financial statements in the 2019 Form 10-K.
3.
Series H was payable semiannually until July 15, 2019, and is now payable quarterly.
4.
Series J was payable semiannually until July 15, 2020, and is now payable quarterly.
 i 
Cumulative Adjustments to Beginning Retained Earnings Related to the Adoption of Accounting Updates
 
Nine Months Ended
$ in millions
Financial Instruments—Credit Losses
$
( i 100
)
 
Nine Months Ended
$ in millions
Leases
$
 i 63


 / 
 
 i 
Accumulated Other Comprehensive Income (Loss)1   
$ in millions
CTA
AFS
Securities
Pension,
Postretirement
and Other
DVA
Total
$
( i 1,017
)
$
 i 1,827

$
( i 620
)
$
( i 189
)
$
 i 1

OCI during the period
 i 81

( i 62
)
 i 5

( i 562
)
( i 538
)
$
( i 936
)
$
 i 1,765

$
( i 615
)
$
( i 751
)
$
( i 537
)
$
( i 865
)
$
 i 108

$
( i 574
)
$
( i 720
)
$
( i 2,051
)
OCI during the period
( i 96
)
 i 214

 i 3

 i 332

 i 453

$
( i 961
)
$
 i 322

$
( i 571
)
$
( i 388
)
$
( i 1,598
)
$
( i 897
)
$
 i 207

$
( i 644
)
$
( i 1,454
)
$
( i 2,788
)
OCI during the period
( i 39
)
 i 1,558

 i 29

 i 703

 i 2,251

$
( i 936
)
$
 i 1,765

$
( i 615
)
$
( i 751
)
$
( i 537
)
$
( i 889
)
$
( i 930
)
$
( i 578
)
$
 i 105

$
( i 2,292
)
OCI during the period
( i 72
)
 i 1,252

 i 7

( i 493
)
 i 694

$
( i 961
)
$
 i 322

$
( i 571
)
$
( i 388
)
$
( i 1,598
)
 
CTA—Cumulative foreign currency translation adjustments
 / 
1.
Amounts are net of tax and noncontrolling interests.
 
 
 i 
Components of Period Changes in OCI
 
Three Months Ended
September 30, 2020
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests
Net
CTA
OCI activity
$
 i 34

$
 i 76

$
 i 110

$
 i 29

$
 i 81

Reclassified to earnings
 i 

 i 

 i 

 i 

 i 

Net OCI
$
 i 34

$
 i 76

$
 i 110

$
 i 29

$
 i 81

Change in net unrealized gains (losses) on AFS securities
OCI activity
$
( i 26
)
$
 i 6

$
( i 20
)
$
 i 

$
( i 20
)
Reclassified to earnings
( i 55
)
 i 13

( i 42
)
 i 

( i 42
)
Net OCI
$
( i 81
)
$
 i 19

$
( i 62
)
$
 i 

$
( i 62
)
Pension, postretirement and other
OCI activity
$
( i 1
)
$
 i 1

$
 i 

$
 i 

$
 i 

Reclassified to earnings
 i 6

( i 1
)
 i 5

 i 

 i 5

Net OCI
$
 i 5

$
 i 

$
 i 5

$
 i 

$
 i 5

Change in net DVA
OCI activity
$
( i 747
)
$
 i 178

$
( i 569
)
$
( i 1
)
$
( i 568
)
Reclassified to earnings
 i 8

( i 2
)
 i 6

 i 

 i 6

Net OCI
$
( i 739
)
$
 i 176

$
( i 563
)
$
( i 1
)
$
( i 562
)
 
Three Months Ended
September 30, 2019
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests
Net
CTA
OCI activity
$
( i 26
)
$
( i 73
)
$
( i 99
)
$
( i 3
)
$
( i 96
)
Reclassified to earnings
 i 

 i 

 i 

 i 

 i 

Net OCI
$
( i 26
)
$
( i 73
)
$
( i 99
)
$
( i 3
)
$
( i 96
)
Change in net unrealized gains (losses) on AFS securities
OCI activity
$
 i 307

$
( i 73
)
$
 i 234

$
 i 

$
 i 234

Reclassified to earnings
( i 26
)
 i 6

( i 20
)
 i 

( i 20
)
Net OCI
$
 i 281

$
( i 67
)
$
 i 214

$
 i 

$
 i 214

Pension, postretirement and other
OCI activity
$
 i 

$
 i 

$
 i 

$
 i 

$
 i 

Reclassified to earnings
 i 4

( i 1
)
 i 3

 i 

 i 3

Net OCI
$
 i 4

$
( i 1
)
$
 i 3

$
 i 

$
 i 3

Change in net DVA
OCI activity
$
 i 441

$
( i 106
)
$
 i 335

$
 i 5

$
 i 330

Reclassified to earnings
 i 2

 i 

 i 2

 i 

 i 2

Net OCI
$
 i 443

$
( i 106
)
$
 i 337

$
 i 5

$
 i 332


 

 / 

 
83
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
Nine Months Ended
September 30, 2020
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests
Net
CTA
OCI activity
$
 i 19

$
( i 17
)
$
 i 2

$
 i 38

$
( i 36
)
Reclassified to earnings
( i 3
)
 i 

( i 3
)
 i 

( i 3
)
Net OCI
$
 i 16

$
( i 17
)
$
( i 1
)
$
 i 38

$
( i 39
)
Change in net unrealized gains (losses) on AFS securities
OCI activity
$
 i 2,142

$
( i 503
)
$
 i 1,639

$
 i 

$
 i 1,639

Reclassified to earnings
( i 106
)
 i 25

( i 81
)
 i 

( i 81
)
Net OCI
$
 i 2,036

$
( i 478
)
$
 i 1,558

$
 i 

$
 i 1,558

Pension, postretirement and other
OCI activity
$
 i 20

$
( i 4
)
$
 i 16

$
 i 

$
 i 16

Reclassified to earnings
 i 16

( i 3
)
 i 13

 i 

 i 13

Net OCI
$
 i 36

$
( i 7
)
$
 i 29

$
 i 

$
 i 29

Change in net DVA
OCI activity
$
 i 967

$
( i 233
)
$
 i 734

$
 i 41

$
 i 693

Reclassified to earnings
 i 14

( i 4
)
 i 10

 i 

 i 10

Net OCI
$
 i 981

$
( i 237
)
$
 i 744

$
 i 41

$
 i 703

 
Nine Months Ended
September 30, 2019
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests
Net
CTA
OCI activity
$
 i 2

$
( i 58
)
$
( i 56
)
$
 i 16

$
( i 72
)
Reclassified to earnings
 i 

 i 

 i 

 i 

 i 

Net OCI
$
 i 2

$
( i 58
)
$
( i 56
)
$
 i 16

$
( i 72
)
Change in net unrealized gains (losses) on AFS securities
OCI activity
$
 i 1,726

$
( i 406
)
$
 i 1,320

$
 i 

$
 i 1,320

Reclassified to earnings
( i 89
)
 i 21

( i 68
)
 i 

( i 68
)
Net OCI
$
 i 1,637

$
( i 385
)
$
 i 1,252

$
 i 

$
 i 1,252

Pension, postretirement and other
OCI activity
$
 i 

$
( i 1
)
$
( i 1
)
$
 i 

$
( i 1
)
Reclassified to earnings
 i 10

( i 2
)
 i 8

 i 

 i 8

Net OCI
$
 i 10

$
( i 3
)
$
 i 7

$
 i 

$
 i 7

Change in net DVA
OCI activity
$
( i 713
)
$
 i 177

$
( i 536
)
$
( i 36
)
$
( i 500
)
Reclassified to earnings
 i 9

( i 2
)
 i 7

 i 

 i 7

Net OCI
$
( i 704
)
$
 i 175

$
( i 529
)
$
( i 36
)
$
( i 493
)

 
18.  i Interest Income and Interest Expense
 i 
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Interest income
 
 
 
 
Investment securities
$
 i 529

$
 i 579

$
 i 1,603

$
 i 1,563

Loans
 i 967

 i 1,208

 i 3,171

 i 3,599

Securities purchased under agreements to resell and Securities borrowed1
( i 187
)
 i 871

 i 70

 i 2,865

Trading assets, net of Trading liabilities
 i 537

 i 728

 i 1,902

 i 2,188

Customer receivables and Other2
 i 210

 i 964

 i 1,171

 i 2,931

Total interest income
$
 i 2,056

$
 i 4,350

$
 i 7,917

$
 i 13,146

 
 
 
 
 
Interest expense
 
 
 
 
Deposits
$
 i 178

$
 i 505

$
 i 804

$
 i 1,460

Borrowings
 i 714

 i 1,219

 i 2,534

 i 3,941

Securities sold under agreements to repurchase and Securities loaned3
 i 165

 i 681

 i 883

 i 2,016

Customer payables and Other4
( i 487
)
 i 727

( i 746
)
 i 2,468

Total interest expense
$
 i 570

$
 i 3,132

$
 i 3,475

$
 i 9,885

Net interest
$
 i 1,486

$
 i 1,218

$
 i 4,442

$
 i 3,261

 
1.
Includes fees paid on Securities borrowed.
2.
Includes interest from Cash and cash equivalents.
3.
Includes fees received on Securities loaned.
 / 
4.
Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions.
Interest income and Interest expense are classified in the income statements based on the nature of the instrument and related market conventions. When included as a component of the instrument’s fair value, interest is included within Trading revenues or Investments revenues. Otherwise, it is included within Interest income or Interest expense. k
 i 
Accrued Interest
$ in millions
Customer and other receivables
$
 i 2,244

$
 i 1,661

Customer and other payables
 i 2,545

 i 2,223


 / 
19.  i Income Taxes
The Firm is under continuous examination by the IRS and other tax authorities in certain countries, such as Japan and the U.K., and in states and localities in which it has significant business operations, such as New York.
The Firm believes that the resolution of these tax examinations will not have a material effect on the annual financial statements, although a resolution could have a material impact in the income statements and on the effective tax rate for any period in which such resolutions occur.

September 2020 Form 10-Q
84
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

The Firm has established a liability for unrecognized tax benefits, and associated interest, if applicable (“tax liabilities”), that it believes is adequate in relation to the potential for additional assessments. Once established, the Firm adjusts such tax liabilities only when new information is available or when an event occurs necessitating a change.
It is reasonably possible that significant changes in the balance of unrecognized tax benefits may occur within the next 12 months. At this time, however, it is not possible to reasonably estimate the expected change to the total amount of unrecognized tax benefits and the impact on the Firm’s effective tax rate over the next 12 months.
 i 
Net Discrete Tax Provisions (Benefits)
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Recurring1
$
 i 

$
 i 

$
( i 94
)
$
( i 127
)
Intermittent
( i 113
)
( i 89
)
( i 10
)
( i 190
)
 
1. Recurring discrete tax items are related to conversion of employee share-based awards.
 / 
The current quarter included intermittent net discrete tax benefits principally associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of tax examinations in certain jurisdictions.
The prior year quarter included intermittent net discrete tax benefits primarily associated with the filing of the 2018 federal tax return and the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.
The prior year period included intermittent net discrete tax benefits primarily associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations and other matters.
 
20.  i Segment, Geographic and Revenue Information
 i 
Selected Financial Information by Business Segment
 
Three Months Ended September 30, 2020
$ in millions
IS
WM
IM
I/E
Total
Investment banking
$
 i 1,707

$
 i 135

$
 i 

$
( i 16
)
$
 i 1,826

Trading
 i 2,807

 i 268

 i 2

 i 15

 i 3,092

Investments
 i 87

 i 1

 i 258

 i 

 i 346

Commissions and fees1
 i 639

 i 477

 i 1

( i 80
)
 i 1,037

Asset management1
 i 114

 i 2,793

 i 795

( i 38
)
 i 3,664

Other
 i 114

 i 94

 i 1

( i 3
)
 i 206

Total non-interest revenues
 i 5,468

 i 3,768

 i 1,057

( i 122
)
 i 10,171

Interest income
 i 1,086

 i 1,065

 i 7

( i 102
)
 i 2,056

Interest expense
 i 492

 i 176

 i 8

( i 106
)
 i 570

Net interest
 i 594

 i 889

( i 1
)
 i 4

 i 1,486

Net revenues
$
 i 6,062

$
 i 4,657

$
 i 1,056

$
( i 118
)
$
 i 11,657

Income before provision for income taxes
$
 i 2,048

$
 i 1,120

$
 i 315

$
 i 4

$
 i 3,487

Provision for income taxes
 i 385

 i 278

 i 72

 i 1

 i 736

Net income
 i 1,663

 i 842

 i 243

 i 3

 i 2,751

Net income applicable to noncontrolling interests
 i 16

 i 

 i 18

 i 

 i 34

Net income applicable to Morgan Stanley
$
 i 1,647

$
 i 842

$
 i 225

$
 i 3

$
 i 2,717

 
Three Months Ended September 30, 2019
$ in millions
IS
WM
IM
I/E
Total
Investment banking
$
 i 1,535

$
 i 118

$
 i 

$
( i 18
)
$
 i 1,635

Trading
 i 2,533

 i 61

 i 2

 i 12

 i 2,608

Investments
( i 18
)
 i 

 i 105

 i 

 i 87

Commissions and fees1
 i 643

 i 416

 i 1

( i 70
)
 i 990

Asset management1
 i 100

 i 2,639

 i 664

( i 40
)
 i 3,363

Other
 i 51

 i 81

 i 

( i 1
)
 i 131

Total non-interest revenues
 i 4,844

 i 3,315

 i 772

( i 117
)
 i 8,814

Interest income
 i 3,112

 i 1,378

 i 4

( i 144
)
 i 4,350

Interest expense
 i 2,933

 i 335

 i 12

( i 148
)
 i 3,132

Net interest
 i 179

 i 1,043

( i 8
)
 i 4

 i 1,218

Net revenues
$
 i 5,023

$
 i 4,358

$
 i 764

$
( i 113
)
$
 i 10,032

Income before provision for income taxes
$
 i 1,307

$
 i 1,238

$
 i 165

$
 i 

$
 i 2,710

Provision for income taxes
 i 189

 i 276

 i 27

 i 

 i 492

Net income
 i 1,118

 i 962

 i 138

 i 

 i 2,218

Net income applicable to noncontrolling interests
 i 45

 i 

 i 

 i 

 i 45

Net income applicable to Morgan Stanley
$
 i 1,073

$
 i 962

$
 i 138

$
 i 

$
 i 2,173





 / 

 
85
September 2020 Form 10-Q

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

 
Nine Months Ended September 30, 2020
$ in millions
IS
WM
IM
I/E
Total
Investment banking
$
 i 4,902

$
 i 403

$
 i 

$
( i 66
)
$
 i 5,239

Trading
 i 10,375

 i 413

( i 13
)
 i 56

 i 10,831

Investments
 i 98

 i 9

 i 552

 i 

 i 659

Commissions and fees1
 i 2,230

 i 1,538

 i 1

( i 270
)
 i 3,499

Asset management1
 i 342

 i 7,980

 i 2,144

( i 120
)
 i 10,346

Other
( i 628
)
 i 216

( i 39
)
( i 7
)
( i 458
)
Total non-interest revenues
 i 17,319

 i 10,559

 i 2,645

( i 407
)
 i 30,116

Interest income
 i 4,809

 i 3,468

 i 22

( i 382
)
 i 7,917

Interest expense
 i 3,184

 i 653

 i 33

( i 395
)
 i 3,475

Net interest
 i 1,625

 i 2,815

( i 11
)
 i 13

 i 4,442

Net revenues
$
 i 18,944

$
 i 13,374

$
 i 2,634

$
( i 394
)
$
 i 34,558

Income before provision for income taxes
$
 i 5,991

$
 i 3,317

$
 i 674

$
 i 6

$
 i 9,988

Provision for income taxes
 i 1,326

 i 758

 i 136

 i 1

 i 2,221

Net income
 i 4,665

 i 2,559

 i 538

 i 5

 i 7,767

Net income applicable to noncontrolling interests
 i 75

 i 

 i 81

 i 

 i 156

Net income applicable to Morgan Stanley
$
 i 4,590

$
 i 2,559

$
 i 457

$
 i 5

$
 i 7,611

 
Nine Months Ended September 30, 2019
$ in millions
IS
WM
IM
I/E
Total
Investment banking
$
 i 4,158

$
 i 365

$
( i 1
)
$
( i 55
)
$
 i 4,467

Trading
 i 8,221

 i 525

( i 2
)
 i 37

 i 8,781

Investments
 i 257

 i 1

 i 543

 i 

 i 801

Commissions and fees1
 i 1,889

 i 1,250

 i 1

( i 205
)
 i 2,935

Asset management1
 i 310

 i 7,544

 i 1,893

( i 115
)
 i 9,632

Other
 i 416

 i 281

( i 6
)
( i 6
)
 i 685

Total non-interest revenues
 i 15,251

 i 9,966

 i 2,428

( i 344
)
 i 27,301

Interest income
 i 9,457

 i 4,139

 i 14

( i 464
)
 i 13,146

Interest expense
 i 9,376

 i 950

 i 35

( i 476
)
 i 9,885

Net interest
 i 81

 i 3,189

( i 21
)
 i 12

 i 3,261

Net revenues
$
 i 15,332

$
 i 13,155

$
 i 2,407

$
( i 332
)
$
 i 30,562

Income before provision for income taxes
$
 i 4,365

$
 i 3,669

$
 i 538

$
( i 4
)
$
 i 8,568

Provision for income taxes
 i 703

 i 830

 i 104

( i 1
)
 i 1,636

Net income
 i 3,662

 i 2,839

 i 434

( i 3
)
 i 6,932

Net income applicable to noncontrolling interests
 i 97

 i 

 i 32

 i 

 i 129

Net income applicable to Morgan Stanley
$
 i 3,565

$
 i 2,839

$
 i 402

$
( i 3
)
$
 i 6,803


I/E–Intersegment Eliminations
1.
Substantially all revenues are from contracts with customers.

For a discussion about the Firm’s business segments, see Note 21 to the financial statements in the 2019 Form 10-K.
 
 i 
Detail of Investment Banking Revenues
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Institutional Securities Advisory
$
 i 357

$
 i 550

$
 i 1,181

$
 i 1,462

Institutional Securities Underwriting
 i 1,350

 i 985

 i 3,721

 i 2,696

Firm Investment banking revenues from contracts with customers
 i 95
%
 i 85
%
 i 92
%
 i 90
%

 / 
 i 
Trading Revenues by Product Type
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Interest rate
$
 i 511

$
 i 894

$
 i 2,593

$
 i 2,283

Foreign exchange
 i 138

 i 69

 i 603

 i 383

Equity security and index1
 i 1,478

 i 1,076

 i 4,494

 i 4,005

Commodity and other
 i 495

 i 300

 i 1,363

 i 986

Credit
 i 470

 i 269

 i 1,778

 i 1,124

Total
$
 i 3,092

$
 i 2,608

$
 i 10,831

$
 i 8,781

 
 / 
1.
Dividend income is included within equity security and index contracts.
The previous table summarizes realized and unrealized gains and losses, from derivative and non-derivative financial instruments, included in Trading revenues in the income statements. The Firm generally utilizes financial instruments across a variety of product types in connection with its market-making and related risk management strategies. The trading revenues presented in the table are not representative of the manner in which the Firm manages its business activities and are prepared in a manner similar to the presentation of trading revenues for regulatory reporting purposes.
 i 
Investment Management Investments Revenues—Net Cumulative Unrealized Carried Interest
$ in millions
Net cumulative unrealized performance-based fees at risk of reversing
$
 i 761

$
 i 774


 / 
The Firm’s portion of net cumulative performance-based fees in the form of unrealized carried interest, for which the Firm is not obligated to pay compensation, are at risk of reversing when the return in certain funds fall below specified performance targets. See Note 14 for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received.

September 2020 Form 10-Q
86
 

 
Notes to Consolidated Financial Statements
(Unaudited)
mslogo3q20.jpg

Investment Management Asset Management RevenuesReduction of Fees Due to Fee Waivers
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Fee waivers
$
 i 37

$
 i 11

$
 i 70

$
 i 32


The Firm waives a portion of its fees in the Investment Management business segment from certain registered money market funds that comply with the requirements of Rule 2a-7 of the Investment Company Act of 1940.

Certain Other Fee Waivers
Separately, the Firm’s employees, including its senior officers, may participate on the same terms and conditions as other investors in certain funds that the Firm sponsors primarily for client investment, and the Firm may waive or lower applicable fees and charges for its employees.
 i 
Net Revenues by Region
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Americas
$
 i 8,387

$
 i 7,489

$
 i 24,798

$
 i 22,336

EMEA
 i 1,473

 i 1,409

 i 4,670

 i 4,687

Asia
 i 1,797

 i 1,134

 i 5,090

 i 3,539

Total
$
 i 11,657

$
 i 10,032

$
 i 34,558

$
 i 30,562


 / 

For a discussion about the Firm’s geographic net revenues, see Note 21 to the financial statements in the 2019 Form 10-K.
 i 
Revenue Recognized from Prior Services
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
$ in millions
2020
2019
2020
2019
Non-interest revenues
$
 i 556

$
 i 841

$
 i 1,616

$
 i 1,995

The previous table includes revenue from contracts with customers recognized where some or all services were performed in prior periods and is primarily composed of investment banking advisory fees and distribution fees.
 / 

 i 
Receivables from Contracts with Customers
$ in millions
Customer and other receivables
$
 i 2,854

$
 i 2,916


 / 
Receivables from contracts with customers, which are included within Customer and other receivables in the balance sheets, arise when the Firm has both recorded revenues and has the right per the contract to bill the customer.

 
 i 
Assets by Business Segment
$ in millions
Institutional Securities
$
 i 704,323

$
 i 691,201

Wealth Management
 i 244,425

 i 197,682

Investment Management
 i 7,192

 i 6,546

Total1
$
 i 955,940

$
 i 895,429

 / 
1. Parent assets have been fully allocated to the business segments.



 
87
September 2020 Form 10-Q

 
Financial Data Supplement (Unaudited)

mslogo3q20.jpg



Average Balances and Interest Rates and Net Interest Income
 
Three Months Ended September 30,
 
2020
2019
$ in millions
Average
Daily
Balance
Interest
Annualized
Average
Rate
Average
Daily
Balance
Interest
Annualized
Average
Rate
Interest earning assets
Investment securities1
$
133,726

$
529

1.6
 %
$
104,700

$
579

2.2
%
Loans1
144,985

967

2.7

122,320

1,208

3.9

Securities purchased under agreements to resell and Securities borrowed2:
U.S.
123,614

(99
)
(0.3
)
146,578

835

2.3

Non-U.S.
58,567

(88
)
(0.6
)
76,871

36

0.2

Trading assets, net of Trading liabilities3:
U.S.
78,417

443

2.2

78,169

630

3.2

Non-U.S.
21,092

94

1.8

17,104

98

2.3

Customer receivables and Other4:
U.S.
81,908

171

0.8

62,113

703

4.5

Non-U.S.
63,657

39

0.2

60,073

261

1.7

Total
$
705,966

$
2,056

1.2
 %
$
667,928

$
4,350

2.6
%
Interest bearing liabilities
Deposits1
$
236,119

$
178

0.3
 %
$
179,715

$
505

1.1
%
Borrowings1, 5
205,166

714

1.4

196,777

1,219

2.5

Securities sold under agreements to repurchase and Securities loaned6:
U.S.
30,154

81

1.1

36,335

505

5.5

Non-U.S.
28,320

84

1.2

30,111

176

2.3

Customer payables and Other7:
U.S.
119,846

(399
)
(1.3
)
121,800

448

1.5

Non-U.S.
64,524

(88
)
(0.5
)
65,036

279

1.7

Total
$
684,129

$
570

0.3
 %
$
629,774

$
3,132

2.0
%
Net interest income and net interest rate spread
$
1,486

0.9
 %
 
$
1,218

0.6
%

 

 
Nine Months Ended September 30,
 
2020
2019
$ in millions
Average
Daily
Balance
Interest
Annualized
Average
Rate
Average
Daily
Balance
Interest
Annualized
Average
Rate
Interest earning assets
Investment securities1
$
122,613

$
1,603

1.7
 %
$
99,782

$
1,563

2.1
%
Loans1
142,261

3,171

3.0

118,926

3,599

4.0

Securities purchased under agreements to resell and Securities borrowed2:
U.S.
127,868

194

0.2

144,686

2,774

2.6

Non-U.S.
59,831

(124
)
(0.3
)
76,814

91

0.2

Trading assets, net of Trading liabilities3:
U.S.
76,418

1,558

2.7

77,434

1,922

3.3

Non-U.S.
22,570

344

2.0

14,362

266

2.5

Customer receivables and Other4:
U.S.
78,705

892

1.5

61,479

2,110

4.6

Non-U.S.
61,699

279

0.6

59,033

821

1.9

Total
$
691,965

$
7,917

1.5
 %
$
652,516

$
13,146

2.7
%
Interest bearing liabilities
Deposits1
$
223,733

$
804

0.5
 %
$
178,894

$
1,460

1.1
%
Borrowings1, 5
199,855

2,534

1.7

192,854

3,941

2.7

Securities sold under agreements to repurchase and Securities loaned6:
U.S.
30,315

501

2.2

32,479

1,489

6.1

Non-U.S.
29,315

382

1.7

31,555

527

2.2

Customer payables and Other7:
U.S.
123,662

(693
)
(0.7
)
116,383

1,587

1.8

Non-U.S.
64,608

(53
)
(0.1
)
65,331

881

1.8

Total
$
671,488

$
3,475

0.7
 %
$
617,496

$
9,885

2.1
%
Net interest income and net interest rate spread
$
4,442

0.8
 %
 
$
3,261

0.6
%

1.
Amounts include primarily U.S. balances.
2.
Includes fees paid on Securities borrowed.
3.
Excludes non-interest earning assets and non-interest bearing liabilities, such as equity securities.
4.
Includes Cash and cash equivalents.
5.
Includes borrowings carried at fair value, whose interest expense is considered part of fair value and therefore is recorded within Trading revenues.
6.
Includes fees received on Securities loaned. The annualized average rate was calculated using (a) interest expense incurred on all securities sold under agreements to repurchase and securities loaned transactions, whether or not such transactions were reported in the balance sheets and (b) net average on-balance sheet balances, which exclude certain securities-for-securities transactions.
7.
Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions.


September 2020 Form 10-Q
88
 

 
Glossary of Common Terms and Acronyms
mslogo3q20.jpg


2019 Form 10-K
Annual report on Form 10-K for year ended December 31, 2019 filed with the SEC


ABS
Asset-backed securities


ACL
Allowance for credit losses
 
 
AFS
Available-for-sale


AML
Anti-money laundering


AOCI
Accumulated other comprehensive income (loss)


AUM
Assets under management or supervision


Balance sheets
Consolidated balance sheets


BEAT
Base erosion and anti-abuse tax


BHC
Bank holding company


bps
Basis points; one basis point equals 1/100th of 1%


Cash flow statements
Consolidated cash flow statements


CCAR
Comprehensive Capital Analysis and Review


CCyB
Countercyclical capital buffer


CDO
Collateralized debt obligation(s), including Collateralized loan obligation(s)


CDS
Credit default swaps


CECL
Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update


CFTC
U.S. Commodity Futures Trading Commission


CLN
Credit-linked note(s)


CLO
Collateralized loan obligation(s)


CMBS
Commercial mortgage-backed securities


CMO
Collateralized mortgage obligation(s)


CVA
Credit valuation adjustment


DVA
Debt valuation adjustment


EBITDA
Earnings before interest, taxes, depreciation and amortization
 
ELN
Equity-linked note(s)


EMEA
Europe, Middle East and Africa


EPS
Earnings per common share


E.U.
European Union


FDIC
Federal Deposit Insurance Corporation


FFELP
Federal Family Education Loan Program


FFIEC
Federal Financial Institutions Examination Council


FHC
Financial Holding Company


FICC
Fixed Income Clearing Corporation


FICO
Fair Isaac Corporation


Financial statements
Consolidated financial statements


FVA
Funding valuation adjustment


GILTI
Global Intangible Low-Taxed Income


G-SIB
Global systemically important banks


HELOC
Home Equity Line of Credit


HQLA
High-quality liquid assets


HTM
Held-to-maturity


I/E
Intersegment eliminations


IHC
Intermediate holding company


IM
Investment Management


Income statements
Consolidated income statements


IRS
Internal Revenue Service


IS
Institutional Securities


LCR
Liquidity coverage ratio, as adopted by the U.S. banking agencies


LIBOR
London Interbank Offered Rate


M&A
Merger, acquisition and restructuring transaction


MSBNA
Morgan Stanley Bank, N.A.


MS&Co.
Morgan Stanley & Co. LLC



 
89
September 2020 Form 10-Q

 
Glossary of Common Terms and Acronyms
mslogo3q20.jpg


MSIP
Morgan Stanley & Co. International plc


MSMS
Morgan Stanley MUFG Securities Co., Ltd.


MSPBNA
Morgan Stanley Private Bank, National Association


MSSB
Morgan Stanley Smith Barney LLC


MUFG
Mitsubishi UFJ Financial Group, Inc.


MUMSS
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.


MWh
Megawatt hour


N/A
Not Applicable


N/M
Not Meaningful


NAV
Net asset value


Non-GAAP
Non-generally accepted accounting principles


NSFR
Net stable funding ratio, as proposed by the U.S. banking agencies


OCC
Office of the Comptroller of the Currency


OCI
Other comprehensive income (loss)


OIS
Overnight index swap


OTC
Over-the-counter


OTTI
Other-than-temporary impairment


PRA
Prudential Regulation Authority


PSU
Performance-based stock unit


RMBS
Residential mortgage-backed securities


 
ROE
Return on average common equity


ROTCE
Return on average tangible common equity


ROU
Right-of-use


RSU
Restricted stock unit


RWA
Risk-weighted assets


SEC
U.S. Securities and Exchange Commission


SLR
Supplementary leverage ratio


SOFR
Secured Overnight Financing Rate


S&P
Standard & Poor’s


SPE
Special purpose entity


SPOE
Single point of entry


TDR
Troubled debt restructuring


TLAC
Total loss-absorbing capacity


U.K.
United Kingdom


UPB
Unpaid principal balance


U.S.
United States of America


U.S. GAAP
Accounting principles generally accepted in the United States of America


VaR
Value-at-Risk


VIE
Variable interest entity


WACC
Implied weighted average cost of capital


WM
Wealth Management

September 2020 Form 10-Q
90
 


Other Information
None.
Legal Proceedings
The following developments have occurred since previously reporting certain matters in the Firm’s 2019 Form 10-K, the Firm’s Quarterly Reports on Form 10-Q for the quarterly period ended March 31, 2020 (the “First Quarter Form 10-Q”) and the quarterly period ended June 30, 2020 (the “Second Quarter Form 10-Q”). See also the disclosures set forth under “Legal Proceedings” in the 2019 Form 10-K, the First Quarter Form 10-Q, and the Second Quarter Form 10-Q.

Residential Mortgage and Credit Crisis Related Matter
On July 24, 2020, the First Department in China Development Industrial Bank v. Morgan Stanley & Co. Incorporated, et al. denied the Firm’s motion for leave to appeal to the First Department’s decision denying the Firm’s motion for sanctions relating to spoliation of evidence and otherwise affirming the order of the Supreme Court of NY denying the Firm’s motion for summary judgment.

On September 2, 2020, the parties in U.S. Bank National Association, solely in its capacity as Trustee of the Morgan Stanley Mortgage Loan Trust 2007-2AX (MSM 2007-2AX) v. Morgan Stanley Mortgage Capital Holdings LLC, Successor-by-Merger to Morgan Stanley Mortgage Capital Inc. and GreenPoint Mortgage Funding, Inc. entered into a settlement agreement, which was approved in a Trust Instructional Proceeding on October 20, 2020

European Matter
The plaintiff and the Firm are due to file final submissions in the Court of Appeal of Milan in the matter styled Banco Popolare Societá Cooperativa v. Morgan Stanley & Co. International plc & others by November 23, 2020.

 
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Three Months Ended September 30, 2020
$ in millions, except per share data
Total 
Number of Shares Purchased1
Average Price Paid Per Share
Total Shares 
Purchased as Part of Share Repurchase Program2,3
Dollar Value of Remaining Authorized Repurchase
July
30,610

$
48.10


$

August
560,008

$
48.90


$

September
18,360

$
52.08


$

Total
608,978

$
48.96


 

1.
Refers to shares acquired by the Firm in satisfaction of the tax withholding obligations on stock-based awards granted under the Firm’s stock-based compensation plans during the three months ended September 30, 2020.
2.
Share purchases under publicly announced programs are made pursuant to open-market purchases, Rule 10b5-1 plans or privately negotiated transactions (including with employee benefit plans) as market conditions warrant and at prices the Firm deems appropriate and may be suspended at any time. On April 18, 2018, the Firm entered into a sales plan with Mitsubishi UFJ Financial Group, Inc. (“MUFG”). See Note 17 to the financial statements for further information on the sales plan.
3.
The Firm’s Board of Directors has authorized the repurchase of the Firm’s outstanding stock under a share repurchase program (the “Share Repurchase Program”) from time to time as conditions warrant and subject to regulatory non-objection. The Share Repurchase Program is a program for capital management purposes that considers, among other things, business segment capital needs, as well as equity-based compensation and benefit plan requirements. The Share Repurchase Program has no set expiration or termination date.
 
Share repurchases by the Firm are subject to regulatory non-objection. On June 27, 2019, the Federal Reserve published summary results of CCAR and the Firm received a non-objection to its 2019 Capital Plan. The Firm’s 2019 Capital Plan includes a share repurchase of up to $6.0 billion of its outstanding common stock during the period beginning July 1, 2019 through June 30, 2020. On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs. As a result, $1.7 billion of share repurchase authorization expired unused on June 30, 2020. On June 25, 2020, the Federal Reserve published summary results of CCAR and announced that large BHCs, including the Firm, generally would be restricted in making share repurchases during the current quarter, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020. For further information, see Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests.”


 
91
September 2020 Form 10-Q


Controls and Procedures
Under the supervision and with the participation of the Firm’s management, including the Chief Executive Officer and Chief Financial Officer, the Firm conducted an evaluation of the effectiveness of the Firm’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Firm’s disclosure controls and procedures were effective as of the end of the period covered by this report.
No change in the Firm’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) occurred during the period covered by this report that materially affected, or is reasonably likely to materially affect, the Firm’s internal control over financial reporting.
Exhibits
Exhibit No.
Description
 
 
3.1
 
 
10.1
 
 
15
 
 
31.1
 
 
31.2
 
 
32.1
 
 
32.2
 
 
101
Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”).
 
 
104
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).

September 2020 Form 10-Q
92
 


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
MORGAN STANLEY
(Registrant)
 
 
By:
/s/ JONATHAN PRUZAN
 
Jonathan Pruzan
Executive Vice President and
Chief Financial Officer
 
 
By:
/s/ RAJA J. AKRAM
 
Raja J. Akram
Deputy Chief Financial Officer,
Chief Accounting Officer and Controller


S-1

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
3/21/31
12/31/22
10/6/21424B2,  FWP
7/1/21424B2,  FWP
4/1/21424B2,  DEF 14A,  DEFA14A,  FWP
3/31/2110-Q,  13F-HR,  424B2,  FWP
11/23/20424B2,  FWP
11/13/2013F-HR,  424B2,  FWP,  SC 13G
Filed on:11/3/204,  424B2,  FWP,  SC 13G
11/2/20424B2,  FWP
10/30/20424B2,  FWP
10/20/20424B2,  FWP
10/15/20424B2,  425,  8-K,  FWP
10/8/20424B2,  425,  8-K,  FWP
10/7/20424B2,  FWP
10/2/203,  4,  424B2,  8-K,  FWP
10/1/20424B2,  FWP
For Period end:9/30/2013F-HR,  424B2,  FWP,  SC 13G
9/17/20424B2,  FWP
9/15/20424B2,  FWP
9/4/20424B2,  FWP
9/2/20424B2,  FWP
7/24/20424B2,  FWP
7/15/20424B2,  FWP
7/1/20424B2,  FWP
6/30/2010-Q,  13F-HR,  424B2,  FWP
6/29/20424B2,  8-K,  FWP
6/25/20424B2,  FWP
6/22/20424B2,  FWP
6/19/204,  424B2,  FWP,  SC 13G
5/21/20424B2,  8-K,  DEF 14A,  FWP
5/12/20424B2,  FWP
4/22/20424B2,  FWP
4/16/20424B2,  425,  8-K,  FWP
4/6/20424B2,  FWP,  SC 13G
4/1/20424B2,  FWP
3/31/2010-Q,  13F-HR,  13F-HR/A,  25-NSE,  424B2,  FWP
3/27/20424B2,  FWP
3/26/20424B2,  FWP
3/20/20424B2,  FWP,  SC 13G
3/19/20424B2,  FWP
3/15/20
2/27/2010-K,  424B2,  FWP
1/31/204,  424B2,  FWP
1/1/20
12/31/1910-K,  11-K,  13F-HR,  424B2,  FWP,  SC 13G
9/30/1910-Q,  13F-HR,  4,  424B2,  FWP
7/15/19424B2,  FWP
7/1/19424B2,  FWP
6/30/1910-Q,  13F-HR
6/28/19424B2,  FWP
6/27/19424B2,  8-K,  FWP,  SC 13G
6/4/194,  424B2,  FWP
3/7/19424B2,  FWP,  SC 13G,  SC 13G/A
1/25/19424B2,  FWP
1/24/19424B2,  FWP
1/17/19424B2,  8-K,  FWP
12/31/1810-K,  11-K,  13F-HR,  FWP,  SC 13G
12/21/18424B2,  FWP,  SC 13G
12/20/184,  424B2,  FWP
10/19/18424B2,  FWP
9/13/18424B2,  FWP
4/26/184,  424B2,  FWP
4/18/18424B2,  8-K,  FWP,  SC 13D/A
1/23/17424B2,  FWP
12/11/15424B2,  FWP
1/23/154,  424B2,  FWP
9/23/14424B2,  FWP
2/28/1110-K,  424B2,  FWP
7/15/10424B2,  CORRESP,  FWP
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  Morgan Stanley                    10-K       12/31/23  224:45M
 2/24/23  Morgan Stanley                    10-K       12/31/22  227:50M
 2/24/22  Morgan Stanley                    10-K       12/31/21  225:51M
 5/26/21  Morgan Stanley                    S-8         5/26/21    4:80K                                    Shearman & Sterling LLP
 2/26/21  Morgan Stanley                    10-K       12/31/20  225:50M
 1/29/21  Mirror Merger Sub 2, LLC          8-K:7,9     1/29/21   11:4.2M                                   Broadridge Fin’l So… Inc
 1/29/21  Morgan Stanley                    424B3                  1:3.5M                                   Broadridge Fin’l So… Inc
 1/19/21  Morgan Stanley                    S-4/A                  9:4.2M                                   Broadridge Fin’l So… Inc
12/04/20  Morgan Stanley                    S-4                    7:3.7M                                   Broadridge Fin’l So… Inc
Top
Filing Submission 0000895421-20-000527   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 8:55:40.4am ET